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ABSTRACT
Fluorescence methods for disease diagnosis and detection of important analytes are
becoming popular route as a technique, as they offer a simple non-invasive approach. Recently,
many novel fluorophores and probes have been reported for selectively and sensitively detecting
low abundance biological species in disease pathways.
Biological thiols, such as glutathione, cysteine, and homocysteine, along with the smallest
member hydrogen sulfide, are key thiol analytes in biological environments, and they play a vital
role in living systems by maintaining the redox homeostasis of cells. Alteration of their ratios can
cause cellular dysfunction and cell death. Furthermore, thiol levels in cells and biological fluids
act as biomarkers of several diseases, including neurodegenerative disorders, liver disease, cystic
fibrosis, pulmonary and cardiovascular diseases, and Alzheimer’s disease. Thus, the
development of efficacious methods for detection and quantification of biological thiols has
received significant attention in recent years. Although many traditional thiol detection methods
are available, fluorescent methods hold more promise for simple, non-invasive detection with
simple instrumentation.
The work presented in this dissertation discusses the successful fluorescent detection of
biologically important thiols with two probes HMBQ-Nap 1 and DCM-Cys. The HMBQ-Nap 1
probe consists of a hydroxymethyl benzoquinone trigger group (HMBQ) and 4-amino-9-(nbutyl)-1,8-naphthalimide (Nap 2) as the reporter dye. This probe led to excellent class selective
detection of the free thiols glutathione, cysteine, and homocysteine versus other analytes found
in the body. The second probe, DCM-Cys, is composed of a cysteine-selective acrylate moiety
attached to dicyanomethylene-4H-pyran (DCM) reporter dye via a benzyl alcohol linker. DCMCys exhibited a remarkable ability to detect free cysteine in media versus other thiols and various
potent analytes found in biological environments. Both HMBQ-Nap 1 and DCM-Cys offer nM in
vitro detection, and successful in cyto imaging of thiols. Selectivity, a relative low limit of
detection (nM), the ability to function under physiological conditions and a high signal-tobackground ratio of these methods as well as low thiol-to-probe ratios for the qualitative and
quantitative detection, and relatively short response time make these probes excellent systems for
thiol analysis.

ix

CHAPTER 1
INTRODUCTION
1.1 Research Goal and Aims
Precise understanding and monitoring of the molecular causes, effect, and signature of a
disease are essential for increasing the advancement of modern medicine. Personalized
treatments directed at highly specific disease sub-states now influence insight into the molecular
origin and signature of these disorders.1 The ever-growing demand on advanced treatment
options puts more burden on the development of advanced, easy-to-operate early diagnostic
techniques. The objective of small molecule-based reporter systems is to assist specific detection
of biochemical signatures in living cells or organisms with minimal interruption to native
physiological processes. The expression levels of target molecules, such as a protein receptor or
the activity of a disease-related specific analyte, or in other words “biomarkers”, can be used
diagnostically to give information about a disease state, such as disease staging or predicting
responses to specific therapies.2 Small molecule-based fluorescent reporters such as thiol
detecting agents, possess superior advantages over other traditional methods in that they
facilitate non-invasive live cell detection and provide cost-effective simple instrumentation.
Therefore, the main goal of my research is to build a reliable set of small-molecule fluorescent
probe systems that can detect and quantify cellular thiols in vivo and in cyto with a relative short
analysis time.
In living systems, thiols are found as cysteine and derived molecules of cysteine possessing
low and high molecular weights. Specifically they can be divided into two main categories:
protein-based thiols with high molecular weights and small molecular weight non protein thiols.3
There is a growing interest in the importance of thiol physiology, and in the number of
physiological functions involved these small but crucial molecules. Given their effective redox
capabilities, and their high intracellular concentration and prevalent distribution, the role of thiols
as a potent defense agent against oxidative and electrophilic stress is well established.4 -Lglutamyl-L-cysteinylglycine (glutathione or GSH), cysteine (Cys) and homocysteine (Hcy) are
the main non-protein thiols found in the body. In proteins, cysteine accounts for 3% or less of the
its amino acid composition, and cysteine is responsible for almost all the protein thiols found in
mammalian cells.4
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The main thiol/disulfide couples in cells are glutathione/glutathione disulfide (GSH/GSSG),
cysteine/cystine (Cys/CySS), and the thioredoxins (Trx) enzyme systems. Out of these, GSH is
the most abundant non-protein thiol present in all mammalian tissues at 1–10 mM concentrations
intra-cellularly, and it acts as the main defense against oxidative stress. In addition, GSH plays a
key role in many other regulatory pathways, including cellular proliferation and apoptosis, and
the post-transcriptional modification of proteins through S-glutathionylation.5 Furthermore
GSH’s are also important in the detoxification of hydroperoxides and diverse xenobiotic
compounds.5 Also, GSH has been proven to be vital to mitochondrial function and maintenance
of mitochondrial DNA and may be relevant to DNA methylation.6 Given the diverse roles of
GSH in cellular physiology, the clinical importance of altered glutathione homeostasis is gaining
significant attention. GSH homeostasis variations have been implicated in neurodegenerative
disorders, liver disease, cystic fibrosis, pulmonary and cardiovascular diseases, as well as chronic
age-related disorders such as Alzheimer’s disease.6 On the other hand, homocysteine and
cysteine are both precursors of glutathione, and they play a crucial physiological role in the
body. Bioavailability of cysteine limits the rate of GSH synthesis in cells.6 Abnormal levels of
Cys are associated with many diseases, including slow growth, hair depigmentation, skin
lesions,7 and cystinuria, the latter being a common heritable disorder of amino acid transport.8
Moreover, the cysteine residue plays a major role in protein functionality in cells, although it is
one of the least abundant amino acids incorporated into proteins in many organisms. It is found
to concentrate in functionally important positions of protein backbones, such as the active site of
enzymes.9

Importantly, redox-active enzymes, such as thioredoxins (Trx), have catalytic

activities that depend on the reactivity of the Cys residue in their active site. Homocysteine, on
the other hand, is a well-known risk factor for atherosclerosis and premature cardiovascular
diseases, birth defects, and hyperhomocysteinemia.7-8
Given the importance of small molecule-based reporter systems, the first aim of this research
is to invent the properties of novel redox active moiety—hydroxymethyl benzoquinone (HMBQ)
as potential trigger for targeted delivery of molecules. The kinetics of quinone methide formation
by HMBQ and self-immolation ability of the attached probe releasing the reporter was
investigated using absorption and NMR spectroscopies. As the next aim of this project, two
different fluorescent probes were synthesized and characterized to selectively detect and quantify
non protein cellular thiols. In Figure 1.1 it shows the basic design strategy of the thiol-reporter
2

system. It basically consists of a reporter dye whose fluorescence is quenched by thiol-reactive
moiety that is attached to the reporter dye. Upon reacting the thiol-targeted trigger group
(reactive moiety) with thiols, chemical alteration of the thiol-reactive moiety causes unmasking
of the fluorescence, giving rise to a bright reporter signal. The fluorophore choices for the thiol
reporter systems were 4-amino-9-(n-butyl)-1,8-naphthalimide and dicyanomethylene-4H-pyran
due to their excellent photo-physical properties. The first probe I synthesized contains 4-amino9-(n-butyl)-1,8-naphthalimide reporter (Nap 2) attached to a hydroxymethyl benzoquinone
(HMBQ) trigger group, which is a potential reactive site for thiols. The 4-amino-1,8napthalimide and its derivatives are conventional fluorescent dyes used in fiber materials and
polymers, and they have recently become well-known in the development of biological sensing
and imaging probes.10 They have interesting optical properties, such as strong absorption and
emission in the visible region (green), and large Stokes shifts (difference in absorption and
emission energies). Their fluorescence can be modulated through intramolecular charge transfer
(ICT) events. The latter feature is important for the design of the probe in my work. 11 As a result
of the ICT nature of the dye once the HMBQ trigger group is attached, the thiol probe should
have its fluorescence completely quenched.

Figure 1.1 Schematic representation of the basic concept of thiol detection with a triggarable
probe.
The next probe I synthesized has a dicyanomethylene-4H-pyran (DCM) as the reporter
fluorophore. Similar to Nap, DCM is also an ICT dye with remarkably large Stoke shift (> 100
3

nm). Therefore, once attached to the potential reactive site, the initial fluorescence will be
altered. Unmasking of the fluorescence will happen only with the elimination of the reactive
moiety, thereby resulting in a lower background signal. DCM also has good fluorescence
brightness, with its emission in the red region, and it also has a very high photostability in
comparison to other NIR dyes that are being used in the literature.12-13 The cysteine selective
probe has a DCM dye attached to an acrylate moiety via a short benzyl alcohol spacer. The probe
is designed to utilize both the sulfhydryl group and the amine group of Cys in a nucleophilic
addition and subsequent cyclization reactions. Upon cyclization, the benzyl alcohol linker
undergoes elimination, leading to release of the reporter dye DCM.14
The second aim of this project is characterization of the optical properties of each of the
probes synthesized and determination of the effectiveness of these probes to act as potential thiol
sensors. The quantum yields of the free reporters and probes are determined in order to assess the
efficiency of PeT quenching. To determine the quantum yield of the free dye and the probe, the
fluorescence signal was compared to known standards. To check the thiol sensing ability of these
probes, solution-phase, fluorescence-based analysis with each thiol was conducted. For the
quantitative determination of thiols, the necessary calibration curves were constructed. To
determine the potential cross reactivity with other analytes, the fluorescence change of the probes
were tested in the presence of excess of other commonly found interferrents (e.g. NADH, amino
acids, ascorbic acid, enzymes, etc.). The solution-phase stability of these probes were also tested
by incubating aqueous solutions of theses probes at 25 °C/ 37 °C. Finally, in order to produce
evidence for the elimination mechanisms, NMR kinetic experiments and mass spectral data after
reacting with each of the corresponding analytes was examined.
The ultimate objective of this research is the determination of the capability of these probes
to detect thiol levels in cellular media. To achieve this objective, suitable cancer cell lines with
up-regulated thiol levels were incubated with each probe, and probe ability to image these cells
were determined using confocal microscopy. As a control experiment, thiols in the cells were
scavenged by incubating the cells with a known thiol capturing agent N-ethylmaleimide, then the
fluorescence change was monitored by incubating these cells with the corresponding thiol probe.
The collective information obtained through this work demonstrates the potential ability of
two novel fluorescent probes to detect thiols in a cellular environment, with high selectivity and
sensitivity. In the long run, I believe that these two probes will diversify the pool of growing
4

research aimed at developing new methods, probes, and tools to image specific molecular targets
that can act as biomarkers of disease conditions in the body.

1.2 Biosynthesis of Glutathione and the Metabolic Relationship with Other Thiols
Methionine (Met) and cysteine (Cys) are the main precursors for the synthesis of glutathione
(GSH) in the body (Figure 1.2).15 The first step involves converting methionine to an
intermediate compound named as S-adenosylmethionine (AdoMet); a universal methyl donor in
transmethylation reactions in the presence of adenosine triphosphate (ATP). This process is
catalyzed by the enzyme methionine adenosyltransferase (MAT). The transfer of the methyl
group from AdoMet by a variety of methyltransferases (MTs) yields the intermediate compound
S-adenosylhomocysteine (AdoHcy) that is rapidly hydrolyzed to adenosine and homocysteine via
the enzyme SAHH (S-adenosylhomocysteinehydrolase). The generation of Hcy is a critical
juncture in the sulfur cycle, because it can either be methylated to regenerate methionine, or it
yields cysteine and H2S in the transsulfuration pathway. The transsulfuration pathway is
composed of two enzymatic steps. In the first step, Hcy (Figure 1.2, compound 2) is condensed
with serine to form cystathionine in a reaction catalyzed by cystathionine -synthase (CBS). This
is followed by the cleavage of cystathionine to -ketobutyrate, ammonia, and cysteine (Figure
1.2, compound 1) in a reaction catalyzed by -cystathionase (CSE). In mammalian tissues, the
transsulfuration pathway is irreversible, and as a result, Cys cannot be converted back to
methionine. Finally, GSH (Figure 1.2, compound 3) is synthesized from cysteine in two ATPdependent enzymatic steps.

Figure 1.2 Schematic representation of GSH biosynthesis and the metabolic relationships of
sulfur analytes in the GSH biosynthesis pathway.4
5

In the first step, -glutamylcysteine is produced from glutamate and cysteine, catalysed by
the enzyme -glutamate-cysteine ligase (GCL), this is considered to be the rate-limiting step in
GSH synthesis. In the final step, GSH is produced by combining -glutamylcysteine and glycine
in a reaction catalyzed by the enzyme GSH synthetase. The reactivity of GCL is subject to
feedback inhibition by GSH which controls the bioavailability of GSH.16-20

1.3 Antioxidant Function and Redox Signaling of GSH
1.3.1 Reactive-oxygen and Reactive-nitrogen Species (ROS/RNS)
ROS and RNS are often small molecules responsible for mediating redox modifications of
various biomolecules, and thus they play a lead role in many diseases, including cancer,
neurodegenerative diseases, and diabetes.21 The overproduction and/or mismanagement of ROS
in cells lead to the general phenomenon of oxidative stress that is implicated in many diseases.
−·

Superoxide ([O2] ), hydrogen peroxide (H2O2), hypochlorous acid (HOCl), singlet oxygen (1O2),
lipid peroxides (ROOH), ozone (O3), and hydroxyl radical ([OH]·) are some of the major ROS in
living systems.22 Although less common than ROS, reactive nitrogen species (RNS), such as
nitric oxide ([NO]), are also important to human physiology. These RNS can react with ROS to
form oxidants such as peroxynitrites (ONOO−), known for their cytotoxic function.22-24
The organelles with localized ROS generation for physiology include phagosomes within
specified cells of the immune system for killing pathogens and peroxisomes that mediate
catabolic oxidation reactions for energy metabolism. In addition, the three other major locations
for ROS generation are the mitochondria, endoplasmic reticulum (ER), and cell membranes.22
The electron-transfer chain (ETC) in mitochondria results in electron transfer from NADH and
succinate along a controlled redox path that results in the four-electron reduction of O2 to H2O
during ATP synthesis. Nevertheless, the flow of electrons through the ETC is an imperfect
process, and occasionally oxygen molecules undergo one or two-electron reduction reactions to
form ROS, especially H2O2 and [O2]−· (Figure 1.3).25 The major source of ROS from the ER
results from oxidative protein folding. Folding proteins often undergo enzyme-catalyzed
disulfide formation using O2 as a two-electron acceptor to form one equivalent of H2O2 for each
disulfide bond formed, creating a strong flux of ROS inside the ER. In addition, the ER can also
house an isoform of NADPH oxidase (NOX4)26-27 that generates H2O2 from O2. Another source
of ROS is cell membrane-localized NOX and their dual oxidase relatives (Duox), that are
6

localized in various cellular membranes.22, 28 In order to keep these ROS/RNS below the toxic
threshold and maintain a healthy environment inside cells, they implement an antioxidant
defense mechanism. This is composed of two main systems that play a leading role, including
GSH/GSSG thiol system and the Trx/TrxR enzyme system.5, 9

Figure 1.3 Generation of ROS and RNS during the mitochondrial respiratory chain and their
physiological effect in normal and pathological conditions.25
1.3.2 Antioxidant Function of GSH
The antioxidant function of GSH is facilitated by GSH peroxidase (GPx)-catalyzed reactions.
As a result, hydrogen peroxide radicals and lipid peroxides are reduced, while GSH is oxidized
to GSSG (Figure 1.4). Then the oxidized GSSG, in turn, is reduced back to GSH by GSSG
reductase through NADPH consumption to make NADP+. This mechanism is particularly
important in the mitochondria as a defense against both physiologically– and pathologically–
generated oxidative stress.29-31
The GSH to GSSG ratio largely determines the intracellular redox potential (proportional to
the log of [GSH]2/[GSSG]). Therefore to prevent a major shift in the redox equilibrium when
oxidative stress overcomes the ability of the cell to reduce GSSG back to GSH, the GSSG can be
actively exported out of the cell or react with a protein sulfhydryl group, leading to the formation
of a mixed disulfide. Hence, severe oxidative stress depletes cellular GSH as it oxidized to
GSSG (Figure 1.4).3, 5
7

Figure 1.4 Antioxidant and redox signaling function of GSH inside the cell.5
1.3.3 Role of GSH for Redox Signaling in Cells
The effect of reactive species (e.g. ROS or RNS) can range from cellular damage to subtle
effects on cell metabolism, morphology, or signaling pathways. Especially at lower
concentrations, these reactive species act more as function regulators than damaging species.
The overall impact of a reactive species on a cellular function varies greatly with the type of
reactive species, cell type, level of endogenous antioxidant, or antioxidant enzymes present, as
well as extracellular environment.32 For example, reactive species, such as NO and H2O2, are
known to activate several transcription factors and protein kinases. As shown in Figure 1.4 GSH
regulates redox-dependent cell signaling. 33-34 GSH can reversibly bind to the free –SH groups of
protein cysteinyl residues (Prot-SH) by a process called glutathionylation, generating
glutathionylated proteins (Prot-SSG). This process can either activate or inactivate the
corresponding protein, which can be responsible for several downstream processes in cells.
These cellular proteins that are constantly undergoing thiol modification are an important part of
cellular housekeeping, and they are involved in key cellular signaling cascades.35 Also, these
mechanisms protect sensitive protein thiols from irreversible oxidation and also serve to prevent
depletion of GSH under oxidative conditions.32 Once the cellular conditions are back to normal
deglutathionylation can occur through glutaredoxin and sulfredoxin enzyme-catalyzed reactions
using GSH as a reductant. As mentioned earlier, many transcription factors and signaling
8

proteins have critical cysteine residues that can be oxidized by ROS and RNS. These reactive
species regulate protein function and cell signaling that can be modulated by GSH.5, 35-36

1.4 Functional Role of Cysteine in Biological Systems
In addition to free cysteine being a crucial intermediate in GSH biosynthesis, and the
regulation of redox function in cells and disease biomarkers, protein-bound cysteines also play a
diverse and yet prominent role in the body. As shown in Figure 1.5, cysteines contribute to the
regulatory activity of several protein kinases, by forming structural disulfides, acting as
nucleophilic catalysts, and binding to metal ions in detoxifications as well as structural
stabilization of the proteins.9, 37-38

Figure 1.5 Diverse role of protein-bound cysteine in biological systems.9

The anionic thiolate form of cysteine acts as a ligand and binds strongly to several metal
ions, including Fe2+/3+, Zn2+, Cd2+ and Cu+. Due to its ability to adopt a wide range of oxidation
states (−2 to +6),9 sulfur is able to accommodate a large number of bonds and geometries,
leading to a very diverse set of metal-protein complexes.23 These metal-bound cysteines are
generally unreactive, as the cysteine is tightly coordinated to the metal, but they are usually
reactive in the unbound state in the protein. This has been utilized as a regulatory pathway of
9

enzyme activity. As another function, cysteines are involved in regulatory activity of catalytic
reactions. However, regulatory cysteines are not directly involved in catalysis, due to their
proximity to the active site or surfaces involved in essential protein-protein interactions.
Moreover Cys-containing proteins can act as redox catalytic enzymes, and they are called
oxidoreductases. Thioredoxin, a typical member of the thiol oxidoreductase family plays a vast
role in conjunction with GSH, to maintain the redox balance in cells. As shown in Figure 1.6, the
thioredoxin system is composed of thioredoxin (Trx) together with thioredoxin reductase (TrxR)
and NADPH. The active site of human Trx contains two cysteine residues at positions 32 and 35,
and it acts as the hub for many redox catalysis reactions. Upon reduction of a disulfide bond in a
substrate protein, the two redox-active cysteines in Trx undergo reversible oxidation to form an
intramolecular disulfide bond. When TrX is oxidized, it is then recycled to the reduced state
through the simultaneous action of TrxR and NADPH (Figure 1.6).9

Figure 1.6 Thioredoxin (Trx)/Thioredoxin reductase (TrxR) system in redox modulation.9

Not only the Trx/TrxR system, but many enzyme active sites contain cysteine residues that
serve as catalytic nucleophiles. This is mainly due to the reversible oxidation, and reduction
ability of these motifs; however, the overall oxidation state of these units remains unchanged
during the catalytic cycle. Most of these cysteine residues tend to be highly conserved across
related species, and they are found in a variety of enzyme classes.9, 23

1.5 Functional role of H2S in Biological System
1.5.1 Gasotransmitters in Cells
Gasotransmitters are important gaseous small molecules synthesized in cells that are
involved in regulating physiological functions and cellular signaling. Among them—NO, CO,
10

and H2S—are the most important known gasotransmitters, and they have attracted a great
amount of research interest.39 However, it is important to note, that until very recently, these
molecules were known only as toxic molecules or environmental pollutants until their
physiological and pathological role was revealed. Gasotransmitters have inverted the traditional
concept of intercellular communication. For instance, unlike other signaling molecules, gaseous
substances are not readily stored in vesicular structures or cells, and they must necessarily be
synthesized as needed.

40

. Instead of binding to plasma membrane receptors these gaseous

molecules are cell membrane-permeable; therefore they diffuse freely through the plasma
membrane to adjacent cells and interact with their targets.40

1.5.2 Gasotransmitter Characteristics
Nitric Oxide (NO)—NO was first identified as a mediator of two processes: i) relaxation of
blood vessels and macrophages and ii) activation of anti-inflammatory responses. Macrophages
that elicited tumorcidal and bactericidal activities involved a production of NO inside the cells.
The reaction of NO with superoxide generates peroxynitrites that kill bacteria and tumor cells.40
The second most important function is relaxation of blood vessels, involving activation of the
secondary messenger cGMP. NO activates the cGMP by forming an enzyme guanylcyclase by
binding to iron in the active site of the enzyme. In a similar fashion, NO also activates several
mitochondrial heme proteins and may also interfere with cellular energetics. NO also serves as
an intermediate in several other functions, S-nitrosylation of cysteine residues in proteins, and
modification of several ion channels.40
Carbon monoxide (CO)—CO is a colorless and odorless gas and is typically produced in
nature when carbon-containing compounds are only partially oxidized.41 The major source of CO
in the body is from the breakdown of heme by the enzyme hemeoxygenase. At high
concentrations, CO is toxic to animals, as it binds to hemoglobin about 200-times more strongly
than O2, and the resulting carboxyhemoglobin is no longer available for oxygen transport.41
Despite the toxicity at even lower concentrations, CO also has a similar reactivity as NO. CO
plays an important role as a cell signaling molecule and neurotransmitter, hormone release, also
as a cytoprotective agent, and in the regulation of vascular tone.42-43 CO is involved in several
important anti-inflammatory pathways by upregulating anti-inflammatory cytokines, and it
prevents arteriosclerotic lesions by inhibiting smooth muscle cell proliferation. 44-45
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Hydrogen Sulfide (H2S)—H2S is the most recently identified high-valued major
gasotransmitter, and it joins CO and NO as important signaling molecules in the body. Similar to
CO and NO, at high concentrations H2S is toxic; about five times more than CO.46 Though only
recently recognized as being formed under physiological conditions in mammalian cells, H2S has
been known to exist in animal tissues for many years. H2S is also known as the smallest member
of the thiol family, and it is produced as a byproduct of glutathione synthesis.47 Being the
smallest member of the thiol family, the importance of H2S and its physiological role will be
briefly discussed below.

1.6 H2S Metabolism in Cells
As shown in Figure 1.7, the major sources of H2S are from cysteine via the GSH metabolism
pathway, methionine and dietary cysteine/cystines. These precursor molecules enter cells via
specific transporters and go through a biochemical pathway that leads to the synthesis of H2S as
a byproduct.

Figure 1.7 Pathways of H2S metabolism. Cysteine metabolism from methionine, and dietary cyst
(e)ine that enter cells via transporters, leads to H2S production.47

H2S is basically derived from three main sulfur sources in the pathway. This includes
cysteine, cystine, and 3-mercaptopyruvate. The enzyme 3-mercaptopyruvate sulfurtransferase
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(Figure 1.7, MST) and 2-cysteine aminotransferase (Figure 1.7, CAT) produce H2S from 3MP.
One of the two important H2S enzymes—cystathionine--synthase (Figure 1.7, CBS) catalyzes
the -replacement of cysteine with homocysteine (Hcy) to generate H2S and the corresponding
thiol ether (Hcy-S-Cys). A second enzyme cystathionine--lyase (Figure 1.7, CSE), catalyzes disulfide elimination on cystine, the product of this reaction reacts with available thiols (e.g.
Cys) to generate H2S and a disulfide.47-48

1.7 Functional Role of H2S in Cells
1.7.1 H2S as a Signaling Molecule
H2S participates in cellular signaling pathways49 by modifying proteins through a process
called protein persulfidation.50-52 Due to the strong nucleophilic properties of H2S, persulfidation
can occur by direct nucleophilic attack of the sulfide anion on an oxidized cysteine. Depending
on the type of protein and the site where it is persulfidated, the activity of proteins is up regulated
or down regulated. For example, persulfidation of the active site cysteine in protein tyrosine
phosphatase inhibits its activity, resulting in a buildup of phosphorylating endoplasmic reticulum
kinases, which enhance the cellular response to endoplasmic reticulum (ER) stress.53
Persulfidation of ATP-sensitive potassium channels results in channel opening and
hyperpolarization of endothelial smooth muscle cells, leading to vasodilation.16,

46,

54

Sulfhydration of various electrophiles, including 8-nitro-cyclic GMP (nitro derivatives of
unsaturated fatty acids and cyclopentenone prostaglandin) provides an additional molecular
mechanism for H2S signaling. Another mechanism for H2S-mediated signaling is through its
interactions with metal centers in the active sites of proteins. Depending on the stereo electronic
characteristics of these centers, H2S can be reduced or it will coordinate to the metal and modify
the activity of the protein.

1.7.2 Physiological Effect of H2S
H2S shows its effect on several important sites in the body, including the cardiovascular
system, central nervous system (CNS), and endoplasmic reticulum (ER) of cells, and it also plays
a role in anti-inflammatory action, as shown in Figure 1.8.48 Similar to other members of the
gasotransmitter family, H2S also dilates blood vessels in the body. H2S vasodilation largely
depends on hyperpolarization elicited by opening ATP-sensitive potassium channels (KATP).42
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Due to the promising cardiovascular action of H2S, a variety of drugs have been developed based
on this gasotransmitter. Some are simple H2S donors, although some structures are combined
with anti-inflammatory drugs or classic vasodilators.49 H2S can affect the synaptic potential and
concentration of neurotransmitters, like epinephrine, norepinephrine, and serotonin in the central
nervous system.55 In particular, H2S can act as a neuro protectant in the central nervous system
by increasing production of GSH and suppressing mitochondrial oxidative stress.16 The
beneficial effect of H2S on the ER is alleviating the stress response56-57 induced during the
special protein folding taking place in ER. H2S inhibits specific protein kinases that govern this
process, by changing the oxidative potential in the ER lumen.53,

58

The anti-inflammatory

influences of H2S have led to discoveries of new therapeutic agents. Classic non-steroidal antiinflammatory drugs (NSAIDs) often cause gastric irritation in patients by inhibiting
prostaglandin formation, which is the cyto-protectant of gastric mucosa.47 H2S reduces mucosal
inflammation and protects the gastrointestinal mucosa from injury and also enhances tissue
repair.59-60 Upon comparison of naproxen and its H2S-linked derivative, the latter exhibits
comparable therapeutic efficacy with reduced gastric damage;61-62 similarly, several other
NSAIDs have also been combined with H2S donors to improve therapeutic effects.62

Figure 1.8 Involvement of H2S in various physiological and pathological functions.48
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1.8 Fluorescence Technologies for Biochemical Sensing
The platform is diverse for molecular imaging capabilities available via small molecules,
fluorescence proteins, and polymeric nanoparticles for the detection of low-abundance
biomarkers of a disease pathway.63 The effort continues toward improving traditional imaging
and detecting technologies in order to obtain advanced capacity for rapid identification of
chronic conditions that require continuous monitoring. Molecules functionalized with
fluorescence moieties remain one of the best methods for analyte detection due to their simple
architecture. As shown in Figure 1.9, molecules including glycosides, peptides, aptamers,
antibodies and nanoparticles bound to fluorescent dyes can be used to design “smart probes”.64
Each of these diagnostic techniques has their own specific application and specific design that
are promising for clinical and biomedical applications; hence, a short description of each of the
methods follows below.

Figure 1.9 Five classes of molecular-specific optical contrast agents in the order of increasing
size.64
1.8.1 Peptide and Protein Based Fluorescence Sensing
Peptides are particularly useful as surrogates of whole proteins, especially when site-specific
modification of or purification of a particular protein is impractical. Peptides are small enough to
be easily manipulated on the bench top using standard laboratory protocols and solid-phase
techniques.65 The polymeric nature of peptides facilitates the ability to add a select amino acid
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sequence with high affinity for a particular target. Peptide scaffolds, being intrinsically modular,
allow for the introduction of multiple fluorophores into their backbone while they retain the same
or virtually the same biological activity.66 A wide variety of sensors, such as proteins and
enzyme sensors, ion sensors and nucleic acid sensors, have been developed using peptide
scaffolds. An interesting approach to detect HIV antibodies using the peptide beacon (PB)
concept has been reported by Plaxco67 and coworkers. They attached a ruthenium(II)
bispyridine-phenanthroline to one end of the peptide as a fluorophore and methyl viologen as a
quencher to the other end. Similar to any unbound, unstructured polypeptide, the two labelled
ends collided with each other leading to quenching of the Ru(II) fluorophore. However when it is
bound to its target antibody, the peptide epitope adopts a rigid extended conformation. Due to
this binding-induced segregation of fluorophore and the quencher, the possibility of electron
transfer is decreased, leading to a 6-fold fluorescence enhancement that allows for the detection
of the targeted antibody (Figure 1.10).67

Figure 1.10 Schematic of PB architecture comprises a long-lived fluorophore, an electron
accepting quencher, and a recognition peptide.67
As a another peptide-based strategy; to detect collagenase protease activity in cells,
Mattoussi et al. connected quantum dots and a rhodamine dye by a short tetrapeptide that can be
cleaved by the effects of collagenase, giving rise to a different fluorescent output.68 This probe
showed remarkable selectivity towards the collagen protease versus other proteolytic enzymes,
such as thrombin, and chymotrypsin. Zhang’s group has used peptides modified with the NBD
(7-nitrobenz-2-oxa-1,3-diazol-4-yl) fluorogenic unit at the N-terminus to determine the natural
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binding location of a transcription factor (GCN4).69 Peptides can also be used as ion sensors;
Nitz and coworkers have used the 6-methoxyquinolinium fluorophore to detect chloride ions in
their cellular assays.70 Certain disadvantages of peptide probes are difficulty in cell
internalization, sensitivity toward vast amounts of proteases present in cells, and the need for
longer sequences to fold into stable three-dimensional structures limit their use in analyte
detecting probes.66
The discovery of proteins with strong visual fluorescence (“Fluorescent protein”, FP)71-72
have revolutionized protein labelling and in vivo detection. FPs are naturally occurring in marine
coelenterates, such as jelly fish and corals.71 The advantage of FPs for molecular imaging is, that
cells can be forced to express the gene encoding for a particular FP, which make the cells
fluorescent. Because these proteins are being made inside the cells in their natural environment,
toxicity issues are much diminished. The fluorescence of the FP can be modulated depending on
the cell environment or the presence of a special target. Tsien and coworkers were the first to
discover green fluorescent proteins, and his group has performed a great deal of work on FP as a
cellular probe. As shown in Figure 1.1172 the Tsien group has built up an entire library of FP
ranging from short wavelength emission to longer red emission derived from modified green
fluorescent protein (GFP) and red fluorescent protein (RFP).66, 71, 73 Lately many other groups
have attempted to use FPs for various analyte detections. For example recently Zhang et al. used
enhanced green florescent proteins to detect cancer cells (Ramos cells/human Burkitt lymphoma
cells) using a triplex molecular beacon. Plasmids74 with the specific gene code for expression of
GFP was transferred to cells, and cancer cells were identified depending on the expression level
of the protein.74

Figure 1.11 Emission color pallet of fluorescent proteins (FPs), ranging from the shortest
wavelength to the longest emission wavelength.72
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To investigate the specificity of this system, other cells were also incubated with plasmid,
and expression of GFP (eGFP) was measured. However eGFP fluorescent signal was only
observed in the target cells providing a promising route to detect cancer cells.75 As another
approach for GFP-mediated analyte detection, Ai and coworkers developed a modified GFP
probe, hs-GFP, for H2S detection by incorporating an H2S-reactive moiety in the

GFP

backbone.76 The probe exhibits good selectivity toward H2S versus other commonly found
oxidants in the body.77 The major disadvantages of fluorescence proteins include difficulty of
protein modification for specific chemical labelling, narrow wavelength range of proteins, poor
photo-stability, and the large time consumption required for expression in cells.66

1.8.2 Aptamer-based Fluorescence Sensing
Aptamers78 are single-stranded nucleic acids that can fold into 3-dimenssional structures so
as to bind to target molecules. Aptamers have attracted the attention of molecular-targeted
researchers due to their small size, high binding affinity for target molecules, and ease of
modification.79-82 Most aptamers are obtained through a combinatorial selection process called
systematic evolution of ligands by exponential enrichment (SELEX).83 As shown in Figure 1.12,
79

this SELEX process is a rather time-consuming process, it needs specialized

Figure 1.12 Schematic representation of isolation of aptamers using SELEX process. In this
example, the target molecule is immobilized on a bead to achieve separation.79
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instrumentation like PCR amplification and it involves tedious separation strategies. Hence,
these complex preparation steps are the main disadvantage of aptamer sensors. In addition,
aptamers can be the target of degradation by enzymes like RNAses84 and DNAses85-86 that are
commonly found in the body. Also the pH, ionic strength, and temperature, of the system and the
presence of matrix molecules greatly affect the success of the target binding.79 However, there is
a broad range of aptameric fluorescence sensors to detect analytes, such as peptides, small
molecules, proteins, and metal ions and also more complex targets, such as whole cells and
material surfaces.79 As reported by Lu and coworkers, a new DNA-based aptamer (Figure 1.13)
can be used for a label-free detection of analytes.87 A selected DNA aptamer with the appropriate
sequence was coupled to an additional sequence that served as a binding site for the fluorophore
(2-amino-5,6,7-trimethyl-1,8-naphthyridine).88 In the absence of the targeted analyte, the binding
site sequence was stabilized by intramolecular forces and fluorescence was suppressed.83, 87, 89

Figure 1.13 Target-oriented, label-free aptamer probe with fluorophore binding sequence
minimizes fluorescence in the absence of analyte.83
Upon binding the analyte, the aptamer underwent a structural change that resulted in
florescence emission. They have utilized this approach to synthesize several fluorescent probes
for metal ions (Pb2+, Hg2+, UO2+) and adenosine.89 Tan et al. reported an aptamer-based
fluorescence complex for protein detection in biological fluids. They have molecular engineered
a light-switching excimer aptamer for protein monitoring both in steady-state and time-resolved
fluorescence microscopy. The aptamer sequence that binds with high affinity to the target protein
(platelet-derived growth factor, PDGF-BB) is labeled with a pyrene molecule at both ends.
Binding of the aptamer to its target protein induces a conformational change in the probe,
resulting in two pyrene molecules in close proximity to form an excimer. This excimer formation
shifts the fluorescence, an event that can be easily detected. This method facilitates the direct
detection of target protein without any need for sample clean-up process.90
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1.8.3 Antibody-based Fluorescence Sensors
Antibodies can be easily modified covalently so as to be attached to a wide variety of
substrates without losing their antigen effect. Due to their high affinity, variability in target
binding, and remarkable biocompatibility, antibodies are an ideal candidate for bio-molecular
imaging and analyte detection.91-92 One of the first labelling techniques for antibodies were
iodine and other radioactive isotopes, and for non-radiative labeling, biotin was used. More
recently labelling with small-molecule fluorophores like fluorescein, cyanine 5/7, and
Alexafluor, and bioluminescence, has emerged for cellular and in vivo detection of targets. There
are many variants of antibody assays available; however, two main types are “label-based”
assays and “sandwich-based” assays. In label-based assays, target proteins are labeled with a
fluorescent tag that allows detection after capture by an immobilized antibody. The sandwich
assay involves immobilized antibodies, that capture unlabeled proteins, and the captured proteins
are detected by a secondary antibody possessing a fluorescent tag. Sandwich assays are more
specific and sensitive because two antibodies target the same analyte.93 Antibody-based probes
are particularly useful for cancer-targeted diagnosis, especially in vivo cancer imaging.94-95
Rosenthal and coworkers used an anti-EGFR (epidermal growth factor receptor) antibody
labelled with Cy 5.5 fluorophore for in vivo detection of tumors in mice. The analysis of images
showed the probe selectively accumulates in the tumor region.96-97 Due to increased deep-tissue
penetration and low autofluorescence, Zou et al. used Cy 7 dye conjugated to both murine and
human CC49 (anti TAG-72) antibodies to image tumor-associated glycoprotein (TAG-72) in
colorectal cancer in mice. The data showed successful tumor-specific accumulation and longer
retention times at the tumor site than that for previously reported probes.98 Although widely used
in cancer therapies and other analyte detection there are a few drawbacks, such as loss of
recognition after conjugation with the fluorophore, lack of stability due to attack by the body’s
immune system, the loss of fluorescence signal after a dye conjugation needs to be addressed to
make antibody probes more beneficial.64

1.8.4 Nanoparticle-based Fluorescence Sensors
Recent advances with nanotechnology and nanomaterials have successfully contributed to the
development of many nanomaterial-based probes for medical and analytical purposes. Out of
numerous diagnostic techniques that are associated with nanomaterials, fluorescent nanoparticles
20

(NPs) have advantages over traditional techniques in relation to sensitivity, stability, and the
ability to be multiplexed99-100 in cellular imaging and analyte detection. Compared to the
traditional use of single organic dye probes, fluorescent NPs have been made by encapsulating
organic dyes in a particle matrix. These particles are much brighter than a single dye, and
therefore more photostable because the dye entrapment enhances its stability and
biocompatibility. In addition to the dye entrapment route, NPs such as quantum dots (QDs) are
intrinsically fluorescent with excellent optical properties. Nano particles can also be made out of
organic matrices such as polymers (polystyrene,101 acrylate derivatives102-103) or dendrimers. But
the majority of NPs are synthesized with inorganic materials like silica,104 semiconductor
quantum dots,105-106 magnetite,107 and noble metals such as gold, silver, and platinum. In
addition, carbon and silicon NPs have been used to make NPs.100 Wen et al. used peptidetemplated Au NPs to develop a real-time, label-free sensing approach for the detection of posttranslationally modified enzymes (PTM) and peptidases. Enzyme modification of the peptidase
causes significant fluorescence quenching, as shown in Figure 1.14. The chemical modification
destroys the peptide coating on Au NPs, and as a result, oxygen-mediated quenching and
oxidation of the fluorescent Au NPs took place more easily. The fluorescence decrease is a linear
function of enzyme concentration, allowing quantitative determination of the enzyme.108-110

Figure 1.14 Mechanism for peptide-templated Au NPs as a label-free sensor for posttranslationally modified enzyme.108
Both Frangioni and Prasad with their coworkers used Cd/Se/Te-based quantum dots with
NIR emission to facilitate cancer surgery via sentinel lymph node mapping. Frangioni’s group
used a polydentate phosphine coating to make the QDs soluble, dispersed, and stable in serum.
Injection of only 400 pmol of NIR QDs facilitated easy imaging of 1-cm deep sentinel lymph
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nodes in real time using 500-nm excitation and low power density.111 Lysine cross-linked
mercaptoundecanoic acid was used by Prasad and coworkers to coat their Cd quantum dots, and
they also successfully demonstrated the in vivo distribution of NPs in tumors, their clearance,
and the cytotoxicity of these quantum dots.112
One of the major disadvantages of NPs and quantum dots are their cytotoxicity. Toxicity of
NPs are closely associated with surface chemistries, size, dose, and the administration route of
the NPs. Frangioni and coworkers reported that in vivo behavior of QDs greatly depend on their
hydrodynamic size, and according to their observations, QDs smaller than 5.5 nm can be rapidly
cleared through renal excretion, whereas QDS larger than 15 nm accumulate in the liver and
spleen.113 Another concern with NPs, especially for in vivo applications, is their interaction with
matrix protein and other bio-macromolecules. Protein binding to NPs may induce conformational
changes and concomitantly alter NPs intended function. Dawson and coworkers reported the loss
of function of transferring receptor targeted silica NPs due to the binding of serum protein
(Figure 1.15).114

Figure 1.15 a) Schematic depiction of blocked transferrin-transferrin receptor interaction in the
solution phase in the presence of serum protein. b) Schematic representation of the loss of
targeting capability of transferring-conjugated NPs towards transferring receptor on the cell
surface in the presence of serum protein.114
1.8.5 Small-molecule-based Fluorescence Probes
Small molecule probes are one of the most indispensable tools in chemical biology and
medicine. Simple architecture and ubiquitous role they play as cellular stains, enzyme substrates,
bimolecular labels and environmental indicators are the greatest advantages of small molecular
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probes.115-117 When compared to other detection techniques, small molecules with organic
fluorophores have extreme modularity. They facilitate the attachment of various reactive
functional groups, substrate moieties, chelating components, and other chemical entities, to a
small number of “core” fluorophores to generate a diverse set of new molecular probes with
unique properties.118 As stability, fluorescence characteristics, and design of these “core
fluorophore” are well established, selection and design of a new class of probes are quiet
simplified. There are several endogenous molecules like quinine, certain amino acids,119 and
NADH120 that can act as natural fluorophores, especially at short wavelengths (UV region,
Figure 1.16).118 These natural fluorophores can sometime be useful, but most of the time, they
can be interfering with the emission of other synthetic fluorophores that give rise to tissue autofluorescence.121 The synthetic classes of fluorophores which are being synthesized and are
inspired by naturally fluorescent molecules, can be classified into several categories, such as
polycyclic

aromatics,

coumarins,

quinolines,

indoles

and

imidazoles,

rhodamines,

naphthoxanthenes, bodipys, cyanines and phthalocyanines (Figure 1.16).118

Figure 1.16 Commonly used organic fluorophores for probe synthesis with fluorophore
brightness (ϵ × Φ) vs the wavelength of maximum absorption (λmax); the color of the structure
indicates its wavelength of maximum emission (λem).118
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Fluorescence probes used for analyte detection primarily fall into two categories: “alwayson” probes and “off-on” (activatable) probes. Always-on probes have a constant fluorescence
signal, and as a result yield high background signals and limited signal contrast, especially in
cellular environments and in vivo. However, “off-on” probes are activated only at specific site
or only in the presence of specific analyte. These probes can offer significantly reduced
background signal, and improved contrast and sensitivity.122 The main routes towards
development of “off-on” activated probes are as shown in Figure 1.17—photoinduced electron
transfer (PeT) and Foster (or fluorescence) resonance energy transfer (FRET).123 PeT is electron
transfer to (or from) the fluorophore in the excited state from (or to) an electron donor (or
acceptor) moiety that is introduced in close proximity to the fluorophore. When PeT occurs, the
excited state of the fluorescent molecule is quenched, thereby decreasing the fluorescence
intensity.

Figure 1.17 Design strategies for fluorescence probes: a) General concept of activatable
fluorescence probes; b) Design concept for PeT-based fluorescence probes; and C) Design
concept for FRET-based fluorescence probes.123
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In the case of activatable fluorescent probes, the PeT mechanism is made inactive by
chemical reactions of the probe with target molecule, thereby unmasking the highly intense
fluorescence of the reporter dye (Figure 1.17 b). The second method, FRET, is a non-radiative
transfer of energy between two fluorescent molecules, with one molecule being a donor and the
second being the acceptor (Figure 1.17 c). When this process occurs, fluorescence of the donor is
weakened, allowing fluorescence from the acceptor to be prominent, even though the donor is
the one being irradiated. For efficient FRET, factors like spectral overlap of the donor and
acceptor and distance between the two fluorophores are important. As in the example in Figure
1.16 c, if the bond between the donor and the acceptor is disrupted, FRET is cancelled, thereby
restoring donor fluorescence.122-124 Both PeT and FRET mechanisms have been greatly exploited
by many researchers to develop activatable probes for different analytes, such as enzymes, metal
ions, and thiols, as well their application in cancer imaging.
As described before, the disadvantages of organic fluorophores are tissue absorbance and
interference from biological autofluorescence. Sometimes adverse side reactions of the probe or
the fluorophore with other biological analytes, and cellular toxicity, can also be an issue.

1.9 Fluorescence-based Detection of Important Analytes in the Body
Living organisms are composed of a diverse set of cells that are morphologically and
functionally different depending on the location, function, and organ in which they are located.
Each of these cells, regardless of what function they perform, contains an enormous variety of
biomolecules. The concentrations, chemical modification, and interaction of these molecules are
generally precisely controlled, both spatially and temporally. Alteration of these analytes can be
an indicator of disease state or a change in an important biological process in the body.125
Conventional clinical chemistry relies on the detection and measurement of a wide range of body
substances, including gases, electrolytes, hemoglobin, hydrogen ions, enzymes, metabolites,
hormones, vitamins, proteins, and therapeutic drugs. Monitoring of these disease biomarkers
provides an idea of disease progression, and the effect of therapeutic drugs, including the
assessment of eventual drug resistance effects.126 Compared to other detection methods, such as
radioisotope labelling, MRI, ESR, electrochemical methods, HPLC and GC/MS that are
currently used in clinical diagnosis, fluorescence imaging has many advantages. It enables highly
sensitive, noninvasive, and safe detection using simple instrumentation.125 As a result, there is a
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huge interest in developing fluorescence based sensors for the detection of various analytes
found in the body. In the following section, several important analytes, such as metal ions,
enzymes, NADH, glucose, pH, and ROS/RNS, and methods for their fluorescent detection will
be discussed.

1.9.1 Fluorescent Probes for Metal Ions
Metal ions play a critical role in fundamental processes of cells, including osmotic
regulation, catalysis, metabolism, and signal transduction.127 Group I and II metals, such as
sodium, potassium, calcium and magnesium, are highly abundant in most biological systems.
Transition metal ions, including copper, manganese, cobalt, nickel, and chromium, are often
found in trace quantities compared to group I and II metals but still play a critical role in
body.128-129 Out of many attempts reported in the literature, Zhu and coworker have developed
the 6-hydroxyindole BODIPY-based fluorescent probe (1-OH) for the detection of Zn2+ ions.130
The sensing mechanism of the probe is based on chelation-enhanced fluorescence upon Zn2+
binding to the Schiff-base ligand, where it deprotonates the phenol group to yield a chelate that
exhibits high fluorescence at wavelength around 680 nm. This sensor was used to locate Zn2+ in
the perinuclear area of the cytosol in living cells.130 Tang and coworkers131 developed a NIRfluorescent probe Cy-Cu, composed of a tricarbocyanine fluorophore and 2,2′-azanediyl-bis(Nhydroxyacetamide) as the Cu+ receptor ligand. When Cu+ binds to the receptor, the PET
mechanism is blocked, resulting in a fluorescent enhancement. The cell membrane-permeable
analog of Cy-Cu was used to detect labile Cu+ in living cells and mice. Tian et al. developed a
tricarbocyanine-based probe 132 for Hg2+ and CH3Hg+ ions. The response of these probes to Hg2+
depends on the strong thiophilic affinity of mercury. Release of the free dye by mercury presence
results in a large shift in absorption and emission maxima from 664 nm to 840 nm.129

1.9.2 Fluorescent Probes for pH Changes
Measuring intracellular or extracellular pH changes provides important information about the
nature of physiological or pathological processes.129 As acidic environments are generally
associated with inflammation and tumor progression, sensing even slight changes in pH is
important to build therapeutic targets.133 Achilefu and coworkers synthesized indolium cyanine
probe 1 as a pH indicator.134 The probe is non-fluorescent when unprotonated, but the probe
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becomes strongly fluorescent at 800 nm when an acidic environment is present. As another
strategy, Nagano and coworkers developed a cyanine dye attached to ethylene diamine and a
piperazine conjugate. This strategy involving tuning of the pKa values of the diamine moiety, to
provide an effective method to design and predict the ratiometric measurement of pH changes
over a wide range of pH, both in vitro and in vivo.135

1.9.3 Fluorescent Probes for the Detection of Enzymes
Fluorescence-based probes for the detection of enzyme activity are particularly attractive for
the easy, sensitive, and selective monitoring of enzymes behavior, that alter their expression
level as a result of a disease conditions. Numerous fluorescent probes have been developed for
determining the functional role of enzymes in the physiological environment.136-137 Nagano and
coworkers138 reported a glutathione-S-transferase (GST)139-140 activatable fluorescent probe
(DNAF) based on 3,4-dinitrobenzanilide and the 5– and 6– isomers of amino fluorescein.
DNAFs have shown excellent kinetic parameters on yielding fluorescence upon activation by
GST. In order to detect intracellular distribution of GST, the authors have synthesized DNATMe, which exhibited a dramatic fluorescence increase once exposed to cells with upregulated
GST.138 Peng et al. recently reported a novel “off/on” fluorescent probe targeting
cyclooxygenase-2 (COX-2) localized in the Golgi apparatus of cancer cells.141 The probe ANQIMC-6 consists of a green fluorescent dye at 560 nm (ANQ) as fluorophore and indomethacin
(IMC) as the recognition moiety. The probe yields a high selectivity toward COX-2142-143 and has
successfully been used to image COX-2 in the Golgi apparatus.136 The contribution from the
McCarley group towards detection of human NAD(P)H quinone oxidoreductase 1 (NQO1)144-145
used a quinone propionic acid trigger group attached to the fluorophore 1,8 naphthalimide.146-147
Upon reduction of the quinone propionic acid moiety by NQO1, the cloaked probe undergoes a
rearrangement, thereby releasing the highly fluorescent naphthalimide reporter. These reporter
probes have successfully demonstrated the ability to detect cellular NQO1 with high selectivity.
As another successful strategy, the probe TG-Gal was reported by Urano and coworkers for
detection of the -galactosidase148-149 activity in living cells.150-151 The probe TG-Gal is
composed of -galactoside as the enzyme activatable group and O-alkylated xanthene as the
fluorophore. Upon hydrolysis, the -galactoside group was released, and fluorescence is turned
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on. Due to the reasonable membrane permeability of the probe, Urano was able to detect the galactosidase enzyme activity in a real-time manner.136

1.9.4 Fluorescent Probes for the Detection of Reactive-oxygen Species (ROS) and Reactivenitrogen Species (RNS)
ROS and RNS play an important role in cellular health and function. Therefore, to
understand the chemistry of these very small and transient species in living systems, it is
important to monitor their concentration precisely, especially in the cellular environment.152 As a
major ROS in living systems, H2O2 plays a key role as a secondary messenger in cellular signal
transduction. Developing fluorescent probes for H2O2 gives a unique opportunity for real-time
noninvasive detection of H2O2. Shabat and coworkers recently developed a cyanine-based NIRprobe,153 composed of a boronate moiety as a specific reaction site for H2O2. Upon reaction the
boronate group is chemically modified to a phenol group that results in generation of an
extensive -conguated NIR fluorophore, which gives a fluorescence signal around 720 nm.
Chang and coworkers154 developed a ratiometric fluorescent probe RPF1 for H2O2 detection that
contains a coumarin donor and a boronate-protected fluorescein acceptor linked through a
spacer.155 In the absence of oxidant, only coumarin emission is observed; whereas, with the
addition of H2O2, the intensity of the green fluorescence associated with the fluorescein acceptor
increases via a FRET process, when excite at the coumarin wavelength. The concentration
changes of H2O2 are readily determined by measuring the ratio of the intensities of the two
wavelengths.156 As another strategy, Yang et al. developed a BODIPY-based peroxynitrite probe
HK-green 2, which does not have emission in the absence of peroxynitrite. In the presence of
excess peroxynitrite, the probe exhibits a 69-fold fluorescence enhancement, and the
fluorescence-intensity increases linearly, proportionate with the concentration in the range of 0–
15 M.157 Tang and coworkers developed a BODIPY-based probe, TEMPO-BDP, for the
detection of hydroxyl radicals. The probe itself shows weak fluorescence in the absence of the
hydroxyl radical, but in the presence of hydroxyl radicals and with the addition of DMSO, a
significant fluorescence enhancement was observed.158
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1.9.5 Fluorescent Probes for the Detection of Anions
Anions also play a crucial part in physiology, just like their cation counterparts. Anions, such
as CN− (important analyte in cystic fibrosis), and PPi (inorganic pyrophosphate, generated from
ATP hydrolysis)159-160 play an important role in the body. Yoon et al. reported a probe for CN−
ions designed with tricarbocyanine dye and a copper receptor moiety; when the probe binds to
Cu2+ to form the probe-Cu2+ complex the absorption maximum at 718 nm shifts to 743 nm and
fluorescence at 748 nm is quenched. When CN− was added to a solution of copper-bound probe,
the fluorescence intensity at 748 nm increased rapidly, giving rise to a copper cyanide complex.
Using this probe, they were able to detect CN− selectively without an effect from other anions.
Zhu and coworkers developed a fluorescent probe, DCEA, which acts on PPi anion in aqueous
solution. The precursor probe consists of dicyanomethylene-4-H-chromene as a fluorophore and
the iminodiacetate group as Cu2+ receptor ligand. Fluorescence is decreased by Cu2+ addition
with chelation to the diacetate group in the ligand moiety. Once the anion PPi was added,
fluorescence at 675 nm increased due to interaction between Cu2+ and the PPi anion. However,
its intensity did not completely return to that of a free reporter, suggesting that the coordination
of PPi anion is not strong enough to cause complete removal of Cu2+ from the DCEA-Cu2+
probe.133, 161

1.10 Traditional Thiol Detection Methods
Conventional techniques for the determination of thiols, such as high-performance liquid
chromatography162 and capillary electrophoresis (CE) separations, can be coupled with different
detection methods like ultraviolet absorbance (UV), fluorescence, and electrochemical detection
to provide superior resolution. Typically for amino acids thiols, UV and fluorescence detection
methods are based on derivatization of the thiol either at the amino end or thiol moiety.
However, some of these derivatives are not stable, or accurate measurement of that are hampered
by the presence of excess reagents and products from side reactions in the system.163 HPLClinked electrochemical detection of thiols first introduced by Kahn et al.,164 using a glassycarbon working electrode during chromatographic separations to analyze thiols in human
plasma.165 D’Eramo and co-workers also used HPLC with an electrochemical detection protocol
by using a glassy carbon electrode, total homocysteine levels were detected with a low limit of
detection.166
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Due to simple instrumentation and quick analysis with relatively small amounts of sample,
CE has become a popular route in thiol analysis.167-168 UV-vis and electrochemical approaches
are the most commonly used detection methods to date for CE. However, spectroscopic detection
has drawbacks due to the small path length across the capillary, yielding the limitation of lower
sensitivity. Electrochemical detection in CE has the advantage of simplicity, ease of
miniaturization, high sensitivity, and relatively low cost. Both HPLC and CE methods have their
own benefits including good selectivity and low detection limits; however, they often require
extensive, time-consuming sample preparation (both pre- and post-column) and derivatization
steps prior to sample analysis.164, 169
Direct electrochemical approaches for thiol detection and quantification have offered
potential simplicity among other traditional techniques. However, direct electro-oxidation of
thiol compounds on common solid electrodes limits its selectivity because of the similarity in
oxidation potential for most biological reducing substances in comparison to thiols Also,
methods based on direct oxidation of thiols at solid electrodes are time consuming and usually
require a large overpotential.170 Although this can be alleviated by indirect detection on mercury
amalgam electrodes the toxicity associated with mercury hinders further use of these methods for
live sample analysis. According to the literature, some other organic and inorganic electroactive
indicators as electron mediators have also been used, yet the necessity of delicate and finely
tuned experimental conditions for the success of the electro-catalytic reaction between the thiol
compounds and the indicator limits their wide application especially live monitoring of
samples.170-172
Mass spectrometric-based assays are also another widely used method for thiol detection.
Mass methods, such as trap-and-release membrane introduction mass spectrometry (T&RMMS),173 gas chromatography and liquid chromatography coupled to mass spectrometry (GCMS, LC-MS)174 are applied to thiol detection.175 Mass spectrometry provides specificity in that it
is able to monitor select mass ions from fragment parent ions; it provides enhanced signal-tonoise ratio, and decreased time due to minimal sample cleanup and derivatization. Each of these
methods has their drawbacks, such as extensive sample processing, complexity, high equipment
cost, long run time, and limited number of samples processed at a given time and/or validation
parameters assessed; these issues make them impractical for high-throughput routine clinical or
research purposes.176
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In addition, other techniques, such as nuclear magnetic resonance spectroscopy (NMR)
methods,177-178 are being used for GSH and GSSG detection in brain cells in vivo and intact cells
in cyto. Trabesinger and coworkers pioneered a method applicable to the human brain wherein
they used 1H NMR with double quantum coherence filtering in combination with point-resolved
spectroscopy volume selection with a relatively low strength field.178 The GSH concentration can
also be assayed in blood through
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F NMR, as reported by Potapenko et al. by measuring the

product of the exchange reactions of thiols with a newly synthesized fluorinated disulfide
2,3,5,6-tetrafluoro-4-mercaptobenzoic acid.179 Another important route of NMR measurement is
investigation of thiol content in intact cells. Kenett et al. used 1H spin-echo NMR and 13C NMR
to measure the intracellular and extracellular GSH redox status of cells while keeping the cells

alive.180
Among these various thiol detection methods, optical techniques, including florescence or
colorimetric approaches have proven to be some of the most convenient. Fluorescence
techniques especially have a number of advantages, including simplicity, low detection limits,
and ease of handling. Above all, the most beneficial use of fluorescent probes is the ability to
monitor live cells and intracellular analytes. With this purpose in mind, during the last couple of
decades, a great effort has been devoted to the development of fluorescent and colorimetric
sensors that can selectively sense biological thiols.7

1.11 Fluorescence Probes for Bio-Thiol Detection
Most of the fluorescent probes reported in the literature for the detection of thiols are based
on one of the two basic qualities observed for thiols. These methods have utilized either the high
nucleophilicity of thiols toward a reporter system or the high binding affinity of thiols toward
metal centers.176,

181

The probes take advantage of high nucleophilicity can be sub-divided

depending on their reactivity as—Michael addition,182-184 cyclization with aldehydes,185-186
conjugate addition-cyclization reactions,187-188 cleavage of sulfonamide and sulfonate esters,189190

thiol-halogen nucleophilic substitution,191 and disulfide exchange.181,

192-193

The potential

capabilities of a few of the recently reported thiol probes are discussed here below.
Lee and coworkers reported a single galactose-appended naphthalimide probe for hepatic
thiol determination. According to the authors, the galactose subunit in their probe acts as a guide
for the probe to reach hepatocytes by targeting asialoglycoprotein receptors (ASGP-R). When
31

bound to the receptor, the probe was internalized by receptor-mediated endocytosis. Inside the
cell, the disulfide bond of the probe undergoes disulfide cleavage by reaction with targeted
intracellular thiols; this releases the naphthalimide reporter leading to a fluorescence change. The
authors were able to image cellular thiol levels with a minimum 20-min incubation time using a
5000:1 thiol to probe ratio.194
Guan et al. reported a benzofurazan sulfide-based probe; by changing the substituent in the
benzofurazan ring, they were able to tune the reactivity of the probe. By incubating for 90 min,
they were able image cellular thiols; however, any solution- phase kinetics or comment about
thiol to probe ratio required for an efficient signal was not reported.192 Zhang reported a
coumarin-based thiol probe designed with 7-hydroxyl-coumarin dye as the fluorophore and an

-unsaturated ketone in the 8-position of the dye as the Michael acceptor. The initial non
fluorescent probe became fluorescent upon Michael addition of thiols to the ketone, followed by
a cleavage of the hemiketal, which resulted in the formation of a fluorescent 7-hydroxyl
coumarine derivative. This probe was applied to thiol detection in human blood, serum, and
living cells, with a 70:1 thiol-to-probe ratio. A good fluorescence signal was obtained within a
relatively short time (about 10-min incubation) leading to rapid release.195
Kim et al. also reported another thiol probe using a coumarin dye as the reporter. The probe
was designed with three active units: a coumarin moiety acts as the signaling unit; the conjugated
enone is the reactive unit, and the O-hydroxyl group serves as an activation unit through
resonance-assisted hydrogen bonding. When incubated with bio-thiols, a ratiometric response
was observed. The authors were able to detect cellular thiols by incubating the sample for 60
min using 1000:1thiol-to-probe ratio.196 As another approach, Cho and coworkers developed a
ratiometric two-photon probe (SSH-mito) for mitochondrial thiol detection. They used 6(benzo[d]thiazol-2'-yl)-2-(N,N-dimethylamino) naphthalene (BTDN) as the reporter dye, a
disulfide group as the thiol reaction site, and triphenylphosphonium salt (TPP) as the
mitochondrial targeting site. According to the authors, the cationic TPP group facilitates the
probe’s ability to accumulate in mitochondria. Once the disulfide group was cleaved off by
replacement with mitochondrial thiols, subsequent cyclization caused release of the free
fluorophore, offering a probe and reporter with a different fluorescence. They were able to detect
mitochondrial thiols with quite a long incubation time (120 min for fluorescence increase) with a
2000:1 thiol-to-probe ratio.197 Guo and coworkers developed a bodipy-based TMPAB-O-M
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probe (1,3,5,7-tetramethyl-8-phenyl-(2-maleimide)difluoroboradiaza-S-indacene) to detect thiols
in live cells. Initially, the fluorescence of the probe was quenched and reaction of the maleimide
group, with cellular thiols facilitated a fluorescence increase. The probe was incubated with live
cells, and the fluorescence increase was monitored overtime. A very rapid (90 s) fluorescence
turn-on effect was observed, with relatively low thiol to probe ratio (1:1).198
While most of these literature-reported probes are rather successful in achieving their goal,
most of them still suffer from excessively long reaction time, requirement of high analyte, and
lower selectivity in biological media. None of the above-discussed probes have commented on
their signal to background ratios; reporting such values would be an excellent way to prove their
success in cellular imaging. As a result, there remains a great demand for a new class of thiol
detecting probes that would increase both selectivity and sensitivity, alone with a shorter reaction
time, higher analyte signal and lower background fluorescence.
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CHAPTER 2
KINETICS OF A REDOX-ACTIVE TRIGGER SYSTEM AS AN ACTIVATABLE
GROUP FOR CARGO RELEASE
2.1 Introduction
Target–selective delivery of biologically active compounds is becoming an increasingly
important tool in the diagnosis and treatment of diseases, such as cancer.1-2 These types of
selective delivery systems are particularly significant in delivery of prodrugs and selective
detection of analytes at a specific target site.3 These systems are designed in a way that the
activity of a select group of compounds is masked by chemically connecting them together, and
upon chemical disintegration from each other at a select target site, they provide a different
chemical outcome. For example, during chemotherapeutic treatments, delivery of therapeutic
parent drugs as prodrugs can offer numerous advantages over their traditional counterparts.4
Inactive prodrugs can be tailored to be site-specifically activated to release the active drug so as
to exert its biological function at the target site. This will result in higher therapeutic efficacy, as
well as reduced side effects.3,

5-6

To achieve targeted delivery, it is often required to link a

specific chemical or biological reactive group to target molecules that control the activity of the
system.7-8 These systems can be designed by either directly attaching the trigger (activatable
molecule) to a target molecule (Figure 2.1a) or having a linker in between to form a threecomponent (tripartite) system (Figure 2.1b).9
Three-component delivery systems generally consist of a trigger, a linker, and a targeted
delivery molecule.9 The three functionalities of such a tripartite system are illustrated in Figure
2.1b, and can be used as follows: first the system contains the trigger molecule which is
responsible for the site specific activation in the presence of a specific analyte such as an
enzyme;10 second the linker in between facilitates the attachment of target molecule to active
trigger. When a corresponding analyte activates the trigger, such activation will result in
spontaneous reaction that releases the active molecule from the target moiety.9
There are two different mechanisms that are used in active delivery systems. The first one is
based on a spontaneous intra-cyclization reaction to form a stable cyclic molecule. The cleavage
of the activated trigger molecule generates a free nucleophilic center which will undergo an
intra-cyclization to release the target molecule from the linker.11 The second reported method in
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Figure 2.1 Schematic representation of design strategies used for delivery systems.

the literature is elimination based on quinone methide formation. Similar to the first system,
cleavage of the trigger generates a free phenol or amine functionality that subsequently
undergoes a self-immolative reaction via quinone methide rearrangement7, 9, 12-13 to release the
target molecule. As demonstrated in Figure 2.2, the elimination reactions of substituted aniline or
phenol could take place via two routes. Removal of the substrate from compound 1 and 2 leads
to the formation of compound 1a and 2a respectively.

Figure 2.2 p-quinone methide vs o-quinone methide elimination mechanism.7
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Depending on the position of the attached substrate, o– or p– quinone methide will be formed
during the elimination process. Compound 1a undergoes 1,6-elimination to release the activated
molecule (R) and p-quinone methide 1b; compound 2a undergoes 1,4 elimination to release the
activated molecule (R) and o-quinone methide 2b.7 The released end group (R) could be a variety
of activated molecules such as a chromogenic molecule,14-15 polymeric substance,16-17 or a drug
molecule,18-19 depending on the purpose of the designed system. According to literature,
depending on the position of the quinone methide formation, the elimination kinetics and the rate
will vary.20
Over the past 20 years, numerous methods have been developed to address the issues related
to drug encapsulation, retention, and stability of liposomal formulations. There is great attention
in the science community to develop trigger systems that can control the release of contents from
inside liposomes.21-22 Mainly, the stimulus to release the drug should be specific to the target site,
and the liposome must be sensitive enough to the trigger signal to yield effective release. 23-24
Therefore in an effort to invent an effective release system for liposomes,25-26 a novel, reactive
hydroxymethyl benzoquione (HMBQ)27 group was utilized as a possible trigger for activated
delivery of attached cargo. A hydroxmethyl benzoquinone (HMBQ) modified 1,2-dioleoyl-snglycero-3-phosphoethanolamine (DOPE) was synthesized to determine the ability of HMBQDOPE to act as a possible redox activated trigger group for liposomal drug delivery. As shown in
Figure 2.3, upon applying a reductive stimulus, the reduction of the quinone moiety forms the
hydroquinone.

Figure 2.3 Activation mechanism of HMBQ with quinone methide formation and release of the
target molecule.
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The hydroquinone formed will undergo a rapid rearrangement to generate the ortho-quinone
methide and the free target molecule, with concomitant formation of CO2 gas. Adopting this
rearrangement strategy (Figure 2.3), calcein dye-encapsulated HMBQ-DOPE liposomes were
synthesized. When the HMBQ head groups are removed from the DOPE lipids, it is expected
that the liposome will then undergo a conformational change from a stable lamellar phase to an
unstable hexagonal phase causing the release of the encapsulated calcein dye.28 The release of
the highly fluorescent calcein dye can be monitored using fluorescence spectroscopy.
Then as the second part of this work, the para-nitroaniline derivative of HMBQ (HMBQNpc) was synthesized as a model compound to determine the release mechanism of Npc and the
kinetics of quinone methide formation. In this system, HMBQ was connected to paranitroaniline via a carbamate linkage to form HMBQ-Npc. HMBQ-Npc was expected to undergo
a similar mechanism to that described in Figure 2.3, wherein there is release of the free paranitroaniline reporter moiety and quinone methide. Using the absorbance spectral changes of the
HMBQ-Npc/p-nitroaniline system, the kinetics of the self-immolative system can be determined.

2.2 Experimental
2.2.1 Synthetic Material and Methods
All the column purifications were performed using SNAP silica columns on a
Flashmaster Personal from Biotage. Chemicals were purchased from Sigma-Aldrich or
Fisher Scientific. Thin-layer chromatography was performed on aluminium-backed 60 F254
silica plates from EMD Chemicals Incorporated. 1H NMR and

13

C NMR spectra were

collected in chloroform-d or DMSO-d6 at 25 °C on a Bruker AV-400 Spectrometer.
Chemical shifts are reported in the standard  notation of parts per million, using
tetramethylsilane (TMS) as an internal reference. Absorption bands in NMR spectra are
listed as singlet (s), doublet (d), triplet (t), or multiplet (m), and the coupling constants J are
expressed in hertz (Hz). Mass spectral analyses were carried out using an Agilent 6210 ESITOFMS. All the solutions were prepared using Nanopure water from a Barnstead Diamond
Nanopure Water System (18 MΩ-cm).
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2.2.2 Synthesis
Hydroxymethylbenzoquinone (HMBQ), HMBQ-DOPE and HMBQ-Npc were synthesized
by adapting literature methods. Synthesis schemes for HMBQ,27 HMBQ-DOPE,28-29 and
HMBQ-Npc30 are shown in Scheme 2.1, Scheme 2.2 and Scheme 2.3, respectively.

Scheme 2.1 Synthesis of HMBQ

Scheme 2.2 Synthesis of HMBQ-DOPE

Scheme 2.3 Synthesis of HMBQ-Npc
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1,4-Dimethoxy-3,5,6-trimethyl benzene (1)
In a dry, three–neck flask equipped with a condenser and a magnetic stirring bar under argon
environment, sodium hydride (0.87 g, 36.14 mmol) was dissolved in a small amount of dry DMF
(10 mL), and 2,3,5-trimethylhydroquinone (2.50 g, 16.43 mmol) was added in small portions
(dissolved in dry DMF) over 15–20 min using an addition funnel. After evolution of H2 gas had
ceased, methyl iodide (4.1 mL, 65.72 mmol) was added dropwise over 15–20 min using an
addition funnel. When the addition was finished, the reaction mixture was stirred at 40 °C for 6 h.
Brine (200 mL) was added to the flask, and the resulting mixture was extracted with diethyl ether
(3 × 50 mL). The combined organic layers were washed with water (2 × 50 mL) and then dried
over MgSO4. After filtration the solvent was evaporated under reduced pressure, and the residue
was purified on a flash column (4:1 Hex:EtOAc, v/v). The final product was obtained as a
yellow oil in 80% yield. 1H NMR (400 MHz, chloroform-d) δ 6.60 (s, 1H), 3.83 (s, 3H), 3.72 (s,
3H), 2.35 (s, 3H), 2.27 (s, 3H), 2.19 (s, 3H). ESI-MS: for C11H16O: expected m/z = 181.1230
[M+H]+; found m/z =181.1210 [M+H]+; 11.0 ppm error.

2,5-Dimethoxy-3,4,6-trimethylbenzaldehyde (2)
Anhydrous TFA (12 mL) was added to a solution of compound 1 (1.5 g, 8.5 mmol) in
hexamethylenetetramine (1.19 g, 8.5 mmol). The solution was stirred at room temperature for 1 h
and then heated at reflux (72.5 °C) for 28 h. After cooling, the solution was poured into ice
water, and then neutralized with Na2CO3, followed by extraction with CH2Cl2 (3 × 100 mL).
The organic layer was washed with water, dried (MgSO4), and concentrated under reduced
pressure. Product was purified on a flash column (4:1 CH2Cl2:Hex, v/v) to obtain the final
product as a yellow solid in 73% yield. 1H NMR (400 MHz, chloroform-d) δ 10.48 (s, 1H), 3.77
(s, 3H), 3.64 (s, 3H), 2.49 (s, 3H), 2.26 (s, 3H), 2.20 (s, 3H). ESI-MS: for C12H16O3: expected
m/z = 209.1180 [M+H]+; found m/z = 209.1160 [M+H]+; 9.50 ppm error.

1-Hydroxymethyl-2,5-dimethoxy-3,4,6-trimethylbenzene (3)
To a stirred suspension of NaBH4 (0.14 g, 3.6 mmol) in MeOH (4.0 mL) under N2 gas at
0 °C, was introduced a solution of aldehyde 2 (0.36 g, 1.7 mmol) in MeOH with a syringe
within 10 min. The mixture was stirred for a further 3 h at 0 °C and then allowed to warm to
RT. After evaporation of MeOH, the crude product was dissolved in CH 2Cl2 (50 mL), which
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was washed with water (3 × 50 mL). The organic layer was dried (MgSO4), filtered and the
solvent was then evaporated under vacuum to yield a white solid. The compound was used
for the next step without further purification (77% yield). 1H NMR (400 MHz, chloroformd) δ 4.73 (s, 2H), 3.74 (s, 3H), 3.65 (s, 3H), 2.32 (s, 3H), 2.19 (d, J = 7.4 Hz, 6H), 2.01 (d, J
= 4.6 Hz, 1H). ESI-MS: for C12H18O3: expected m/z = 233.1156 [M+Na]+; found m/z =
233.1154 [M+Na]+; 0.9 ppm error.

tert-Butyl[(2,5-dimethoxy-3,4,6-trimethylphenyl)methoxy]dimethylsilane (4)
Compound 3 (0.28 g, 1.33 mmol) was dissolved in DMF (3.0 mL), with the solution
then cooled to 0 °C. Imidazole (0.27 g, 3.99 mmol) and TBSCl (0.6 g, 3.99 mmol) were
added. The reaction was allowed to warm to room temperature, and it was stirred for an
additional 2 h. The reaction was monitored by TLC. Upon completion, the reaction was
diluted with diethyl ether, and then it was washed with NH 4Cl solution. The organic layer
was dried over magnesium sulfate, and the solvent was removed under reduced pressure.
The resulting oil was purified on a flash column (9:1 Hex:EtOAc, v/v) to afford a yellowishwhite oil in 70% yield. 1H NMR (400 MHz, chloroform-d) δ 4.73 (s, 2H), 3.72 (s, 3H), 3.66
(s, 3H), 2.31 (s, 3H), 2.19 (d, J = 6.6 Hz, 6H), 0.93 (s, 10H), 0.14 (s, 6H).

13

C NMR (101

MHz, chloroform-d) δ 153.30, 130.76, 130.25, 129.39, 128.13, 77.54, 62.27, 60.31, 57.80,
26.20, 18.63, 13.08, 12.77, 12.04, -5.14.

2-Hydroxymethyl-3,5,6-trimethyl-1,4-benzoquinone (5, HMBQ)
To a solution of compound 4 (0.16 g, 0.51 mmol) in CH3CN (2.0 mL) was slowly added
a solution of ammonium cerium (IV) nitrate (0.7 g, 1.31 mmol) in water. The resulting
mixture was stirred for 4 h at RT and then diluted with water (25 mL). The organic layer
was extracted with CH2Cl2 (3 × 50 mL), dried, and concentrated under vacuum. The
compound was purified on a flash column (100 % CHCl3) to give an orange solid in 80%
yield.

1

H NMR (400 MHz, chloroform-d) δ 4.52 (d, J = 6.0 Hz, 2H), 2.74 (t, J = 6.7 Hz,

1H), 2.07 (s, 3H), 2.00 (dt, J = 4.3, 1.3 Hz, 6H).

13

C NMR (101 MHz, chloroform-d) δ

188.64, 187.82, 141.72, 141.48, 140.68, 140.34, 57.83, 12.67, 12.24, 11.93. ESI-MS: for
C12H18O3: expected m/z = 179.0706 [M−H]−; found m/z = 179.0722 [M−H]−; −8.93 ppm
error.
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4-Nitrophenyl (2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methyl carbonate (6)
To a solution of 5 (41.0 mg, 23.0 mmol) in anhydrous THF (10.0 mL) under argon, 4nitrophenyl chloroformate (99.6 mg, 49.4 mmol) was added, alone with anhydrous pyridine
(55.7 L). The mixture was stirred 24 h in RT. The resulting white solid was filtered off, and the
filtrate was evaporated under vacuum. The resulting yellow residue was purified using a flash
column (1:1 EtOAc:Hex, v/v) to afford compound 6 as a pale yellow solid in 85% yield. 1H
NMR (400 MHz, chloroform-d) δ 8.28 (d, J = 9.2 Hz, 2H), 7.39 (d, J = 9.2 Hz, 2H), 5.25 (s, 2H),
2.20 (s, 3H), 2.06 (d, J = 2.2 Hz, 6H). ESI-MS: for C17H15O7: expected m/z = 345.0748
[M+Na]+; found m/z = 368.0735 [M+Na]+; 3.5 ppm error.(Crystal structure is shown in
Figure 2.4)

Figure 2.4 Crystal structure of compound 6

Synthesis of HMBQ-DOPE
To a cooled (0 °C) solution of DOPE lipid (109.6 mg, 0.15 mmol) in CH2Cl2 (15.0 mL),
triethylamine (125 L, 0.87 mmol) and compound 6 (53.89 mg, 0.15 mmol) were added
dropwise. The resulting mixture was stirred 24 h at RT. Then the reaction mixture was diluted
with CH2Cl2 to 30 mL and washed with 5% NaHCO3 (2 × 25 mL). The organic layer was dried
with MgSO4, filtered and concentrated under vacuum. The crude residue was purified by a flash
column with gradient elution (1:1 CH2Cl2:EtOAc, v/v and 3:1 EtOAc:MeOH, v/v) to afford
HMBQ-DOPE as a brown wax in 35% yield. ESI-MS: for C52H87NO12P−: expected m/z =
948.5971 [M]−; found m/z = 984.5954 [M]−; 1.8 ppm error.
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Synthesis of HMBQ-Npc
HMBQ (6; 59.8 mg, 0.33 mmol) and dibutyltin dilaurate (DBTL; 20 L, 0.03 mmol) were
added to a solution of 4-nitroaniline isocyanate (65.6 mg, 0.40 mmol) in dry THF (5.0 mL). The
reaction mixture was heated to 45 °C and stirred for 1 h. Then the solvent was evaporated under
vacuum, and the reaction mixture was purified on a flash column (1:1 EtOAc:Hex, v/v) to obtain
HMBQ-Npc as a yellow solid in 70% yield. 1H NMR (400 MHz, chloroform-d) δ 8.19 (d, J = 9.2
Hz, 2H), 7.53 (d, J = 9.2 Hz, 2H), 6.99 (s, 1H), 5.16 (s, 1H), 2.20 (s, 3H), 2.12–1.92 (m, 6H). 13C
NMR (101 MHz, chloroform-d) δ 187.22, 185.90, 152.21, 145.12, 143.51, 143.21, 141.33,
140.78, 136.06, 125.24, 117.78, 58.65, 12.53, 12.36. ESI-MS: for C17H16N2O6: expected m/z =
367.091 [M+Na]+; found m/z = 367.100 [M+Na]+; 24.5 ppm error.

2.2.3 Cyclic Voltammetry of HMBQ trigger group
Cyclic voltammetry (CV) was performed in 0.1 M, pH 7.4 phosphate–buffered saline
(PBS) under anaerobic conditions with 1% ethanol to help solubilize the quinone (HMBQ).
Power Suite 2.53 operating software was used with a Princeton Applied Research Model
273A Potentiostat/Galvanostat. Voltammograms were collected at scan rate of 0.1 Vs −1 at
room temperature (25 °C) after degassing the solution with nitrogen for 20 min. A threeelectrode cell was used containing glassy carbon working (BAS, 3-mm diameter), platinum
wire counter, and Ag reference (BAS) electrode, and the potentials were referenced versus
ferrocene/ferrocenium internal standard.

2.2.4 Synthesis of Liposome-Encapsulated Calcein
HMBQ-DOPE liposomes containing calcein were prepared adopting standard liposome
preparation techniques reported in the literature.28,

31

The HMBQ-DOPE lipid mixture was

thoroughly dissolved in a small amount of CHCl3 to get a homogeneous lipid solution. Then a
portion of the dissolved lipid was transferred to a pre–weighed culture tube, and the solvent was
removed using a dry nitrogen stream in a fume hood. Next, the final lipid weight was measured
to obtain usually 1–2 mg of lipids. The lipid mixture was thoroughly dried to remove residual
organic solvents by placing the tube under vacuum for a few hours. Next, for the hydration of the
resulting lipid cake, 40 mM calcein dye (Sigma-Aldrich, Milwaukee, WI) in degassed (purged
with N2 for 15 min) 0.1 M, pH 7.4 phosphate-buffered saline (PBS; 0.5 mL) was added to the
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lipid mixture, with subsequent aging for a few hours in a refrigerator at 10 °C. Then the mixture
was subjected to 6 freeze–thaw cycles by freezing the sample in a dry ice/acetone bath and
warming the sample back to room temperature in a water bath with vigorous vortexing for a few
seconds during each cycle. Then the lipid mixture was placed in a Lipex lipid extruder (Northern
Lipids; Vancouver, BC, Canada) and passed through a 100-nm pore size polycarbonate filter
(Whatman Nucleopore, track-etched) for 19 times to obtain a homogeneous size distribution of
the final suspension. To remove excess calcein that is not encapsulated in liposomes, the lipid
mixture was passed through a short Sephadex column. A 300 L aliquot of liposome mixture
was added on top of the Sephadex spin column and centrifuged at 500 × g for 3 min. The
liposome sample was filtered through the column and it was collected to an Eppendorf tube kept
at the end of the column. Finally, the suspension was characterized by dynamic light scattering
(DLS) to obtain the particle size and its poly dispersity index (PDI)

2.2.5 Liposome Characterization
Dynamic light scattering measurements were obtained from backscatter intensities (173°,
633-nm red laser) at a temperature of 25 °C for calcein–loaded liposome in 0.1 M, pH 7.4
phosphate-buffered saline using a Zetasizer Nano ZS particle size analyzer (Malvern
Instruments, Worcestershire, U.K.).

2.2.6 Spectroscopic Methods
All spectroscopic measurements were performed in degassed 0.1 M, pH 7.4 phosphatebuffered saline at 25 °C. Fluorescence data were collected using a Perkin Elmer LS-55
spectrometer,

and

absorption

spectra

were

recorded

using

a

Varian

Cary-50

spectrophotometer. Samples for absorption and emission measurements were obtained in 1cm × 1-cm quartz cuvettes (3.5-mL volume, Sigma-Aldrich).

2.2.7 Calcein Release Studies
The purified calcein-encapsulated liposomes (0.75 L) were diluted with 0.1 M, pH 7.4 PBS
(3 mL) to achieve to a concentration around 80–100 M of lipids. A 50 L aliquot of aqueous
Na2S2O4 (DT; Sigma-Aldrich) 10 equivalents or/and 7.5 L of 30% (v/v) Triton X-100 (SigmaAldrich) were added to the cuvettes as appropriate. Fluorescence intensities were recorded using
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the florescence spectrophotometer at 25 °C. Samples were excited at ex = 485 nm and emission
was measured at em = 525 nm with excitation and emission slit widths of 2.5 nm, with a ND 0.5
emission filter.

2.2.8 UV-Vis Studies of HMBQ-Npc
A stock solution of 150 µM HMBQ-Npc was prepared in 60% DMSO:40% 0.1 M, pH 7.4
phosphate–buffered saline and subsequently diluted to prepare preferred concentration solutions
of HMBQ-Npc in 12% DMSO:88% 0.1 M, pH 7.4 PBS. Stock solutions of aqueous Na2S2O4
were freshly prepared prior to each experiment. Absorbance spectra were recorded at 25 °C using
a Varian Cary-50 spectrophotometer, scanning from 250–800 nm. All the spectral data were
blank corrected using 12%DMSO:88% 0.1 M, pH 7.4 PBS solution.

2.2.9 NMR Kinetics of Dithionite Induced Reduction of HMBQ-Npc
A HMBQ-Npc (2.0 mg) sample was dissolved in 400 L of 6:1 DMSO:D2O solution under
argon at 25 °C and initial NMR spectra were recorded using a Bruker AV-400 spectrometer.
Then a 10 L aliquot of (2 equivalents) solution of Na2S2O4 (DT) dissolved in D2O was injected
in to the sample tube and NMR spectra were recorded every 2 min for 4 h. NMR spectra of paranitroaniline and HMBQ were also recorded using equivalent conditions for comparison purposes.

2.3 Results and Discussion
2.3.1 Reduction Potential of HMBQ Trigger Group
The standard redox potential of HMBQ reduction was measured (converted to standard
hydrogen electrode by adding 0.210 V)32 using the CV graph shown in Figure 2.5. The cathodic
potential (Ep,c) was 0.007 V, and the anodic potential (Ep,a) was 0.199 V, giving a half wave
potential of (E1/2) 0.103 V vs SHE (calculated according to Equation 2.1). As implied by positive
E1/2 of HMBQ, it should be rapidly reduced by a strong reducing agent such as DT (E1/2 = −0.66
V).33
∆𝐸𝑝
𝐸1 = (
) + 𝐸𝑝 ,𝑐
2
2
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Equation 2.1
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Figure 2.5 Cyclic voltammetry of HMBQ trigger group at a 3-mm diameter glassy carbon
working electrode using 0.1 M, pH 7.4 PBS with 1% ethanol. Scan rate was 0.1 V s−1 at T = 25
°
C. The blue colored line is the HMBQ and the dashed green line is background voltammogram
of the buffer.
2.3.2 Characterization of HMBQ-DOPE Liposomes
In order to obtain the average size of the HMBQ-DOPE liposomes, dynamic light scattering
experiments were performed in solutions of 0.1 M, pH 7.4 phosphate-buffered saline at 25 °C. As
shown in Figure 2.6, the average diameter of the liposomes was determined to be 150 nm. The
measurement of the size heterogeneity of the molecules in the mixture, the polydispersity index
(PDI),34 was obtained as 0.055, indicating a small variation in the diameter of the liposomes.

2.3.3 Reduction of HMBQ-DOPE Liposomes and Calcein Release Studies
According to previously reported data from the McCarley group28 and others, a rapid
increase in the fluorescence intensity was expected as soon as the reducing agent DT was added
to the HMBQ-DOPE liposomes. The sample was excited at ex = 458 nm and emission was
detected at em = 525 nm, the maximum excitation and emission wavelength range of the calcein
dye. However, as shown in Figure 2.7, such an increase in the fluorescence intensity was
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not observed, indicating that an inability of the DT-exposed liposomes to release the
encapsulated calcein dye, even after 1000 min of DT incubation. This outcome was observed
several times (>3 times) with different batches of lipid. Once Triton X-100 detergent was added
to rupture the lipid bilayer,28 a rapid increase in fluorescence was observed. This indicated the
immediate release of the encapsulated calcein from HMBQ-DOPE liposomes. The possible
reason for not observing release from the redox triggered liposomes is discussed in the following
section.

Figure 2.6 Characterization of HMBQ-DOPE liposomes using DLS to obtain their diameter and
distribution of diameter (d) at T = 25 °C
2.3.4 Mechanism of Redox-Triggered Liposomes
The proposed, anticipated reaction mechanism in Figure 2.8 implies a rapid release of
contents from HMBQ-DOPE liposomes. Initially, when the quinone group is attached to the
lipid, a stable lamellar phase (L) will be formed. When lipid is in a stable lamellar phase it will
form the vesicular structure with lipid bilayer encapsulating the calcein dye; thus DLS and Triton
induced lysing experiments support this situation. The hydroquinone formed after the reduction
of the exterior quinone moieties by the strong reducing agent DT will undergo rapid quinone
methide rearrangement, releasing the lipid from the quinone head group. The release of head
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Figure 2.7 Time-dependent monitoring of the fluorescence intensity of calcein-loaded liposomes
at ex = 485 nm and em = 525 nm in 0.1 M, pH 7.4 phosphate-buffered saline at T = 25 °C.

Figure 2.8 Schematic representation of proposed HMBQ-DOPE liposome releasing mechanism
via quinone methide formation.
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group will induce a conformation change in the lipid assembly compelling it to form an unstable
inverted micelle hexagonal phase (HII) resulting in breakdown of the vesicular structure and
release of the encapsulated calcein dye. This proposed mechanism is based on previous
observations in the McCarley group with redox–cleavable head group lipids.28, 35 However, it is
possible that the highly reactive quinone methide species (Figure 2.8, compound a) formed by
the reduction is susceptible to many nucleophilic substitution reactions in the media. When there
is a high local concentration of lipids with a free amine group (Figure 2.8, compound b) in close
proximity, attack of the quinone methide moiety is a possibility to form compound c (Figure 2.8,
compound c). If this reaction took place a stable hydroquinone attached DOPE lipid species will
be formed. This formation will stabilize the lamellar (L) phase inhibiting the phase transition, to
the inverted micelle hexagonal phase. However it is possible that the quinone methide species (a)
does not leave the DOPE lipids. In order to further understand the mechanism of quinone
methide formation and release of attached amine-bearing motifs, I synthesized the HMBQ-Npc
system as a model compound.

2.3.5 Spectral Properties of HMBQ-Npc/para-nitroaniline System
As shown by the absorbance spectrum of HMBQ-Npc in Figure 2.9 (red line), the two bands
centered at max = 264 nm and max = 330 nm correspond to the absorbance of the quinone
moiety and the carbamate bonded nitroaniline, respectively. The main absorbance band of the
compound (max = 330 nm) is blue shifted about 60 nm from the absorbance maximum of the
para-nitroaniline (green line, 390 nm) reporter group. This spectral difference therefore,
facilitates the monitoring of free reporter release upon reduction of HMBQ-Npc by DT.

2.3.5 Reduction Triggered Self-Immolation of HMBQ-Npc
Upon incubating a 40 M sample of HMBQ-Npc with 2 equivalents of aqueous Na2S2O4;
rapid release of para-nitroaniline was achieved (Figure 2.10, green arrow) along with the
concomitant reduction of bands corresponds to HMBQ-NPC. This was evident by the reduction
of the quinone band at max = 260 nm (Figure 2.10, blue arrow) and the carbamate-linked
nitroaniline band at max = 330 nm (Figure 2.10, red arrow). The intensity of the signal level
indicates that full release of the para-nitroaniline reporter occurs within about 1 hour; however,
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Figure 2.9 Absorbance spectra of 40 M HMBQ-Npc (red line) and 40 M para-nitroaniline
(green line) in 12% DMSO:88% 0.1 M, pH 7.4 PBS at T = 25 °C.
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Figure 2.10 Dithionite (2 equivalents) reduction of 40 M HMBQ-Npc in 12% DMSO:88% pH
7.4, PBS at T = 25 °C. Each spectrum was obtained by examining the sample every 2 min ( t =
2 min) for 70 min after the addition of aqueous DT.
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a significantly enhanced signal was achieved within about 20 min after addition of DT, providing
evidence for the rapid nature of the reaction.

2.3.7 Kinetics of Self-Immolation of HMBQ-Npc
According to the proposed reaction mechanism for HMBQ-Npc and the observed absorbance
data, it is assumed that redox activation of the HMBQ moiety results in rapid formation of the
hydroquinone species (R) with elimination of the quinone methide and formation of the free
para-nitroaniline reporter being the rate limiting step (Scheme 2.4). The kinetic constant of the
system was determined as shown below.

k2>>>>k1

Scheme 2.4 The proposed reaction mechanism for formation of para-nitroaniline by quinone
methide formation.
Previously published data in the McCarley group for a wide range of quinone substrates
having redox potentials similar to those of HMBQ revealed that dithionite reduction of the
quinone head group to a reduced hydroquinone is very rapid and complete with in 1s.36-37
Therefore it is assumed that the initial reduction step to cause hydroquinone formation (Scheme
2.4, compound R) has no influence on the overall reaction rate. Additionally, the work reported
by Johnson et al. has reported that zwitterionic carbamic species of N-arylcarbamates (Scheme
2.4, compound I) have short lifetimes (<<seconds).38

Thus, it is assumed that a rapid

decarboxylation step occurs shortly after the reduction without accumulation of the carbamic
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acid species (N-arylcarbamate) and does not provide sufficient contribution to the overall rate
change. When the initial reduction step and decarboxylation were deemed as non-rate limiting
steps, the overall reaction can be simplified to a simple pseudo first–order rate equation,
(Equation 2.2). Using this equation, the pseudo first order rate constant was derived as described
below. The graph of extent of product disappearance measured at maximum absorbance
wavelength of 330 nm, and product (P) appearance measured at 390 nm is shown in the Figure
2.11 a.

𝑅𝑎𝑡𝑒 = −

[𝑅]

∫
[𝑅]0

𝑑 [𝑅]
= 𝑘1 [𝑅]
𝑑[𝑡]

𝑡
𝑑[𝑅]
= −𝑘1 ∫ 𝑑𝑡
[𝑅]
0

𝑙𝑛([𝑅] = [𝑅]0 𝑒 −𝑘1𝑡 )
ln[𝑅] = ln[𝑅]0 − 𝑘1 × 𝑡
[𝑅]
𝑙𝑛 (
) = −𝑘1 𝑡
[𝑅]0

Equation 2.2

According to the Equation 2.2, to determine the order of the reaction, the graph of ln extent
of product appearance and ln reactant disappearance was plotted as shown in Figure 2.11 b. As
expected, a portion of the reactant disappearance (Figure 2.11 b, blue line) is seen to be linear
(Figure 2.11, blue box). However, when the ln graph of product formation was observed, it is
clear that para-nitroaniline product formation (green line) did not follow the linear first order
kinetics because the shape of the graph is more hyperbolic than linear. Therefore, paranitroaniline product formation cannot be used for the rate constant calculations. The linear
portion of the HMBQ-Npc reactant disappearance curve was separately plotted in a graph, in
order to do the linear fit and obtain the rate constant. As shown by Figure 2.12, the linear fit of
the data demonstrates the disappearance of the HMBQ-Npc to form the quinone methide and
para-nitroaniline species follows first order kinetics, with a rate constant of k1 = 0.0303 min−1.
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Figure 2.11 a) a plot of extent of product formation (green line, monitored at max = 330 nm) and
product disappearance (blue line, monitored at max = 390 nm) vs time from Figure 2.10, b) a
plot of ln (extent of reaction) disappearance (blue line) and product formation (green line). The
linear region of the ln graph (first order kinetics) is marked with a blue box.
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2.3.8 NMR Assessment of Kinetics of the HMBQ-Npc Reduction
As another piece of evidence for the mechanism of para-nitroaniline formation from reduced
HMBQ-Npc, NMR kinetic experiments were conducted. The HMBQ-Npc sample was dissolved
in 6:1 DMSO:D2O to obtain a final concentration of 15 mM and an initial spectrum was recorded
(Figure 2.13, panel a ). Then 2 equivalents (10 L of 1.0 M DT sample) of DT dissolved in D2O

ln(Extent of reaction %)
(Linear region of reactant disappearance)

was injected under argon, and spectra were recorded every 2 min for 4 hours.
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Figure 2.12 Linear region of the ln(extent of the reactant disappearance) vs time plot from Figure
2.11 b, exhibiting apparent first-order kinetics.
Shortly after DT was added, peaks corresponding to para-nitroaniline started to appear
around 7.9 ppm and 6.6 ppm (Figure 2.13, panels b and c). Prominent para-nitroaniline peaks
were observed about 15 min after DT addition that matches with the data observed for the
spectroscopic monitoring of HMBQ-Npc reduction by DT, (Figure 2.13, panel b). The two
aromatic hydrogen peaks corresponding to the HMBQ-Npc are located around 8.2 ppm and 7.6
ppm, and they gradually decreased as the reaction progressed (Figure 2.13, panels b and c). After

70

about 90 min, the reaction was completed. The peaks corresponding to the starting compound
HMBQ-Npc, were completely absent (Figure 2.13, Panel d, blue arrow), while peaks
corresponding to para-nitroaniline were clearly prominent (Figure 2.13, panel d, red arrow).
Remarkably, two other peaks around 5.9 ppm and 5.4 ppm (panels b and c, denoted by *)
appeared soon after DT addition and these two peaks diminished as the reaction reached
completion. Because peaks around this region usually correspond to alkene hydrogens, these two
peaks are speculated to be the two alkene protons of the quinone methide intermediate.
Furthermore, the peak at 5.1 ppm that corresponds to the two methylene protons of HMBQ-Npc
also diminished with time (panels b and c, green arrow), and it was virtually non-existent when
the reaction was complete after 90 min (panel d, green arrow).
d)

d

 t = 90 min

c

 t = 30 min

)

c)
)

*
b)

b

*

*

 t = 15 min

)

*

a)
)

a

*

 t = 0 min

Figure 2.13 NMR spectra of HMBQ-Npc in 6:1 DMSO:D2O; a) Initial NMR spectrum of
HMBQ-Npc at t = 0 min before addition of DT, b) NMR spectrum of HMBQ-Npc at t = 15
min after addition of DT, c) NMR spectrum of HMBQ-Npc at t = 30 min after addition of DT,
and d) NMR spectrum of HMBQ-Npc at t = 90 min after addition of DT. * Proposed quinone
methide intermediate. Colored arrows indicate the appearance or disappearance of a peak.
71

2.4 Conclusions
According to cyclic voltammetric data and other spectroscopic data obtained, it is clear that
the redox activity of the novel HMBQ trigger group is quite promising. It has the capability to
undergo rapid reduction by potent reducing agents with subsequent efficient elimination to form
the para-nitroaniline product. This was proven by the HMBQ-Npc system where rapid
elimination of the attached group (para-nitroaniline) was observed by both absorbance data and
NMR kinetics. However, from the HMBQ-DOPE calcein release studies it is concluded that the
efficiency of elimination depends on the property of the leaving group as well. When there is a
more electron-rich leaving group, such as an alkyl chain, nucleophilic re-attack of the quinone
methide is a possible reaction. It is proposed that this is especially possible in a crowded
environment, like liposomes where molecules in close proximity of each other can undergo rapid
reactions. Although expected release from these redox-responsive liposomes could not be
achieved using the HMBQ trigger system, the rapid nature of HMBQ elimination observed by
absorption and NMR spectroscopies hold promise for other triggerable approaches, such as
delivery of prodrugs and possible application as imaging agents.
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CHAPTER 3
A RAPID, SELECTIVE, AND SENSITIVE FLUORESCENT PROBE FOR THE
DETECTION AND CELLULAR IMAGING OF PHYSIOLOGICALLY SIGNIFICANT
THIOLS*
3.1 Introduction
Biologically relevant thiol compounds (bio-thiols)—such as glutathione (GSH), cysteine
(Cys), and homocysteine (Hcy)—play a crucial role in living systems.1 They are the most
abundant low-molecular mass sulfhydryls (LMM-SHs) occurring in the extracellular milieu.
Together with albumin, GSH, Cys, and Hcy, these species represent almost all the thiols in
mammalian plasma.2
Variations in cellular bio-thiol levels are intimately linked to a wide collection of
diseases, such as cancer, HIV, cystic fibrosis, Parkinson’s disease, and diabetes. 3
Monitoring the ratio of GSH to its corresponding disulfide is a key route for assessing
cellular oxidative stress levels associated with these diseases. As an example, in diabetic
patients chronic exposure to hyperglycemic conditions that can lead to cellular dysfunction
become irreversible over time; this process is termed glucose toxicity. As a result, elevated
glutathione levels are observed in the pancreatic β-cells of diabetic patients because reactive
oxygen species are produced via oxidative phosphorylation during anaerobic glycolysis.
According to recent findings, aging is also correlated with a decrease in plasma GSH and
other main sulfhydryl compounds, with a concomitant rise in most oxidized forms of
LMM-SHs.4 Furthermore, GSH metabolism has an intricate and significant role in both
cancer and antineoplastic therapy.5 As good scavenger of reactive species, thiols are
important in detoxification of harmful chemicals, such as epoxides, alkenes, halides, heavy
metals, and various oxygen– and nitrogen–centered radicals. But on the other hand, elevated
levels of thiols in many types of tumors may also increase resistance to chemotherapy and
radiotherapy.5
*

Portions of this chapter previously appeared as Nawimanage, R. R.; Prasai, B.;
Hettiarachchi, S. U.; McCarley, R. L., Rapid, Photoinduced Electron Transfer-Modulated,
Turn-on Fluorescent Probe for Detection and Cellular Imaging of Biologically Significant
Thiols. Anal.Chem., 2014, 86, 12266-12271. (Featured article “ACS Editor’s Choice”). It is
reprinted by permission of copyright (2014) from the American Chemical Society.
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Increased total Hcy level in blood is denoted as hyperhomocysteinemia, and it is
emerging as a strong risk factor for atherosclerotic vascular diseases. Moreover, Hcy levels
in plasma and serum are also valuable indicators of pregnancy complications, vitamin B12
and folate deficiencies, and mental disorders.6
In cells, bio-thiols exist mostly in their reduced thiol form, with total LMM thiol
concentration being 2–17 mM; glutathione makes up approximately 90% of intracellular
LMM bio-thiols.2, 7 In stark contrast, cysteine, homocysteine, and glutathione are present in
the extracellular (plasma) environment at very low concentrations, roughly 12–20 µM.7 In
the cytosolic compartment, protein thiols are more abundant (10–50 mM) than free LMM
thiols, and they are over whelmingly in the reduced from (90%). Human serum albumin is
the most abundant plasma protein, and it accounts for 55–60% of the measured serum
protein.8 Although most of the previously reported probes are sensitive to millimolar levels
of thiols, there are few extant methods that can detect LMM thiols at low micromolar
concentrations with good selectivity and sensitivity.9-10
Thus, the development of efficacious methods for detection and quantification of biothiols has received significant attention in recent years.7 Many instrumental methods for the
detection of thiols have been reported, such as high performance liquid chromatography,
capillary electrophoresis, mass spectrometry, and electrochemical methods. However, these
methods have certain limitations, such as complex sample processing and high equipment
cost, which make them impractical for routine clinical analysis. Owing to their simplicity,
low cost, and selectivity, a variety of colorimetric and fluorescent probes have gathered
much attention during the last decade, particularly those probes that take advantage of either
the high nucleophilicity of thiols or their affinity for transition metals.1 Presently, there is a
small group of environmentally stable probes whose fluorescence is turned on in the
complex media of mammalian cells only by the collective presence of the biologically
relevant thiol compounds. Fluorescence ensues from these probes upon their activation by
thiol reactions of varying selectivity; for example, cleavage,11 cyclization,12 or metalcomplex displacement,13 to name a few. Recent approaches that make use of Michael
addition reactions for probe activation include those employing Michael acceptors, such as
maleimide,14-15 squarine,15 oxa-norbornadiene,16 chromane,17 propiolate,18 acrylic acid,19
unsaturated aldehydes/ketones,19-21 and malonitrile,22 as well as quinones.23-24
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To date, most of these probes that respond to thiol presence are limited in bio-analysis
and cellular imaging applications, as a result of slow response time and decreased water
solubility of probe, the large fluorescence background response of the probe in comparison
to the signal of the reporter (caused by spectral overlap of probe and reporter
absorption/emission), and the requirement of highly concentrated analyte to elicit significant
reporter response (leads to high limits of detection). Furthermore, the GSH/Cys/Hcy
selectivity of these previously reported probes with regard to presence of H2S or protein
thiols is either not known or is quite poor.
Thus, due to the crucial role that GSH, Cys, and Hcy play in biological systems,
particularly within cells, it is important to develop probes that are passively taken up by
cells in a quick fashion; whose fluorescence signal is rapidly turned on in the presence of
these three biological thiols, while remaining fluorescently silent upon exposure to other
biologically important analytes; and whose fluorescence background response in
comparison to the signal of the reporter is exceedingly small (minimal spectral overlap of
probe and reporter absorption/emission), so as to allow for cellular imaging with high
contrast (large signal-to-background ratio).
The work here presents the design, synthesis, and evaluation of a quinone–based, turn on
probe HMBQ-Nap 1 (Figure 3.1) that offers rapid and selective detection of physiological
thiols at the sub-micromolar level, and yields quick (<5 min) and selective imaging of biothiols within human cancer cells. The general design rationale of the photoinduced-electron

Figure 3.1 Design concept of thiol–activated fluorescence probe HMBQ-Nap 1.
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transfer (PeT) quenched fluorescence probe HMBQ-Nap 1 is as follows. HMBQ-Nap 1
contains 4-amino-9-(n-butyl)-1,8-naphthalimide (Nap 2) as the reporter dye and
hydroxymethyl benzoquinone (HMBQ) as the PeT quencher and potential reaction site for
thiols. Thus, upon successful thiol–probe interaction (elimination of thiol-HMBQ product
and CO2), a highly intense fluorescence signal is expected. Furthermore, the electrically
neutral HMBQ-Nap 1 should enter cells readily25 and report the presence of bio-thiols.

3.2 Experimental
3.2.1 Synthetic Material and Methods
All the column purifications were performed using SNAP silica columns on a
Flashmaster Personal from Biotage. Chemicals were purchased from Sigma-Aldrich or
Fisher Scientific. Thin-layer chromatography was performed on aluminium-backed 60 F254
silica plates from EMD Chemicals Incorporated. All the 1H NMR and

13

C NMR spectra

°

were collected in D2O or DMSO-d6 at 25 C on a Bruker AV-400 Spectrometer. Chemical
shifts are reported in the standard  notation of parts per million, using tetramethylsilane
(TMS) as an internal reference. Absorption bands in NMR spectra are listed as singlet (s),
doublet (d), triplet (t), or multiplet (m), and the coupling constants J are expressed in hertz
(Hz). Mass spectral analyses were carried out using an Agilent 6210 ESI-TOFMS. All the
solutions were prepared using Nanopure water from a Barnstead Diamond Nanopure water
System (18 MΩ-cm).

3.2.2 Synthesis
The synthesis of hydroxymethyl benzoquinone (HMBQ) was described in the previous
chapter, 4-amino-9-(n-butyl)-1,8-naphthalimide (Nap 2) and HMBQ-Nap 1 were
synthesized by adapting literature methods. A synthesis scheme for the synthesis of HMBQNap 1 is shown in the Scheme 3.1. 26

4-Amino-9-(n-butyl)-1,8-naphthalimide (Nap 2)
Under nitrogen atmosphere, 4-amino-1,8-napthalic anhydride 4 (1.14 g, 4.6 mmol) was
dissolved in 250 mL ethanol and brought to reflux. Upon addition of the n-butylamine (2.0 mL,
20.23 mmol) the mixture was refluxed for 14 h. After cooling, the solvent was removed under
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reduced pressure, and the crude material was purified on a flash column (20:1 DCM:
EtOAc) to yield the product Nap 2 as a yellow solid in 75% yield.
1

H NMR (400 MHz, DMSO-d6) δ 8.61 (d, J = 8.4 Hz, 1H), 8.43 (d, J = 7.3 Hz, 1H), 8.24 –

8.13 (m, 1H), 7.66 (t, J = 7.9 Hz, 1H), 7.43 (s, 2H), 6.85 (d, J = 8.6 Hz, 1H), 4.01 (t, J = 7.5
Hz, 2H), 1.58 (p, J = 7.5 Hz, 2H), 1.33 (h, J = 7.7 Hz, 2H), 0.95 – 0.89 (m, 3H).

13

C NMR

(126 MHz, DMSO-d6) δ 14.22, 20.30, 30.31, 108.04, 108.62, 119.83, 122.27, 124.45,
129.73, 130.14, 131.45, 134.40, 153.14, 163.36, 164.23.

ESI-MS: for C16H16: N2O2:

expected m/z = 269.1292 [M+H]+; found m/z = 269.1288 [M+H]+; 1.5 ppm error.

Scheme 3.1 Synthesis of HMBQ-Nap.

Synthesis of HMBQ-Nap 1
4-Dimethylaminopyridine (DMAP; 32.92 mg, 0.27 mmol) was added to a solution of
Nap 2 (36.39 mg, 0.14 mmol) in anhydrous DCM, then to the mixture was added a solution
of phosgene (15% toluene, 1 mL) at −10 °C and stirred under argon for 3 h. The excess
phosgene was removed by bubbling argon gas through the solution for 30 min. To this
resulting solution was added compound 5 (70.39 mg, 0.39 mmol), and the solution was
stirred at 0 °C for an additional 12 h. The reaction mixture was quenched with water (30 mL)
and extracted with CH2Cl2 (3 × 50 mL). The organic phase was dried over Na2SO4,
subsequently filtered, and the solvent was evaporated. The crude product was purified by
silica gel flash column using CH2Cl2/EtOAc (10:1, v/v). The final product was obtained as a
yellow solid.

1

H NMR (400 MHz, DMSO-d6) δ 10.30 (s, 1H), 8.65 (dd, J = 8.8, 3.7 Hz,

1H), 8.57–8.43 (m, 2H), 8.16 (dd, J = 8.3, 3.7 Hz, 1H), 7.82 (td, J = 8.2, 3.6 Hz, 1H), 5.14
(d, J = 3.5 Hz, 2H), 4.03 (q, J = 6.0, 4.4 Hz, 2H), 2.15 (d, J = 3.7 Hz, 3H), 1.99 (d, J = 3.5
Hz, 6H), 1.61 (p, J = 7.4 Hz, 2H), 1.42–1.30 (m, 2H), 0.97–0.87 (m, 3H).
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13

C NMR (100

MHz, DMSO-d6) δ 12.56, 12.72, 14.18, 20.26, 30.14, 58.52, 117.70, 118.89, 122.70,
124.40, 126.86, 128.78, 129.76, 131.37, 132.11, 136.80, 140.48, 141.14, 144.82, 154.19,
163.38, 163.92, 185.92, 187.42 ESI-MS: for C27H26N2O: expected m/z 475.188 [M+H]+;
found m/z = 475.1864 [M+H]+; 1.5 ppm error.

3.2.3 Spectroscopic Methods
All spectroscopic measurements were performed in phosphate buffer/0.1 M KCl
solutions, pH 7.4. Fluorescence data were collected using a Perkin Elmer LS-55
spectrometer,

and

absorption

spectra

were

recorded

using

a

Varian

Cary-50

spectrophotometer. Samples for absorption and emission measurements were obtained in 1cm × 1-cm quartz cuvettes (3.5 mL volume, Sigma-Aldrich).

3.2.4 Voltammetric Measurements
Cyclic voltammetry was performed in 0.1 M (n-butyl)4NClO4/dry acetonitrile under
anaerobic conditions. Power Suite 2.53 operating software was used with a Princeton
Applied Research Model 273A Potentiostat/Galvanostat. Voltammograms were collected at
scan rate of 0.1 Vs−1 at room temperature (25 °C) after degassing the solution with nitrogen
for 20 min. Glassy carbon working (BAS, 3-mm diameter), platinum wire counter, and
Ag/AgCl reference (BAS) electrodes were used, and the potentials were referenced versus
ferrocene/ferrocenium internal standard.

3.2.5 Procedure for Thiol Sensing
A stock solution of 100 µM

HMBQ-Nap 1 was prepared in 100% DMSO and was

subsequently diluted to prepare preferred concentration solutions of HMBQ-Nap 1 in pH 7.4
DMSO/PBS buffer (10% DMSO:90% 0.1 M PBS buffer). Stock solutions of thiol were freshly
prepared prior to each experiment. For the calibration curve, the solution of HMBQ-Nap 1 was
incubated with different concentrations of thiols at 25 °C for 15 min, and spectral data were
recorded. Excitation was performed at 432 nm, and emission was detected at 540 nm. The
excitation and emission slit widths were set at 2.5 nm.
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3.2.6 NQO1 Enzyme Kinetics
All fluorescence measurements (λex = 432 nm, λem = 540 nm) were obtained at 25 °C, using a
Fluorostar Optima plate reader with solutions made in pH 7.4, 0.1 M PBS/0.1 M KCl/0.007%
BSA. A stock solution of 400 M β-nicotinamide adenine dinucleotide reduced disodium salt
(NADH, Sigma-Aldrich) was prepared in pH 7.4, 0.1 M PBS/0.1 M KCl/0.007% BSA so the
subsequent assay solutions possessed a final concentration of 1 × 10−4 M β-NADH in each well.
A stock solution of HMBQ-Nap 1 in 100% DMSO was made and then diluted to obtain a
concentration series from 5 × 10−7 to 11.5 × 10−6 M probe in pH 7.4, 0.1 M PBS/0.1 M
KCl/0.007% BSA 2 × 10−3g mL−1 stock solution of recombinant hNQO1 (Sigma-Aldrich) was
prepared using the same buffer/BSA system as above so as to give 2.0 × 10 −6 g hNQO1 per
assay. Assays were performed in a quartz 96-well plate containing an appropriate amount of
HMBQ-Nap 1 stock solution to obtain the preferred concentrations, 50 L of enzyme solution,
and an amount of BSA solution to make a total volume of 150 L in a well. Measurements were
initiated by the addition of 50 L NADH solution. Measurements were collected every 30 s for
10 min. Fluorescence units were converted to concentration by relating the signal increase to a
fluorescence signal derived from a known concentration of Nap 2 reporter. The linear portion of
the plots of velocity versus HMBQ-Nap 1 concentration were used to obtain apparent Km and
Vmax values from nonlinear least-squares analysis employing algorithms developed by Cleland
for Michaelis−Menten kinetics.

3.2.7 Cell Culture
Human non-small cell lung cancer cells H596, cell culture base media, and fetal bovine
serum (FBS) were purchased from American Type Cell Culture (ATCC, Manassas, VA). All cell
culture procedures were performed as suggested by ATCC. H596 cells were cultured in RPMI1640 with 10% FBS and 100 IU/ml penicillin-streptomycin. Cells were incubated at 37 °C in a
humidified incubator containing 5% wt/vol CO2.
3.2.8 Cell Imaging via Scanning Laser Confocal Microscopy
H596 cells were cultured overnight on 22-mm × 22-mm glass cover slips on a treated tissue
culture 6-well plate purchased from Fisher Scientific. The existing growth medium was replaced
with 2 mL of fresh medium and then incubated at 37 °C. Solutions of HMBQ-Nap 1 dissolved in
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DMSO were added to the cells to give final concentration of 2 × 10−5 M of HMBQ-Nap 1,
keeping the DMSO concentration at < 1%. Then cells were incubated with HMBQ-Nap 1 at 37
C for 10 min. Cells were then treated with 3.0 × 10−6 M DRAQ5 (nuclear stain obtained from

°

Thermo Scientific) for 1 min. Next, the medium was removed, and the cells were fixed in 2 mL
of 4% paraformaldehyde for 15 min with shaking. After fixing, the cells were rinsed with
Nanopure water, and the cover slips were mounted to glass slides with Immumount (obtained
from Fisher Scientific). Glass slides were left in the dark overnight to allow the Immumount to
dry. Confocal images were acquired using a Leica TCS SP2 spectral confocal microscope. For
images of cells exposed to HMBQ-Nap 1, samples were excited using the 458-nm line of an
Ar/KrA laser (laser intensity = 72%), and the spectral emission was collected between 458 and
514 and 514 and 680 nm (Leica DD458/514); PMT voltage = 710 V. Similarly, cells exposed to
DRAQ5 were excited using the 633-nm line of a HeNe laser (laser intensity = 35%), and the
spectral emission was collected between 678 and 773 nm. All images were collected using a
pinhole of 3.1 Airy units. Images were frame and line averaged 4 times. Image analysis was
performed using ImageJ and Leica LAS AF lite software. As the control experiment to scavenge
all the thiols in cells, H596 cells were pre–incubated with 10 mM N-ethylmaleimide (NEM) at 37
°

C for 30 min. Then the cells were washed with 0.1 M, pH 7.4 PBS to remove any excess NEM,

followed by incubation with 2 × 10−5 M HMBQ-Nap 1 prior to their being fixed as described
previously.

3.3 Results and Discussion
3.3.1 Spectral Properties of HMBQ-Nap 1 / Nap 2 System
To demonstrate the off-on nature of the probe 1/reporter 2 system, the absorbance and
fluorescence emission spectra of HMBQ-Nap 1 probe and pure Nap 2 reporter were obtained in
aqueous phosphate buffer media at physiological pH (pH 7.4), Figure 3.2. HMBQ-Nap 1 probe
shows absorbance maximum around 380 nm and very low (almost negligable) emission
maximum around 460 nm Figure 3.2 (a). The free reporter Nap 2 (Figure 3.2 (b)) displays
absorbance maximum at 432 nm with significantly large fluorescence enhancement at 540 nm.
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Figure 3.2 Absorption and emission spectra of 2 × 10−6 M (a) HMBQ-Nap 1 and (b) Nap 2 in
10% DMSO/90% 0.1 M, pH 7.4 phosphate-buffered saline (PBS) at 25 °C.

Nap 2 exhibits a strong Stokes shift between its absorption (abs = 432 nm) and fluorescence
emission (em= 535 nm) maximum due to internal charge transfer, and the absorption maximum
84

of Nap 2 is red–shifted by ~70 nm from that of the HMBQ-Nap 1 probe making this set an
excellent probe/reporter pair with minimum spectral overlap. To make sure efficient PeT
quenching, quantum yields were also obtained in 90% aqueous buffered media with pH 7.4
phosphate buffered saline in 10% DMSO as co-solvent.

3.3.2 Calculation of Quantum Yield
Fluorescence quantum yields of Nap 2 dye and

HMBQ-Nap 1 were determined with

reference to two different standards, coumarin in EtOH () and quinine sulfate in 1 N
H2SO4 ().27 Initially, a stock solution of Nap 2 was prepared in DMSO and diluted with
10% DMSO:90% 0.1 M, pH 7.4 phosphate–buffered saline to yield an absorbance between
0.02–0.08 absorbance units. Similarly, stock solutions of coumarin samples were also prepared
in ethanol and diluted until the absorbance fell between 0.02–0.08 absorbance units. Then
solutions were transferred to a 1-cm × 1-cm quartz cuvette and fluorescence measurements were
taken by exciting the sample at the cross–over point of the absorbance spectra as shown in Figure
3.3 (a). In the same way as described above, fluorescence measurements were obtained for the
HMBQ-Nap 1 probe and the quinine sulfate sample (Figure 3.3 b).

𝐴

𝐹

2

𝑛

𝛷𝐹(𝑋) = ( 𝑆 ) ( 𝑋 ) ( 𝑋 ) 𝛷𝐹(𝑆)
𝐴
𝐹
𝑛
𝑋

𝑆

Equation 3.1

𝑆

The quantum yields were then calculated according to the Equation 3.1 where ФF is the
fluorescence quantum yield, A is the absorbance at the excitation wavelength, F is the area under
the corrected emission curve, and n is the refractive index of the solvents used. Subscripts S and
X refer to the standard and to the unknown, respectively. Since the samples were excited at the
cross over point of the two sample absorbances the values were canceled out. Similarly refractive
indexes were canceled out due to the majority of the media being aqueous; simplifying the
equation where area F accounts for the number of emitted photons. Calculated quantum yields
for the probe HMBQ-Nap 1 and reporter Nap 2 were ФHMBQ-Nap 1 =0.003 and ФNap 2 = 0.19.
Based on its extremely low intensity emission spectrum (Figure 3.2 (a) ) and miniscule quantum
yield, the fluorescence of the HMBQ-Nap 1 probe is quenched in a highly effective manner in
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stark contrast to the 65 times brighter Nap 2 reporter. This characteristic is attributed to HMBQNap 1 being efficiently PeT quenched. Nap 2 reporter and HMBQ head group in HMBQ-Nap 1
act as a good donor and acceptor moiety making the probe efficiently PeT quenched. To further
evaluate this possibility electrochemical measurements were carried out and are described in the
following section.

3.3.3 Thermodynamic Feasibility of PeT quenching
To assess the thermodynamic feasibility of fluorescence quenching of HMBQ-Nap 1 by
oxidative photo-induced electron transfer (OeT), voltammetric measurements of HMBQ-Nap 1
and its components (Figure 3.3, Figure 3.4 and, Figure 3.5) were used in conjunction with the
Rehm-Weller equation (Equation 3.2) to calculate the free energy of the PeT process.
a)

0.08
0.07

Absorbance

0.06
0.05
0.04
0.03
0.02
0.01
0.00
350
0.08

b)

400

450

500

550

600

Wavelength (nm)

0.07

Absorbance

0.06
0.05
0.04
0.03
0.02
0.01
0.00
300

350

400

450

500

Wavelength (nm)

Figure 3.3 Absorbance overlap of a) Nap 2 (blue) in DMSO/0.1 M, pH 7.4 phosphate-buffered
saline (PBS) with coumarin (green) in EtOH/0.1 M, pH7.4 PBS, and b) HMBQ-Nap (yellow) in
DMSO/ 0.1 M, pH 7.4 PBS with quinine sulfate (blue) in 1 N H2SO4 at 25°C.
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Figure 3.4 Absorption (blue) and emission (green) spectra of Nap 2 in acetonitrile at 25 °C.
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Figure 3.5 Cyclic voltammetry of HMBQ-Nap 1 at a 3-mm diameter glassy carbon working
electrode using 0.1 M tetra–butylammonium perchlorate in acetonitrile. Scan rate was 0.1 V s−1.
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∆𝐺𝑃𝑒𝑇 = 𝐸𝐷 − 𝐸𝐴 − ∆𝐺00 −
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𝜀𝑑

Equation 3.2

From the cyclic voltammetric graphs (Figure 3.5) oxidation and reduction potentials of Nap 2
and head group HMBQ was determined. The OeT process, the redox potential (ED) of the donor
Nap 2 and the potential (EA) of the acceptor HMBQ 3 were determined to be 1.24 V and −0.92
V, respectively. ΔG00, the energy of the first excited singlet state of Nap 2, was found to be 2.67
eV and e2/εd is the Coulombic interaction energy of the ion pair, known to be 0.06 eV. From
these values, the energy change for OeT quenching, ΔGPeT, is calculated to be −0.95 eV,
indicating that electron transfer from the excited Nap 2 to the electron–poor HMBQ 3 is
thermodynamically feasible.

3.3.4 Reduction Initiated Turn-on of HMBQ-Nap 1
As hypothesized, the reduction activation of the HMBQ-Nap 1 should initiate a cascade of
reactions that would eliminate the reporter Nap 2, forming quinone methide and CO2 as by
products (Figure 3.6). Upon reduction the release of the Nap 2 reporter should turn on the bright
fluorescence signal associated with it.

Figure 3.6 Schematic representation of reduction-activated elimination of HMBQ-Nap 1.

In order to determine the capability of HMBQ-Nap 1 to act as a turn-on probe upon
reduction, aqueous solutions of HMBQ-Nap 1 were exposed to a solution of excess sodium
dithionite (DT), and fluorescence was monitored at 540 nm while exciting the sample at 432 nm.
As shown in the Figure 3.7, a rapid increase in fluorescence was observed both in the timedependent fluorescence scan (excited at 432 nm and emission detection at 540 nm) and timelapsed wavelength scan from 450 nm to 650 nm. Maximum release was achieved within about
250 s after addition of DT. Vigorous release of Nap 2 reporter after the initial reduction by
dithionite was apparent by the appearance of the fluorescence band centered around 540 nm
(Figure 3.7 inset), which matched exactly with the free Nap fluorescent band in 10%DMSO:
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90% PBS at pH7.4. Invigorated by these results, I set out to find out the possible thiol–probing
ability of HMBQ-Nap 1.
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Figure 3.7 Time-dependent fluorescence of HMBQ-Nap 1 (10 M), after addition of 50 M
Na2S2O4 (DT) in 10% DMSO:90% pH = 7.4 PBS buffer at 25 °C. Inset: wavelength scan of 2
M HMBQ-Nap 1 after DT addition from 450 nm–650 nm;  t = 2 min.
3.3.5 In Vitro Response to Biological Thiols
The ability of HMBQ-Nap 1 to act as a turn-on thiol probe when in the presence of select
biological thiols was determined by exposing aqueous, buffered solutions of HMBQ-Nap 1 to
three physiologically significant non-protein thiols—GSH, Cys, and Hcy. As expected from
previous DT reduction experiment (Figure 3.7) a rapid reaction response were observed with all
three non-protein thiols. The rapid nature of the turn-on process was evidenced by the ~150 s
time required to reach 90% of the maximum attainable signal, as shown in Figure 3.8. As
expected for this group of biological thiols (similar thiol pKa value) and the HMBQ trigger
group, there is no significant difference in fluorescence signal profile. At this time, it is not
known why the maximum achievable signal plateau is larger for GSH vs Cys and Hcy. The
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temporal integrity of the fluorescence signal generated by production of Nap reporter was
investigated so as to test for possible biological thiol-induced structural alterations of the Nap
reporter. It was found that the fluorescence intensity of Nap was invariant when the reporter was
treated with 100 equivalents of GSH (1 mM, Figure 3.8, green line) for up to 2000 s of
incubation, the maximum time tested.
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Figure 3.8 Time-dependent fluorescence (ex = 432 nm, em= 540 nm) from 10 M HMBQ-Nap
1 incubated with 50 M thiol-containing analyte in 0.1 M, pH 7.4 PBS/DMSO (9:1) at 25 °C.
Fluorescence signals were compared to that from a 10 M solution of Nap 2. The stability of 10
M Nap 2 with 1 mM GSH is demonstrated by the green line.
To determine whether the HMBQ-Nap 1 fluorescence turn-on response is a function of thiol
concentration in the media, varying concentrations of all three thiols were incubated with 2 M
HMBQ-Nap 1 solution for 15 min (Figures 3.9–3.11), and then the turn-on response at 540 nm
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Figure 3.9 a) Fluorescence spectral changes of HMBQ-Nap 1 (2 M) with a GSH (0–2 M ), b)
the fluorescence intensity (λex = 432 nm/λem = 540 nm) plot vs concentration of GSH. Error bars
represent the standard deviation of the average data points for each concentration (n = 3).
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Figure 3.10 a) Fluorescence spectral changes of HMBQ-Nap 1 (2 M) with Cys (0–2 M), b) the
fluorescence intensity (λex = 432 nm/λem = 540 nm) plot vs concentration of Cys. Error bars
represent the standard deviation of the average data points for each concentration (n = 3).
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Figure 3.11 a) Fluorescence spectral changes of HMBQ-Nap 1 (2 M) with Hcy (0–2 M), b)
the fluorescence intensity (λex = 432 nm/λem = 540 nm) plot vs concentration of Hcy. Error bars
represent the standard deviation of the average data points for each concentration (n = 3).

93

was measured. As shown by plots in Figures 3.9–3.11, the extent of the fluorescence increase
was a function of the biological thiol: HMBQ-Nap 1 ratio. Upon evaluation of plots of the
fluorescence intensity versus each biological thiol concentration it was found that there exists a
linear relationship for bio-thiol concentrations up to 2 M (Figure 3.9–3.11, b). From these
calibration curves, it was determined that the concentration limit of detection for GSH, Hcy, and
Cys was 33, 21, and 29 nM; and the concentration limit of quantification was 110, 70, and 98 nM
respectively. These results indicate the potential use of HMBQ-Nap 1 probe for the rapid
detection and quantification of lower nM range of thiols in physiological media.
As speculated by literature reports, possible turn-on mechanism of HMBQ-Nap 1 by thiols
could be the result of either merely redox activation or a nucleophilic addition to the quinone
moiety. Because there is no clear indication of the possible route, 1H NMR and mass
spectrometric studies were conducted to determine the products and then propose a plausible
reaction mechanism for the release of the free reporter. NMR studies were carried out with
mercaptoethanol, a thiol–containing small molecule as a mimic of cellular thiols in the media. As
shown in Figure 3.12 (a and b), the initial NMR Spectrum of 2 mM HMBQ-Nap and 2 mM
reporter Nap 2 in 9:1 DMSO:D2O were recorded. Subsequently, 5 equivalents of
mercaptoethanol were added to the HMBQ-Nap sample, and spectra were recorded every four
seconds for about 4 hours. The rapid increase of peaks corresponding to Nap 2 reporter
production was observed, and in addition, there were two sharp peaks around 6.12 ppm and 5.78
ppm that quickly appeared and then diminished as time progress. These peaks were speculated to
be two alkene hydrogens in a quinone methide. To further evaluate this concept, the products
formed by the added mercaptoethanol stimulus were further characterized by mass spectrometry
analysis after vaccum drying the mercaptoethanol HMBQ-Nap sample. As shown in Figure 3.13,
Nap 2 reporter was formed, as noted by the [M−H]− signal at m/z 267.1138 (expected m/z
267.1134; −1.50 ppm error) in panel a. Similarly, the mercapthoethanol product of the reactive
quinone methide was observed in panel b, evidenced by the [M−H]− signal at m/z 239.0689
(expected m/z 239.0742; 22.2 ppm error). As seen in panel c, free HMBQ, resulting from water
addition to the quinone methide, was also found to be present: [M−H]− signal at m/z 179.0688
(expected m/z 179.0708; 11.2 ppm error).
Outcomes from both 1H NMR and mass spectrometry studies demonstrate that thiols undergo
Michael addition to HMBQ-Nap in aqueous media to unleash Nap reporter and quinone methide
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products; there is no indication of redox activation of HMBQ-Nap 1, as noted by the absence of
spectroscopic signatures for reduced HMBQ (hydroquinone).
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c) Mercapthoethanol added to a, Δt = 1 min
*
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*

*

d) Same as c, Δt = 15 min

Figure 3.12 NMR spectra of: a) HMBQ-Nap 1 (2 mM) sample in 9:1 DMSO:D2O; b) Pure Nap 2
sample in 9:1 DMSO:D2O; c) upon addition of 5 equivalents of mercaptoethanol to a, spectrum
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was recorded 1 min after addition; d) recorded spectrum of reaction mixture 15 min after
addition.

Figure 3.13 Negative-ion mass spectrum of HMBQ-Nap 1 upon reaction with mercaptoethanol
to yield a) reporter 2 as observed by [M−H]− signal at m/z 267.1138 (expected m/z 267.1134,
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−1.50 ppm error), b) mercaptoethanol product observed by [M−H]− signal at m/z 239.0689
(expected m/z 239.0742, 22.2 ppm error), c) HMBQ head group observed by [M−H]− signal at
m/z 179.0688 (expected m/z 179.0708, 11.2 ppm error).
3.3.6 Selectivity of HMBQ-Nap to Biological Thiols
The potential sulfur-based, cross-reactive species H2S and bovine serum albumin (BSA) were
chosen for initial evaluation of HMBQ-Nap 1 selectivity. Hydrogen sulfide (H2S), or more
appropriately HS− at physiological pH, has become an increasingly studied species in cells due to
its link to cellular signaling pathways and a variety of inflammatory–associated diseases.28 Even
though its cellular concentration (nM) is estimated to be dwarfed by that of the more abundant
biological thiols,28 H2S could possibly be an interferent because of the potential for it to undergo
Michael addition to29 or cause reduction of the HMBQ group. In addition, the protein content is
roughly 20–25 wt% inside cells, with many of those proteins possessing free thiol groups.30
Furthermore, over 90% of the extracellular thiols in blood are due to the presence of the most
abundant protein (~60%), serum albumin.31 Human serum albumin (HSA), like BSA, has only
one free thiol (Cys 34);32 this is a potential site of reaction with HMBQ-Nap. BSA was chosen
for study here due to the known variability in the free thiol content of Cys 34 in HSA upon its
storage.32
From the kinetic studies in Figure 3.14, it is found that in stark contrast to the rapid reaction
of HMBQ-Nap with GSH, Cys, and Hcy, an exceedingly sluggish response is observed for
HMBQ-Nap 1 in the presence of H2S and BSA under equivalent conditions. At 150 s, the signal
from GSH is 103-fold higher than that from H2S and 17 times greater than for BSA. However, I
have found that the fluorescence quantum yield of Nap 2 is roughly 25% higher in the presence
of 50 µM BSA (Figure 3.15) under equivalent conditions to those in Figure 3.14, and the
maximum absorbance of Nap 2 was also blue shifted about 10 nm (Figure 3.13); this is possibly
due to viscosity and hydrophobic interaction effects. Thus, the selectivity of HMBQ-Nap
activation by GSH, Cys, or Hcy versus BSA is certainly higher. The slow reaction of the thiol
(Cys 34) in BSA with HMBQ-Nap 1 can be attributed to it being sterically hindered, as the thiol
of Cys 34 is oriented toward the interior of the protein,7 an observation that is consistent with the
slow reactivity of Cys 34 in HSA with Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid)).33 It
is posited that the low reactivity of H2S with HMBQ-Nap 1 is due to the lack of either HMBQ
reduction by H2S or its Michael addition to HMBQ. The reduction potential of HMBQ in probe
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1 is −0.80 V vs SHE in comparison to 0.17 V34 for H2S, and successful Michael addition of H2S
requires a very electron deficient acceptor.29, 35

Figure 3.14 Time–dependent fluorescence (ex = 432 nm, em = 540 nm) of 10 M HMBQ-Nap 1
incubated with 50 M thiol–containing analytes in 0.1 M, pH 7.4 PBS/DMSO (9:1) at 25 °C.
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Figure 3.15 Fluorescence change for free Nap 2 reporter with BSA addition. Nap 2 (red line) in
10% DMSO: 90% PBS buffer pH 7.4 before BSA addition, and Nap 2 (green line) in 10%
DMSO:90% PBS buffer pH 7.4 after BSA addition.
To further describe the selectivity of HMBQ-Nap activation by GSH, Cys, and Hcy, I
examined HMBQ-Nap 1 stability under physiological solution conditions in the presence of
select amino acids and reducing agents that might possibly activate HMBQ-Nap 1 so as to yield
Nap 2 reporter. Upon inspection of Figure 3.16, it is clear that the three thiol-free amino acids (1
mM, 100 equivalents) and the other nucleophilic amino acids, such as serine and threonine, with
the potential to undergo Michael addition to the HMBQ unit, do not interact with HMBQ-Nap 1.
Furthermore, the biological reductants NADH (E1/2 = −0.31 V)36—present at mM levels within
cells—and the ubiquitous ascorbic acid (E1/2 = 0.051 vs. SHE)37 also did not induce the release of
Nap 2 from HMBQ-Nap 1. The lack of redox-induced activation of HMBQ-Nap by these species
is in agreement with the observations above with H2S, as the reduction potentials of these
possible interferents are not sufficient to allow reduction of the HMBQ unit in HMBQ-Nap
probe (−0.80 V vs SHE).
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Figure 3.16 Fluorescence response of HMBQ-Nap (10 µM) incubated at 25 °C for 30 min with 1
mM amino acids and common reductants in 10% DMSO/90% 0.1 M, pH 7.4 PBS. Bars
represent % release of free Nap 2 reporter with respect to that achieved for HMBQ-Nap 1
incubated with GSH for 30 min.
3.3.7 Reactivity of HMBQ-Nap with NADH Quinone Oxidoreductase
NAD(P)H:quinone oxidoreductase-1 (NQO1, DT-diaphorase, EC 1.6.99.2)38-39 is a
ubiquitous, homodimeric flavoprotein with one molecule of FAD non-covalently bound per
monomer.40 NQO1 is generally regarded as a detoxifying enzyme, where its major role has been
considered to be its stability to catalyze the reduction of various quinones by direct two-electron
reduction of quinone to hydroquinones.41 Owing to its known function of reacting with quinones
and its presence mainly in the cytosol, I speculated that it could be a possible interferent for
HMBQ-Nap 1 in cellular media. To test if human NQO1 can initiate the reduction of HMBQNap 1 and release of free Nap 2 reporter, enzyme kinetic assays were used to monitor the
production of fluorescent reporter over time for a given fixed amount of enzyme. (Figure 3.17)

Figure 3.17 Kinetics of human NQO1 (2 × 10−6 g) with HMBQ-Nap (0.5−11.5 × 10−6 M) in pH
7.4, 0.1 M phosphate buffer. Values (n = 3) are the average ±1 sample standard deviation. The
curve is the best fit to the average data. T = 25 °C.
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For quantitative evaluation of HMBQ-Nap 1 activation by human NQO1, I observed the
rapid fluorescence intensity increase at 540 nm with different concentrations of HMBQ-Nap 1
(0.5–11.5 × 10−6 M) with a fixed amount of human NQO1 (2 × 10−6g) and its cofactor NADH (1
× 10−4 M). All the fluorescence units were converted to concentration units using a calibration
curve for free Nap 2 reporter. Control experiments with NADH alone did not yield significant
changes in fluorescence. The initial rate of product formation, V (mol min−1mg.hNQO1−1), was
calculated and plotted as a function of HMBQ-Nap 1 concentration, Figure 3.15. Apparent
kinetic parameters were then obtained by fitting the data in Figure 3.15 to the Michaelis-Menten
equation, namely the Michaelis constant (Km) = 9.959 ± 1.189 M, maximum velocity (Vmax) =
1.483 ± 0.096 mol min−1mg.hNQO1−1, catalytic constant (kcat) = 45.70 ± 0.01 min−1, and
catalytic efficiency (kcat/Km) = 4.37 × 106 ± 0.58 M−1s−1. These results indicate that the reduction
of the quinone moiety of HMBQ-Nap 1 with human NQO1 is possible and quite rapid under
physiological conditions. As a comparison between thiol reduction and NQO1 reduction,
observed rate constants (kobs) were calculated in the presence and absence of GSH; the most
abundant non protein thiol along with NQO1. The experiment was designed such that a mixture
of an equal concentration of (1 × 10−4 M) NADH and GSH were added to each well at the same
time, and the fluorescent increase was monitored over time. Apparent kinetic parameters (kobs)
were then obtained (Figure 3.16 a and b) and compared with each other to understand if there is
any significant difference between the observed rate constants.
The attempt to find out the Michalis–Menten enzyme kinetic parameters for the NQO1
catalysis of HMBQ-Nap 1 with the presence of thiols was not successful due to the reaction not
approaching steady–state kinetics. The enzyme graph (i.e. fluorescence release) in the presence
of thiol was completely linear (graph is not shown); whereas a typical Michaelis–Menten graph
should adopt a hyperbolic shape as it approaches steady–state kinetics. I assumed that the reason
for not approaching the steady–state kinetics was thiols being more efficient reducers of HMBQNap 1 than NQO1. In order to further prove this concept and compare the efficiency of the two
reductions, a comparison of observed rate constants (kobs s−1) was used. As shown in Figure
3.18a, the observed rate constant for fluorescence increase for the NQO1 without the GSH was
6.56 × 10−7 s−1, and the observed rate constant for the fluorescence increase for NQO1 in the
presence of the thiol GSH (Figure 3.18b) was 2.84 × 10−6 s−1. When the two kinetic parameters
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are compared, it is clear that in the presence of thiols the observed rate constant (kobs) is about
four times higher than that of NQO1 alone. From this observation and from the observations
from previous sections of thiol kinetics, it is clear that the thiol reduction of HMBQ-Nap 1 is
more rapid than NQO1 enzymatic reduction.

Figure 3.18 Kinetics (kobs s−1) of a) human NQO1 (2 × 10−6 g) with HMBQ-Nap 1 (0.5–11.5 ×
10−6 M), b) human NQO1 (2 × 10−6 g) with HMBQ-Nap 1 (0.5–11.5 × 10−6 M) in the presence
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of 100 M GSH in pH 7.4, 0.1 M phosphate buffer. Values (n = 3) are the average ±1 sample
standard deviation. The curve is the best fit to the average data T = 25 °C.

3.3.8 Imaging of Biological Thiol Presence in Human Cells
Upon demonstration that HMBQ-Nap 1 allows for class-selective detection of GSH, Cys, and
Hcy under low probe:analyte conditions, an analysis was undertaken to examine the ability of
HMBQ-Nap 1 to act as a possible imaging probe for the presence of these biological thiols in
human cells.
The ability of HMBQ-Nap 1 to detect thiols in live cells was evaluated using the human lung
cancer cell line H596, which is known to have a GSH content of 140±70 nmol mg−1 protein, and
it lacks NQO1.42 Two-dimensional cell cultures were incubated with 20 M HMBQ-Nap 1 for
10 min at 37 °C and subsequently washed with pH 7.4 PBS (0.1 M); after staining the nuclei with
DRAQ5, the cells were fixed using formaldehyde as fixing agent. As the negativecontrol/background experiment, H596 cells were pre-incubated with known thiol capping agent
10 mM N-ethylmaleimide (NEM) at 37 °C for 30 min to scavenge thiols in the cells, then the
cells were washed with pH 7.4 PBS (0.1 M) to remove excess NEM, followed by incubation
with 20 M HMBQ-Nap 1 for 10 min, and then washed with pH 7.4 PBS prior to their being
fixed as above. Fluorescence images were obtained using confocal laser microscopy via
excitation at 458 nm and detection at 458–514/514–680 nm, with integrated cellular fluorescence
intensity being obtained via software.
Unadulterated H596 cells that were exposed to HMBQ-Nap 1 exhibited strong fluorescence
(Figure 3.19, without NEM), whereas there was little fluorescence in the negative control cells
that were pretreated with thiol scavenger (Figure 3.19, with NEM). A signal-to-background ratio
of 4.2 was obtained upon comparison of the integrated fluorescence intensities for the untreated
and NEM-treated cells. Thus, electrically neutral HMBQ-Nap 1 is able to enter cells and report
on the presence of intracellular biological thiols in a rapid and selective fashion (10 min).

3.4 Conclusions
I have designed, synthesized, and made feasible a new dual quenching/trigger group-based
thiol probe whose PeT-quenched fluorescence signal is turned on selectively upon rapid reaction
of quinone trigger group with biologically important thiols leading to probe shedding of the
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thiol-activated trigger group. The probe HMBQ-Nap 1 exhibits high selectivity and rapid
response toward the three biological thiols glutathione, cysteine, and homocysteine, when
compared to protein-associated thiol or the simple gasotransmitter H2S, as well as other potential
interferents commonly found in mammalian systems. Rapid activation of HMBQ-Nap 1 by thiols

Figure 3.19 Microscopy images of human H596 lung cells A–C incubated for 10 min at 37 °C with 20 M
HMBQ-Nap 1, and D–F pre-incubated with 10 mM NEM thiol scavenger for 30 min at 37 °C, followed
by incubation with 20 M HMBQ-Nap 1 for 10 min at 37 °C. Confocal: A, B, D, E; and differential
interference contrast: C and F image. Scale bar = 20 m.

to yield the highly fluorescent reporter Nap 2 is attributed to thiol-addition-initiated elimination of the
trigger group. Although quinone reductase enzyme NQO1 caused considerable activation of the trigger
group, the NQO1 concentration in cells is far less than compared to mM thiol concentrations. Therefore,
NQO1 is most likely a small interferent in comparison to the cellular thiols. Furthermore, it has been
successfully demonstrated that HMBQ-Nap 1 can provide rapid and selective thiol detection in human
cells, and with an exceedingly low limit of detection under in vitro conditions where there is no need for
excessive amounts of probe, unlike previously reported probes that require probe:thiol ratios of 70:1 to
5000:1. Thus, HMBQ-Nap 1 diversifies the pool of biological thiol probes by offering rapid, classselective detection and quantification with high figures of merit.
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CHAPTER 4
CASCADE REACTION-BASED NEAR-INFRARED FLUORESCENT PROBES
FOR THE SELECTIVE DETECTION OF CYSTEINE
4.1 Introduction
Fluorescence-based small molecule probes have recently received much attention for their
use in the tracking of important analytes in cellular environments and biological fluids, without
affecting sample integrity. By making use of the intrinsically unique reactivities of select classes
of organic molecules, these probes can be tailored to detect either broad classes of analytes or
individual targets.1 In recent literature, there are numerous reported fluorescent probes that claim
to selectively detect various analytes, such as enzymes, metal ions, reactive-oxygen and nitrogen
species, and thiols.2-4
The sulfur-containing small molecules glutathione (GSH), cysteine (Cys), and homocysteine
(Hcy) are involved in a number of important biological processes, and they play an important
role in the body.5 Cys and Hcy are clearly prominent out of all the other naturally occurring
amino acids, as they are the only amino acids with a free thiol (–SH) moiety. Hcy and Cys differ
from each other by only a single methylene unit in their side chain, giving them similar structural
and chemical characteristics. The thiol ionization state controls Cys/Hcy nucleophilicity and their
redox susceptibility, facilitates unique functions of Cys/Hcy than other amino acids. For
example, Cys partakes in several important biochemical functions, including bio-catalysis,
allosteric regulation, metal binding, and structural stabilizations.6 The sulfhydryl group in Cys
can act as an ideal nucleophile in enzyme active sites that participate in enzymatic reactions; also
by undergoing reversible oxidation and reduction, Cys helps to maintain the tertiary and
quaternary structure of proteins. Another important property of Cys is its unique metal binding
ability; the thiolate ligand binds to metal ions, such as Fe2+/3+, Zn2+, Cd2+, and Cu+ , making Cys
an important player in the detoxification of metal cations in cells. Furthermore, important posttranslational modifications that regulate protein structure and function are found in cysteinecontaining proteins and peptides.6 Cys can also serve as an important intermediate in the
glutathione biosynthetic pathway.7 As a result, the availability of GSH is strongly dependent on
the availability of reduced Cys in the cytosol.8
Alteration of cytosolic Cys levels can be an indicator of the functional state of the
corresponding enzymes/proteins, or a breakdown in biochemical pathways, and this has been
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correlated with several health complications. Cys has been linked as an indicator of delayed
development in children, hair depigmentation, liver damage, muscle and fat loss, aging, and
cancers.9 Moreover, the plasma concentration of cysteine serves as an important factor in
medical diagnosis. Downs syndrome, Parkinson’s disease, obesity, and cardiovascular diseases
have been associated with altered levels of plasma cysteine.10-15 The traditional determination of
plasma cysteine is greatly dependent on methods, such as HPLC and GC. However, these
detection methods suffer from drawbacks, such as long sample processing time and low
sensitivity or LOD.16-17 Therefore, new, efficient and easy-to-operate routes need to be
developed, and in that case, fluorescence-based probes are ideal candidates.
Owing to their similar chemical reactivity, the selective detection or quantification of a single
thiol analyte by discriminating against other thiol-containing small molecules still remains a
great challenge. When considering their selectivity toward cysteine, only very few reported
probes have the ability to preferentially detect cysteine over Hcy and GSH. Furthermore, most of
these reported probes have not had discussed their selectivity against possible cross reactants,
such as H2S.18-20
As I have mentioned before, the ability to distinguish between Cys and Hcy using a single
probe is an enormous challenge, due to the structural similarity between the two amino acids.
Out of several reported strategies used, one of the commonly used methods for Cys/Hcy
discrimination versus GSH is thiazolidine formation resulting from aldehydes.21 Because the
aldehyde functional group can possibly form 5- or 6- membered rings rapidly with 1,3–or 1,2–
amino thiols where GSH cannot, such a ring structure can be used to distinguish Hcy and Cys
from GSH.22 Another successful strategy reported is conjugate addition, followed by cyclization
with α, unsaturated esters. This method involves thio-ether formation, followed by cyclization
that releases the fluorophore and a lactam. This has been successfully shown to be able to
differentiate Cys from Hcy as a result of the difference in ring formation kinetics.22
Most of the early reported fluorescence probes for biological thiols were based on dyes, such as
coumarin,23-24 1,8-napthalimide,25-27 xanthene,28-30 and fluorescein.31-32 These probes and their
fluorescent counterparts suffer from short-wavelength emission, giving rise to a high background
signal, especially in biological sample analysis.33 NIR fluorescent dyes (650–900 nm) possess
unique advantages for tracing molecular processes in vitro and in vivo with less background
interference.34 High tissue auto-fluorescence taking place from native biomolecules in living
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systems rarely interfere with NIR emission of probes/reporters. Furthermore, most abundant
biomolecules found in the body such as hemoglobin, water, and lipids—the principal absorbers
of red/green light—have their lowest absorption coefficient in the NIR region.4 Therefore, NIR
dyes increase tissue penetration depth, thereby facilitating deep-tissue imaging with minimum
damage to biological samples. The photostability of the NIR fluorophore is another crucial
parameter in designing fluorescence sensors for real-time analyte detection. Although longwavelength cyanine dyes are widely used in designing NIR sensors for bio-imaging, they
typically suffer from poor photostability in aqueous solutions.35 Indocyanine green (ICG), for
example, the only FDA-approved NIR dye for biomedical imaging, has shown very low
photostability in the body, making its prolonged detection rather impossible.36 Therefore, novel
NIR-active fluorophores with exceptional photostability and photophysical properties are desired
for designing biomedical sensors. Dicyanomethylene-4H-pyran (DCM) dyes and their
derivatives have long been used for non-linear optical materials, logic gates,37 and photovoltaic
sensitizers.38-39 Recently, they have received much attention as a possible candidate for
fluorescence-based bio-sensors.33 As a donor––acceptor type chromophore, dicyanomethylene4H-pyran (DCM) derivatives has attractive photophysical properties, 37 such as a tunable
emission wavelength in the red or NIR region via controling the electron donor ability, a large
Stokes-shift explained by ICT, and a high photostability. These properties make them a good
candidate for the design of biosensors.40 The capability of two-photon excitation is another added
advantage of DCM dyes. Compared with other traditional one-photon microscopy (OPM), twophoton microscopy (TPM) utilizes lower energy photons to obtain the excited state of a
fluorophore, resulting in deeper penetration into tissue and less photo-toxicity. Also, TPM has a
higher microscopic resolution (800 m) than confocal (500 m) and epi (20 m) microscopic
techniques.4 However, most of the traditionally known TP dyes have their emission in the short
wavelength region (< 600 nm); therefore, it is important to develop new TP fluorophores with
emission in the red and NIR regions.41
The work here presents the design, synthesis and evaluation of two different fluorescent
probes, Nap-Cys and DCM-Cys, for the selective detection of cysteine in biological fluids
and cellular environments. Out of these two probes investigated here, DCM-Cys offers a
rapid and selective detection of cysteine at sub-nanomolar levels, and it yields a quick (<12
min) response with good selectivity. The general design rationale of the cysteine-activated,
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DCM-Cys fluorescent probe is shown in Figure 4.1, and is described as follows. The
cysteine-selective probes contain a reporter dye attached to a cysteine-reactive acrylate
moiety via a linker. Initially, in the presence of cysteine, the sulfhydryl group will undergo a
Michael addition to ,-unsaturated double bonds in the reactive acrylate moiety to form a
thio-ether. The second step utilizes the amine group in the cysteine amino acid and will
undergoes a nucleophilic attack on the carbonyl carbon of the linker, thereby, forming
cyclized lactam products. Lactam formation will induce a cascade of downstream processes
involving quinone methide formation resulting in release of the linker and free fluorophore.
As a result of these fluorophores being ICT dyes, release of the linker will result in bright
fluorescence enhancement. The probe DCM-Cys has successfully demonstrated to function
as a cysteine selective thiol probe, and has been applied to the in vitro and in cyto detection
of cysteine.

Figure 4.1 Schematic representation of the design rationale for the Cys–selective fluorescent
probe.
4.2 Experimental
4.2.1 Synthetic Materials and Methods
All the column purifications were performed using SNAP silica columns on a Flashmaster
Personal from Biotage. Chemicals were purchased from Sigma-Aldrich or Fisher Scientific.
Thin-layer chromatography was performed on aluminum-backed 60 F254 silica plates from EMD
Chemicals, Incorporated. All the 1H NMR and 13C NMR spectra were collected in chloroform,
D2O or DMSO-d6 at 25 °C on a Bruker AV-400 Spectrometer. Chemical shifts are reported in the
standard notation of parts per million, using tetramethylsilane (TMS) as an internal
reference. Absorption bands in NMR spectra are listed as singlet (s), doublet (d), triplet (t),
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or multiplet (m), and the coupling constants J are expressed in hertz (Hz). Mass spectral
analyses were carried out using an Agilent 6210 ESI-TOFMS. All the solutions were
prepared using Nanopure water from a Barnstead Diamond Nanopure water System (18
MΩ-cm).

4.2.2 Synthesis
The syntheses of two probes, Nap-Cys and DCM-Cys, were performed by adopting
literature reported methods. The synthesis plan for Nap-Cys42-46 is shown in Scheme 4.1,
The synthesis plan for the NIR dye DCM is shown in Scheme 4.241, 46 with that for synthesis
of DCM-Cys in Scheme 4.344-45, 47-48.

Scheme 4.1 Synthesis of probe Nap-Cys

Scheme 4.2 Synthesis of the DCM dye
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Scheme 4.3 Synthesis of probe DCM-Cys.

Synthesis of 4-(N-methylamino)benzyl alcohol (7)
To a cold solution (0°C) of 4-(N-methylamino)benzoic acid (10.0 g, 66.0 mmol) in THF (35
mL) under N2 , 1.0 M borane-THF complex (200 mL, 200.0 mmol) in THF was added dropwise
over a period of 1 h using an addition funnel. The resulting solution was stirred for an additional
6 h at room temperature (RT), and then, cooled to 0 °C. NaOH solution (3 M, 25 mL) was added
to the solution to consume excess hydride and to hydrolyze the amine-borane complex. The
resulting mixture was stirred at RT for an additional 12 h. Then, the aqueous phase was saturated
with potassium carbonate, and the organic layer was collected. The aqueous phase was extracted
with diethyl ether (3 × 50 mL); the combined organic layers were dried over anhydrous MgSO 4.
After filtration, the filtrate was evaporated under vacuum to obtain 7 as a light brown solid (87 %
yield). This material was used in the next step without further purification. 1H NMR (400 MHz,
methanol-d4) δ 7.22–7.01 (m, 2H), 6.69–6.48 (m, 2H), 4.44 (s, 2H), 2.73 (s, 3H).
Synthesis of 4-[[(tert-butyldimethylsilanyl)oxy]methyl]-N-methylaniline (8)
Imidazole (4.27 g, 62.3 mmol) and tert–butyldimethylsilyl chloride (9.45 g, 62.75 mmol)
were added to a cooled (0 °C) solution of 7 (8.6 g, 62.75 mmol) dissolved in DMF (25 mL). The
reaction mixture was stirred at RT for 6 h and then diluted with brine solution. The mixture was
extracted with ethyl acetate (3 × 20 mL) and the organic layer was dried over anhydrous MgSO4.
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A light brown colored oil was obtained after evaporating the solvent under vacuum. The
compound was purified by a flash column using CH2Cl2/Hex (2:1, v/v) to obtain product 8 as a
yellowish oil (85 % yield). 1H NMR (400 MHz, chloroform-d) δ 7.49–7.14 (m, 1H), 6.78–6.51
(m, 1H), 4.70 (s, 1H), 2.87 (d, J = 1.8 Hz, 1H), 1.00 (d, J = 1.7 Hz, 3H), 0.15 (d, J = 1.9 Hz, 2H).
ESI-MS: for C14H25NOSi: expected m/z = 252.1785 [M+H]+; found m/z =252.1768 [M+H]+; 6.0
ppm error.

Synthesis of N-(4-[[(tert-butyldimethylsilyl)oxy]methyl]phenyl)-N-methylprop-2-enamide (9)
To a stirred solution of 8 (5.0 g, 0.019 mmol) and triethylamine (2.65 mL, 0.019 mmol) in 35
mL of CH2Cl2 at 0 °C was added acryloyl chloride (1.54 mL, 0.019 mmol) in 10 mL CH2Cl2. The
reaction mixture was stirred overnight at RT. The mixture was then washed with 5% NaHCO 3
and brine. After drying over MgSO4, the solvent was removed under vacuum to yield the crude
product 9 as brown oil. The compound was used directly for the next step without further
purification (70% yield). 1H NMR (400 MHz, chloroform-d) δ 7.36 (d, J = 7.9 Hz, 2H), 7.13 (d,
J = 7.5 Hz, 2H), 6.31 (d, J = 16.4 Hz, 1H), 6.07 (m, 1H), 5.48 (d, J = 12.9 Hz, 1H), 4.75 (s, 2H),
3.32 (s, 3H), 0.94 (s, 9H), 0.11 (s, 6H). ESI-MS: for C17H27NO2Si: expected m/z = 306.1891
[M+H]+; found m/z =306.1879 [M+H]+; 3.3 ppm error.

Synthesis of N-[4-(hydroxymethyl)phenyl]-N-methylprop-2-enamide (10)
Compound 9 (1.5 g, 4.90 mmol) was dissolved in THF (15 mL), and a solution of TBAF
(7.84 mL, 1 M in THF) was added dropwise. The solution was stirred at RT for 3 h, and upon
completion; the solvent was removed under vacuum. The remaining residue was dissolved in
CH2Cl2, washed with brine and dried over MgSO4. The solvent was removed under vacuum, and
the crude material was purified on a flash column using a gradient elution of Hex/EtOAc (4:1,
v/v) and EtOAc/Hex (5:2, v/v). Final product 10 was obtained as colorless oil with 60% yield. 1H
NMR (400 MHz, chloroform-d) δ 7.36 (d, J = 8.0 Hz, 2H), 7.06 (d, J = 8.1 Hz, 2H), 6.22 (dd, J
= 16.8, 2.0 Hz, 1H), 5.98 (dd, J = 16.8, 10.3 Hz, 1H), 5.39 (d, J = 10.3 Hz, 1H), 4.64 (s, 2H),
4.33–4.11 (m, 1H), 3.23 (s, 3H). ESI-MS: for C11H13NO2: expected m/z = 192.1026 [M+H]+;
found m/z =192.1020 [M+H]+; 2.6 ppm error
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Synthesis of Nap-Cys
The detailed description of the synthesis of Nap 2 is given in the chapter 2 under “synthesis”.
To a solution of Nap 2 (26.8 mg, 0.1 mmol) in anhydrous DCM under argon at −15 °C, 4dimethylaminopyridine (DMAP, 24.24 mg, 0.2 mmol) was added, and the solution was stirred
for a few minutes. Then, a solution of phosgene (15% toluene, 0.7 mL) was added drop wise, and
stirred under argon for 6 h. The excess phosgene was then removed by bubbling argon gas
through the solution for 30 min. To the resulting solution, compound 10 (57.43 mg, 0.3 mmol)
was added, and the reaction was stirred overnight at 0 °C. Then, the reaction mixture was
quenched with water (20 mL) and extracted with CH2Cl2 (2 × 25 mL). The organic layer was
dried over MgSO4, filtered, and concentrated under vacuum. The crude product was purified by a
flash column using CH2Cl2/EtOAc (20:1, v/v) to yield the product as a yellow solid. (35% yield).
1

H NMR (400 MHz, chloroform-d) δ 8.67 (t, J = 8.1 Hz, 2H), 8.42 (d, J = 9.7 Hz, 1H), 8.21 (d, J

= 9.1 Hz, 1H), 7.81 (t, J = 7.9 Hz, 1H), 7.54 (t, J = 9.1 Hz, 2H), 7.24 (t, J = 6.3 Hz, 2H), 6.43 (d,
J = 18.5 Hz, 1H), 6.15 (m, 1H), 5.57 (d, J = 18.5 Hz, 1H), 5.35 (s, 3H), 4.19 (t, J = 7.5 Hz, 2H),
3.39 (s, 3H), 1.75 (quint, J = 7.8 Hz, 2H), 1.62 (sext, J = 7.5 Hz, 2H), 1.00 (t, J = 7.3 Hz, 3H).
13

C NMR (126 MHz, chloroform-d) δ 165.71, 164.11, 163.63, 152.90, 143.73, 138.61, 134.85,

132.47, 131.30, 129.80, 128.93, 128.35, 127.87, 127.56, 126.72, 125.70, 123.57, 122.90, 118.12,
116.81, 67.11, 40.28, 37.45, 30.22, 20.41, 13.88. ESI-MS: for C28H27N3O5 expected: m/z =
486.2031 [M+H]+; found m/z = 486.2030 [M+H]+; 0.2 ppm error.

Synthesis of 1-(2-hydroxyphenyl)butane-1,3-dione (11)
The starting material, 1-(2-hydroxyphenyl)ethanone (10.0 g, 73.50 mmol) was dissolved in
200 mL ethyl acetate, and solid sodium chunks (8.00 g, 0.34 mmol) were slowly added to the
solution. The reaction was left overnight, and a grayish-green solid was isolated by filtration.
The solid was then dissolved in 100 mL of deionized water, followed by adjustment of the pH to
neutral using a few drops of concentrated H2SO4. The aqueous solution was extracted with 200
mL EtOAc, and the organic layer was dried over MgSO4. Then the solution was filtered, and
concentrated under vacuum to yield the final crude product 11 as a brown solid (80% yield). The
product was used directly in the next step without further purification. ESI-MS: for C10H10O3:
expected m/z = 201.0529 [M+Na]+; found m/z = 201.0529 [M+Na]+; 0.0 ppm error.
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Synthesis of 2-methyl-4H-chromen-4-one (12)
Compound 11 (7.0 g, 38.9 mmol) was dissolved in acetic acid (70 mL) and Concentrated
sulfuric acid (5.0 mL) was slowly added to the mixture. The resulting solution was refluxed for
about 2 h and then poured into 800 mL of ice water. The pH of the water was adjusted to neutral
using solid Na2CO3. The aqueous solution was extracted with CH2Cl2 twice (2 × 30 mL), and the
organic layer was dried over MgSO4. The solvent was evaporated under vacuum to afford 12 as a
dark brown solid. (70% yield). The crude product was used directly in the next step without
further purification. ESI-MS: for C10H8O2: expected m/z = 161.0604 [M+H]+; found m/z =
161.0599 [M+H]+; 3.1 ppm error.

Synthesis of 2-(2-methyl-4H-chromen-4-ylidene)malononitrile (13)
Crude product 12 (2.48 g, 15.50 mmol) and malononitrile (1.23 g, 7.70 mmol) were
dissolved in 15 mL acetic anhydride, and the solution was refluxed for 14 h. The solvents were
evaporated under vacuum, and the dark brown residue was refluxed in deionized water for
another 30 min. The mixture was extracted with CH2Cl2 and the organic layer was dried over
MgSO4. The crude product was crystalized from ethanol to obtain pure product 13 as bright
orange solid (40% yield). 1H NMR (400 MHz, chloroform-d) δ 8.91 (d, J = 8.8 Hz, 1H), 7.71 (t,
J = 7.6 Hz, 1H), 7.45 (d, J = 8.4 Hz, 2H), 6.72 (s, 1H), 2.44 (s, 3H).

13

C NMR (126 MHz,

chloroform-d) δ 161.72 , 153.24 , 152.89 , 134.59 , 126.03 , 125.78 , 118.65 , 117.54 , 116.58 ,
115.46 , 105.47 , 76.79 , 62.32 , 20.49. ESI-MS: for C13H8N2O: expected m/z = 209.0717
[M+H]+; found m/z = 209.0709 [M+H]+; 3.8 ppm error.

Synthesis of free dye DCM
Step A) Compound 13 (2.03 g, 9.75 mmol) and commercially purchased N-(4-formyl
phenyl)acetamide (1.5 g, 8.97 mmol) were dissolved in toluene (200 mL) and mixed with
piperidine (5.0 mL) and acetic acid (5.0 mL) under nitrogen at RT. After a Dean Stark trap was
fitted, the mixture was heated and then refluxed overnight to yield an orange precipitate. Then
the mixture was cooled to RT and placed in a refrigerator for another 3 h to let the reaction
mixture get cooled. An orange precipitate (DCM-acetamide, 15 A) was obtained after filtration,
and this was used directly in the next step without further purification. 1H NMR (400 MHz,
DMSO-d6) δ 10.20 (s, 1H), 8.76 (d, J = 7.65 Hz, 1H), 7.94 (t, J = 9.8 Hz, 1H), 7.82 (d, J = 8.8
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Hz, 1H), 7.77–7.67 (m, 3H), 7.63 (t, J= 7.7 Hz, 1H), 7.38 (d, J= 15.0 Hz, 1H), 7.01 (s, 1H), 2.09
(s, 3H). ESI-MS: for C22H15N3O2: expected m/z = 354.1241 [M+H]+; found m/z = 354.1242
[M+H]+; 0.28 ppm error.

Step B) The orange solid obtained (15A) was dissolved in a concentrated HCl:ethanol (2:1,
v/v, 30 mL) mixture , and the mixture was refluxed overnight. After cooling to room
temperature, the pH of the solution was adjusted to neutral using solid Na2CO3. The aqueous
solution was extracted with EtOAc (3 × 20 mL), and the extracts were dried over MgSO4. After
filtering, the solvent was evaporated under vacuum to afford a purple solid which was then
recrystallized from ethanol to afford pure DCM dye as a deep-purple solid. (40% yield). 1H
NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 8.6 Hz, 1H), 7.90 (t, J = 7.7 Hz, 1H), 7.79 (d, J = 7.7
Hz, 1H), 7.67 (s, 1H), 7.59 (m, 1H), 7.50 (d, J = 8.5 Hz, 2H), 7.11 (d, J = 15.4 Hz, 1H), 6.87 (s,
1H), 6.63 (d, J = 7.6 Hz, 2H), 6.02 (s, 2H).

13

C NMR (126 MHz, DMSO-d6) δ 160.26, 153.08,

152.59, 152.54, 141.14, 135.49, 131.15, 126.37, 125.02, 122.76, 119.37, 118.27, 117.70, 116.91,
114.25, 112.88, 105.18, 57.82. ESI-MS: for C20H13N3O: expected m/z = 312.1139 [M+H]+,
found m/z = 312.1127 [M+H]+; 3.8 ppm error.

Synthesis of 4-[[(tert-butyldimethylsilyl)oxy]methyl]phenol (14)
To a solution of 4-hydroxybenzyl alcohol (5 g, 40.30 mmol) and imidazole (2.74 g, 40.3
mmol) cooled to 0 °C in 40 mL DMF, tert-butyldimethylsilyl chloride (TBSCl, 6.0 g, 40.3 mmol)
was added and stirred at the RT overnight. The reaction mixture was diluted with brine solution
and extracted with ethyl acetate (3 × 20 mL). The organic layer was dried over anhydrous
MgSO4, filtered and a light brown-colored oil was obtained after evaporating the solvent under
vacuum. The compound was purified using a flash column with EtOAc/Hex (1:3) to obtain
product 16 as a yellowish oil. (86% yield). 1H NMR (400 MHz, chloroform-d) δ 7.22 (d, J = 8.4
Hz, 2H), 6.78 (d, J = 7.9 Hz, 2H), 6.58 (bs, 1H), 4.73 (s, 2H), 1.01 (s, 9H), 0.17 (s, 6H). ESI-MS:
for C13H22O2Si: expected m/z = 261.1289 [M+Na]+; found m/z = 261.1280 [M+Na]+; 3.4 ppm
error.
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Synthesis of 4-[tert-butyldimethlsilyl]oxy]methyl]phenylprop-2-enoate (15)
To a stirred solution of 14 (5.0 g, 0.021 mmol) and trimethylamine (2.90 mL, 0.021 mmol) in
35 mL of CH2Cl2 at 0 °C, acryloyl chloride (1.70 mL, 0.019 mmol) was added dropwise in 10
mL CH2Cl2. The reaction mixture was stirred overnight at RT, and was then washed with 5%
NaHCO3 and brine. After drying over MgSO4, the solvent was removed under vacuum to yield
crude product 15 as a light brown oil. The compound was purified on a flash column using
EtOAc:Hex (1:10. v/v) to yield compound 15 as a brown solid (70% yield). 1H NMR (400 MHz,
chloroform-d) δ 7.36 (d, J = 7.4 Hz, 2H), 7.11 (d, J = 8.1 Hz, 2H), 6.65 (d, J = 17.1 Hz, 1H),
6.38 (m, 1H), 6.04 (d, J = 10.1 Hz, 1H), 4.76 (s, 2H), 0.97 (s, 9H), 0.13 (s, 6H). 13C NMR (126
MHz, chloroform-d) δ 164.65, 149.41, 139.08, 134.61, 132.43, 128.00, 127.01, 121.22, 64.43,
25.95, 18.41, −5.25. ESI-MS: for C16H24O3Si: expected m/z = 315.1395 [M+Na]+; found m/z =
315.1390 [M+Na]+; 1.6 ppm error.

Synthesis of 4-(hydroxymethyl)phenylprop-2-enoate (16)
To a solution of compound 15 (1.0 g, 3.4 mmol) in methanol (20 mL), amberlyst-15 (150.0
mg, 15% by weight) was added. The reaction was stirred at RT for 6 h. The solid was filtered,
and the filtrate solvent was removed under vacuum to offer a brown oil. The compound was
purified in a flash column with CH2Cl2/Hex (5:1) to afford compound 16 as light yellow oil
(80% yield). 1H NMR (400 MHz, chloroform-d) δ 7.39 (d, J = 8.9 Hz, 2H), 7.13 (d, J = 11.0 Hz,
2H), 6.60 (d, J = 17.6 Hz, 1H), 6.34 (m, 1H), 6.05 (d, J = 10.9 Hz, 1H), 4.65 (s, 2H), 2.33 (s,
1H). ESI-MS: for C10H10O3: expected m/z = 179.0710 [M+H]+; found m/z = 179.0705 [M+H]+;
2.8 ppm error.

Synthesis of DCM-Cys probe
To a solution of DCM (23.45 mg, 0.075 mmol) in anhydrous CH2Cl2 under argon at −15 °C,
4-dimethylaminopyridine (DMAP, 18.30 mg, 0.15 mmol) was added, and the solution was
stirred for 10 minutes. Then a solution of phosgene (15% toluene, 1.0 mL) was added drop wise,
and the reaction was stirred under argon for 12 h; then excess phosgene was removed by
bubbling argon gas through the solution for 30 min. To the resulting solution, alcohol 16 (40.0
mg, 0.23 mmol) was added, and it was stirred overnight at 0 °C. Then the reaction mixture was
quenched with water (20 mL) and extracted with CH2Cl2 (2 × 25 mL). The organic layer was
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dried over MgSO4, filtered, and concentrated under the vacuum. The crude product was purified
by flash column chromatography with a gradient elution of CH2Cl2 (100%) to remove starting
materials and, followed by EtOAc/petether (1:2, v/v). The pure DCM-Cys product was isolated
as a yellow solid (10% yield). 1H NMR (400 MHz, chloroform-d) δ 9.91 (s, 1H), 8.93 (d, J = 7.8
Hz, 1H), 7.85 (d, J = 5.5 Hz, 2H), 7.74 (t, J = 8.3 Hz, 1H), 7.55 (d, J = 8.5 Hz, 2H), 7.44 (m,
4H), 7.15 (d, J = 7.5 Hz, 3H), 6.98–6.69 (m, 3H), 6.59 (d, J = 17.5 Hz, 1H), 6.33 (m, 1H), 6.02
(d, J = 10.9 Hz, 1H), 5.22 (s, 2H). 13C NMR (126 MHz, chloroform-d) δ 190.88, 164.44, 157.64,
152.85, 152.62, 152.35, 150.73, 150.68, 143.35, 138.26, 134.59, 133.39, 133.21, 132.86, 131.84,
131.29, 129.76, 129.72, 129.09, 127.76, 125.93, 125.86, 121.85, 121.83, 118.74, 118.57, 118.07,
117.89, 117.39, 106.61, 66.83. ESI-MS: for C31H21N3O5: expected m/z = 516.1561 [M+H]+;
found m/z = 516.1562 [M+H]+; 0.2 ppm error.

4.2.3 Spectroscopic Methods
All spectroscopic measurements were performed in 0.1 M, pH 7.4 phosphate-buffered
saline solution. Fluorescence data were collected using a Perkin Elmer LS-55 spectrometer,
and absorption spectra were recorded using a Varian Cary-50 spectrophotometer. Samples
for absorption and emission measurements were obtained in 1-cm × 1-cm quartz cuvettes
(1.5-mL volume, Sigma-Aldrich).

4.2.4 Procedure for Solution-phase Thiol Sensing
Stock solutions of 2 × 10−4 M probes (Nap-Cys or DCM-Cys) were prepared in 100% DMSO
and were subsequently diluted to prepare preferred concentration solutions in pH 7.4
PBS/DMSO buffer. Stock solutions of thiol were freshly prepared prior to each experiment. For
the calibration curve of cysteine, a fixed concentration solution of DCM-Cys was incubated with
different concentrations of cysteine at 37 °C for 15 min, and spectral data were recorded. For the
Nap-Cys probe, excitation was performed at 432 nm, and emission was detected at 540 nm (for
the detection of the free dye Nap 2). For the detection of Nap-Cys probe emission, the sample
was excited at 380 nm and detected at 480 nm. The excitation and emission slit widths were set
at 2.5 nm for Nap-Cys sample. For the DCM-Cys probe (detect the release of the free dye),
samples were excited at 520 nm, and emission was detected at 640 nm. The excitation and
emission slit widths were 5 nm and 10 nm respectively.
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4.2.5 Mass-spectrometric Studies for Cysteine End-product
Aqueous solution of cysteine (4 × 10−4 M) was added to a 2 × 10−4 M solution of DCM-Cys
probe in 40% DMSO:60% 0.1 M, pH 7.4 PBS, 10 L and the sample was incubated at 37 °C for
30 min. The solvent was evaporated and vacuum dried until a dry powder was obtained. The dry
powder was re-dissolved in methanol and ESI-MS was obtained both in negative and positive ion
mode.

4.2.6 Cell Culture
Human non-small cell lung cancer cells H596, cell culture base media, and fetal bovine
serum (FBS) were purchased from American Type Cell Culture (ATCC, Manassas, VA). All cell
culture procedures were performed as suggested by ATCC. H596 cells were cultured in RPMI1640 with 10% FBS and 100 IU/ml penicillin-streptomycin. Cells were incubated at 37 °C in a
humidified incubator containing 5% wt/vol CO2.
4.2.7 Imaging of cysteine in cells via Scanning Laser Confocal Microscopy
H596 cells were cultured overnight on 22-mm × 22-mm glass cover slips on a treated tissue
culture 6-well plate purchased from Fisher Scientific. The existing growth medium was replaced
with 2 mL of fresh cysteine free medium and then incubated at 37 °C. Solutions of DCM-Cys
was dissolved in DMSO were added to the cells to give final concentration of 3 × 10−5 M of
DCM-Cys, keeping the DMSO concentration at < 1%. Then cells were incubated with DCM-Cys
at 37 °C for 10 min. Next, the medium was removed, and the cells were fixed in 2 mL of 4%
paraformaldehyde for 15 min with shaking. After fixing, the cells were rinsed with Nanopure
water, and the cover slips were mounted to glass slides with Immumount (obtained from Fisher
Scientific). Glass slides were left in the dark overnight to allow the Immumount to dry. Confocal
images were acquired using a Leica TCS SP2 spectral confocal microscope. For images of cells
exposed to DCM-Cys samples were excited using the 488-nm line of an Ar/KrA laser (laser
intensity = 45.32%), and the spectral emission was collected between 625 and 750 nm (Leica
DD458/514); PMT voltage = 710 V. All images were collected using a pinhole of 1.0 Airy units.
Images were frame and line averaged 4 times with zoom factor 0f 3.25. Image analysis was
performed using ImageJ and Leica LAS AF lite software. As the control experiment to scavenge
all the thiols in cells, H596 cells were pre–incubated with 10 mM N-ethylmaleimide (NEM)
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temperature at 37 °C for 30 min. Then the cells were washed with 0.1 M, pH 7.4 PBS to remove
any excess NEM, followed by incubation with 3 × 10−5 M DCM-Cys prior to their being fixed as
described previously.

4.3 Results and Discussion
4.3.1 Spectral Properties of Nap-Cys/Nap 2 System
To determine the spectroscopic properties of the Nap-Cys/Nap 2 system, absorption and
fluorescence spectra of the Nap-Cys probe were obtained in the aqueous phosphate-buffered
media under physiological pH (7.4). As demonstrated by its highly intense fluorescence with

max at 470 nm (Figure 4.2, blue line), the Nap-Cys probe could be used as a dual-wavelength
ratiometric fluorescent probe. The distinct difference in the spectroscopic properties of the free
Nap 2 reporter (Figure 3.2 b, Chapter 3) and Nap-Cys probe can be attributed to the disruption of
the electron donating ability of the nitrogen by the carbamate bond, making the fluorescence of
the Nap-Cys blue shifted. Also, as an added advantage, the emission of the Nap-Cys probe is
Stokes-shifted (Figure 4.2, blue line) from its maximum absorbance (Figure 4.2, red line) by ̴ 100
nm, providing less background interference for fluorescence measurements.

Figure 4.2 Absorption and emission spectra of 2 × 10−6 M Nap-Cys in 10% DMSO/90% 0.1 M,
pH 7.4 phosphate-buffered saline (PBS) at T = 37 °C.
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When reacted with cysteine, the fluorescence band that corresponds to max = 470 nm
(fluorescence of Nap-Cys) was expected to decrease, with a concomitant rise in fluorescence of
Nap 2 reporter (max = 540 nm).

4.3.2 Cysteine Selective Ability of Nap-Cys and Proposed Reaction Mechanism
In order to determine the Nap-Cys ability to act as a fluorescence sensor for cysteine an
aqueous buffered sample of Nap-Cys (2 M) in 10% DMSO/90% 0.1 M, pH 7.4 PBS was
incubated with 100 M cysteine for 2 h at 37 °C (Figure 4.3). The sample was excited at ex =
380 nm, and emission (em = 470 nm) was observed to check the disappearance of probe
fluorescence. To detect the formation of free Nap 2 reporter, the sample was excited at ex = 440
nm, and emission was detected at em = 540 nm. Surprisingly, probe disappearance at 470 nm
(Figure 4.3, dashed black line and red line) or appearance of a new free Nap 2 dye at 540 nm
(Figure 4.3, orange line and dashed green line) was not observed, even after several hours of
incubation. If the Nap-Cys probe reacted with cysteine as proposed, the band (em = 470 nm) that
corresponds to the Nap-Cys probe should decrease gradually, and the band that corresponds to
free Nap 2 reporter (em = 540 nm) should increase over time. These observations suggested that
the probe did not work according to the proposed design mechanism. The details of the proposed
reaction mechanism are given below and are depicted in Scheme 4.4.
According to the illustrated reaction mechanism in Scheme 4.4, the release of Nap 2 reporter
consists of three major events—thio-ether formation, subsequent cyclization to yield the lactam
(a) and aza-quinone methide (b), followed by release of the Nap 2 reporter. Previously published
work by our group and that of others supports the concept of rapid aza-quinone methide
formation to eliminate the Nap 2 reporter upon production of CO2 (g).48-49 Considering these
reported outcomes, I assumed that the formation of b and elimination of CO2 (g) would act as the
driving force to move the reaction toward its end product, Nap 2, assuming that the first step has
occurred.
However in this probe system, the reason for not observing the expected product formation
may be due to the nitrogen atom being both the leaving group and the nucleophile attack species
during the cyclization process, and therefore the downstream quinone methide formation did not
occur. A similar type of result observed with a previously reported probe in the McCarley group
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Figure 4.3 Emission spectra of 2 × 10−6 M Nap-Cys in 10% DMSO/90% 0.1 M, pH 7.4 PBS
before and after incubated with 1 × 10−4 M cysteine for t = 2 h. All data were recorded at
temperature T = 37 °C. Dashed black line = initial Nap-Cys spectra at t = 0 h, red colored line =
Nap-Cys at t = 2 h, orange colored line = detection of Nap 2 at t = 0 h, dashed green colored line
= detection of Nap 2 at t = 2 h.

Scheme 4.4 Proposed mechanism for reaction of Nap-Cys probe with cysteine to eliminate the
reporter Nap 2.
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supports this hypothesis.50 Therefore, a new strategy to design a cysteine-selective probe was
carried out by changing the linker from an aminobenzyl alcohol to benzyl alcohol in the DCMCys probe system. The ability of the DCM-Cys probe to detect cysteine is further discussed in
the following sections.

4.3.3 Spectral Properties of the DCM-Cys/DCM System
In order to determine the spectral properties of the probe/reporter system, absorption and
fluorescence spectra of DCM-Cys and free DCM reporter dye were obtained in aqueous
DMSO/PBS solution. As shown in Figure 4.4, the DCM-Cys probe shows a weak absorbance
band possessing a maximum absorbance (abs) centered around 440 nm (Figure 4.4, green line);
when the sample was excited at its maximum absorbance wavelength, a fluorescence spectrum
was obtained with a maximum fluorescence (em) centered around 550 nm (Figure 4.4, blue
line).

Figure 4.4 Absorption spectrum (green line) and fluorescence spectrum (blue line) of 30 M
DCM-Cys probe in 40%:60% DMSO:0.1 M, pH 7.4 phosphate-buffered saline (PBS) at 37 °C.
The spectral properties of free DCM reporter shown in Figure 4.5 are described follows. The
DCM has a very strong absorbance band when compared to the DCM-Cys probe with a
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maximum absorbance centered around abs = 490 nm and a large Stokes-shifted emission having
a maximum emission wavelength (em) around 640 nm. The remarkable ~ 150 nm spectral
difference between the absorption and emission spectra of DCM is an added advantage, as it will
facilitate the efficient monitoring of free dye release in biological samples with less background
interference. However, as noted by the two absorption spectra of the DCM-Cys probe and free
DCM reporter, a spectral overlap was observed between the probe and the reporter making it
difficult to follow reaction of the probe with cysteine using UV-vis spectroscopy.

Figure 4.5 Absorption spectrum (blue line) and fluorescence spectrum (red line) of 10 M free
DCM reporter dye in 40%:60% DMSO:0.1 M, pH 7.4 phosphate-buffered saline (PBS) at, T =
37 °C.
4.3.4 Colorimetric Determination of Cysteine Reactivity
As shown in Figure 4.6, an attempt was made using UV-Vis spectroscopy to determine the
ability of the DCM-Cys probe to react with cysteine and provide the expected outcome of release
of the free DCM reporter. The initial spectrum of 30 M aqueous DCM-Cys (Figure 4.6, green
line) was recorded and then the sample was exposed to 60 M cysteine. The solution was then
left in the dark for about 20 minutes at 37 °C, and the final absorption spectrum was obtained. As
seen in Figure 4.6 (red line), a new absorption band that corresponds to free DCM reporter is
present at abs = 490 nm, and the absorption band of DCM-Cys at abs = 440 nm is effectively
reduced. However, as mentioned earlier, the absorption overlap of the DCM-Cys probe and
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DCM reporter make it difficult to monitor whether the reaction has reached completion
(complete disappearance of the probe). However, as an added advantage, the color change of the
aqueous system could clearly be monitored by the naked eye thereby allowing for visual
inspection of the reaction progress. As shown in Figure 4.6a, the initial yellow color of the
solution changed to a red color (Figure 4.6b) as the reaction progressed, making this a promising
approach towards visual detection of cysteine.

Figure 4.6 Monitoring the progress of the reaction using UV-Vis spectra of 30 M DCM-Cys in
40%:60% DMSO:0.1 M, pH 7.4 phosphate-buffered saline (PBS). The initial absorption
spectrum of the solution before 60 M cysteine was added (green line) and the final absorption
spectrum of the sample incubated at T = 37 °C for 20 min after cysteine was added (red line) are
shown. Image depicts the a) color of the solution before cysteine was added, and b) the color of
the solution 20 min after cysteine was added.
4.3.5 Fluorescence Spectroscopic Determination of Cysteine Reactivity
The differences that exist between both the absorption and emission spectra of the DCM-Cys
probe and the reporter DCM dye prompted me to investigate the possibility of DCM-Cys being
used as a ratiometric probe for cysteine. The absorption maximum of the probe (abs = 440 nm) is
blue shifted by about 50 nm in comparison to the absorption maximum (abs = 490 nm) of the
free reporter; also the emission maximum of the probe (em = 540 nm) is blue shifted ~100 nm
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versus that of the free reporter (em = 640 nm). In order to test this possibility DCM-Cys was
excited at different wavelengths (Figure 4.7–Figure 4.9), and the fluorescence signal outcome
was monitored.

Figure 4.7 Fluorescence spectral changes of 30 M DCM-Cys in 40%:60% DMSO:0.1 M, pH
7.4 phosphate-buffered saline (PBS) after adding 60 M cysteine at T = 37 °C. ex = 440 nm (the
maximum absorbance of DCM-Cys probe).

Figure 4.8 Fluorescence spectral changes of 30 M DCM-Cys in 40%:60% DMSO:0.1 M, pH
7.4 phosphate-buffered saline (PBS) after adding 60 M cysteine at T = 37 °C. ex = 490 nm (the
absorbance maximum of DCM free reporter dye).
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Figure 4.9 Fluorescence spectral changes of 30 M DCM-Cys in 40%:60% DMSO:0.1 M, pH
7.4 phosphate-buffered saline (PBS) after adding 60 M cysteine at T = 37 °C. ex = 520 nm (the
absorbance of DCM dye without interference from DCM-Cys probe).
After addition of 60 M cysteine, the fluorescence spectra were recorded every 2 min
intervals. In Figure 4.7 is shown the spectral change when the sample was excited at the
maximum absorbance of DCM-Cys probe (ex = 440 nm). In Figure 4.8 is shown the spectral
change when the sample was excited at the maximum absorbance of the DCM reporter (ex =
490 nm). And in Figure 4.9 is shown the spectral change when the sample was excited at ex =
520 nm, the absorbance wavelength that was selected to avoid emission interference from the
DCM-Cys probe. Upon inspecting the outcomes of each graph it was clear that DCM-Cys acts as
a turn on probe in contrast to the ratiometric response with maximum turn on response showing
at ex = 520 nm with em = 640 without interference from the probe fluorescence. Because the
decrease of the fluorescence response of the DCM-Cys probe at em = 540 nm was not very
prominent (Figure 4.7) when compared to turn on fluorescence response of release of free DCM
reporter, all the analysis for cysteine reactivity was monitored considering DCM-Cys as a turn on
probe at em = 640 nm.
In order to determine the capability of DCM-Cys to act as a turn-on probe upon reaction with
cysteine, an aqueous solution of 30 M DCM-Cys was reacted with 60 M cysteine, and the
fluorescence increase was monitored at 640 nm upon exciting the sample at 520 nm.
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Figure 4.10 Time-dependent fluorescence (ex = 520 nm, em = 640 nm) of 30 M DCM-Cys
incubated with 60 M cysteine in 40%:60% DMSO:0.1 M, pH 7.4 phosphate-buffered saline
(PBS) at T = 37 °C. Inset: a) emission spectra of 30 M DCM-Cys after cysteine addition, 550
nm–750 nm  t = 2 min; b) visualization of the fluorescence change of the aqueous sample under
UV lamp ( = ̴ 365 nm) before and 10 min after cysteine was added, T = 37 °C.
As revealed in Figure 4.10, a rapid increase in fluorescence was observed in both the timedependent fluorescence scan and the time-lapse wavelength scans from 550 nm to 750 nm.
Maximum release was achieved within about 700 s (~12 min) after cysteine was added. The
fluorescent band centered around 640 nm (Figure 4.10 inset) is consistent with the free DCM
fluorescent band obtained by excitation at 520 nm in 40%:60% DMSO:0.1 M, pH 7.4 phosphatebuffered saline, further verifying release of the free reporter.
To determine whether the DCM-Cys fluorescence turn-on response is a function of cysteine
concentration in the media, varying concentrations of cysteine were incubated with 30 M
DCM-Cys solution for 20 min at 37 °C. The turn-on response at 640 nm was measured. As
shown in Figure 4.11a, it is clear that the florescence response increased with the increasing
concentration of cysteine in the media, and after plotting the maximum fluorescence as a
function of concentration, (Figure 4.11b) it was concluded that there exists a linear relationship
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between cysteine concentration and fluorescence response of the DCM-Cys probe up to 30 M
cysteine (1 equivalent), with the concentration limit of detection of 21 nM and the concentration
limit of quantification of 70 nM.

Figure 4.11 a) Fluorescence spectral changes of probe DCM-Cys (30 M) with added cysteine
(0–30 M); b) the resulting fluorescence intensity (λex = 520 nm/λem = 640 nm) vs concentration
of cysteine plot. Error bars represent the standard deviation of the average data for each
concentration (n = 3).
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4.3.6 Mechanism of Cysteine Selectivity
The proposed mechanism of DCM-Cys reaction with cysteine (highlighted in Scheme 4.5) to
yield free DCM reporter is described as follows. Initially, the double bond of acrylate moiety
undergoes a nucleophilic attack by the sulfhydryl group of cysteine to yield a thio-ether
compound. Then, the amino group of cysteine makes a subsequent nucleophilic attack on the
adjacent carbonyl carbon to yield the tetrahedral intermediate that then collapses to yield the
lactam (b). Quinone methide (c) elimination from the benzyl alcohol linker results in free DCM
reporter dye production. The unstable quinone methide intermediate will undergo further
reaction in the water medium to yield benzyl alcohol (c”). The release of the free reporter to give
the expected fluorescence enhancement provides evidence that the initial steps have occurred as
suggested.

Scheme 4.5 Proposed reaction mechanism of DCM-Cys probe with cysteine to produce the free
DCM reporter.
As another strategy for evaluating the expected end-product during the cysteine reaction with
DCM-Cys, mass-spectrometry studies were conducted. A concentrated sample of DCM-Cys
(200 M) was reacted with excess cysteine in aqueous media at 37 °C for 30 min. Then the
sample was vacuum dried until a dry powder was obtained and then dissolved in methanol to
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obtain mass spectral data. Studies were conducted both in negative and positive ion mode to
obtain the best possible ionization. As shown in Figure 4.12, free reporter DCM release (Scheme
4.5, compound a) was noted by the [M−H]− signal at m/z = 310.0978 (expected m/z = 310.0979,
0.32 ppm error) in panel I and the expected cyclized product b was observed by the [M+H] +
signal at m/z = 176.0371 (expected m/z = 176.0383, 6.8 ppm error) in panel ii. These successful
outcomes further provided evidence for the products shown in Scheme 4.5.

Figure 4.12 Mass spectrometric analysis of end-product of DCM-Cys upon reaction with
cysteine. i) free DCM reporter (a) observed by [M−H]− signal at m/z = 310.0978 (expected m/z =
310.0979, 0.32 ppm error), ii) cyclized lactam product (b) observed by [M+H]+ signal at m/z =
176.0371 (expected m/z = 176.0383, 6.80 ppm error).
In addition to free reporter a and cyclized product b, another expected product the benzyl
alcohol linker c” was not observed in mass-spectral data. The reason for not observing the
expected product c’’ was may be due to the low ionization efficiency of benzyl alcohol linker.
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However, the observation of the peaks corresponding to free DCM reporter and lactam provided
adequate evidence in support of the mechanism proposed in Scheme 4.5.

4.3.7 Reactivity of DCM-Cys with Other Thiols
GSH, Hcy and H2S—the other commonly found thiols in the body with similar reactivity to
cysteine—have the probability to act as cross-reactive species with the DCM-Cys probe. The pKa
of GSH and Hcy are very similar (8.72, 8.25, respectively) to that of cysteine (8.10),51 implying
similar reactivity. H2S on the other hand, which is considered more acidic (pKa 6.9) than other
three thiols could act as a stronger nucleophile. In addition, proteins with free cysteine residues
could also act as possible reactive species with the DCM-Cys probe. As described in the previous
chapter, the protein content is roughly 20–25 wt% inside cells, with many of those proteins
possessing free cysteine residues.52 Furthermore, over 90% of the extracellular thiols in blood are
due to the presence of the most abundant protein (~60%), serum albumin.53 Human serum
albumin (HSA), like BSA, has only one free cysteine (Cys 34);54 this is a potential site of
reaction for DCM-Cys. The protein BSA was chosen for study here due to the known variability
in the free thiol content of Cys 34 in HSA upon its storage.54 As shown in Figure 4.13, these
components were tested (60M) by incubating them with aqueous 30 M DCM-Cys. The
fluorescence turn-on signal was examined over ̴ 20 min.
As demonstrated by outcomes of Figure 4.13, none of the potential cross-reactive thiol
components tested exhibits the ability to act as an interferent in the time frame tested, in
comparison to the response for cysteine. The selectivity toward cysteine versus GSH and Hcy
may be due to differences in ring-formation kinetics. As demonstrated by Strongin and
coworkers in 2011,55 the size of the lactam ring formed can offer a selective process, thereby
allowing for discrimination cysteine from GSH and Hcy. According to Scheme 4.6, formation of
the smaller sized 7-membered lactam ring is kinetically favored over the larger sized 8- and 12membered ring formation with Hcy and GSH. Therefore, as demonstrated in Figure 4.13, the
potential turn-on ability of DCM-Cys corresponds to the size of the ring formed. Cysteine was
the fastest reacting species, exhibiting a rapid turn-on response (< 12 min), followed by Hcy (>
30 min), and GSH being the least reactive species. As mentioned in chapter 3, the potentially
lower reactivity of cysteine residues (Cys-34) in BSA may be due to steric hindrance of the Cys
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residue as it oriented more toward the interior of the protein.5 The reason for the lack of
observing any reaction with H2S is due to its inability to undergo ring formation.

Figure 4.13 Time-dependent fluorescence (ex = 520 nm, em = 640 nm) from 30 M DCM-Cys
probe incubated with 60 M thiol-containing analytes in 0.1 M, pH 7.4 PBS/DMSO (60%:40%)
at 37 °C.

Scheme 4.6 Lactam ring formation resulting from reaction of DCM-Cys probe with cysteine.
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4.3.8 Reactivity of DCM-Cys with other Biological Analytes
The results discussed in the previous section demonstrated the selectivity of DCM-Cys
toward cysteine versus other bio-thiols (GSH, Hcy, H2S). In order to further evaluate selectivity,
the response of DCM-Cys with a few select naturally-occurring amino acids, such as glycine
(Gly), methionine (Met), serine (Ser), and threonine (Thr), was investigated. In addition, other
commonly abundant biomolecules in biological milieu, such as the ubiquitous ascorbic acid and
NADH, were also tested as possible interferents. A 30 M aqueous solution of DCM-Cys was
incubated with 150 M of each analyte at 37 °C for 20 min. The fluorescence response was
measured by exciting the sample at ex = 520 nm and measuring the intensity of the emission
maximum at em = 640 nm. As shown in Figure 4.14, both non-thiol nucleophilic amino acids
(Gly, Ser, and Thr) or the thiol-containing amino acid methionine did not cause any significant
increase in fluorescence. The biological reductant NADH, which is present at mM levels within
cells, and the common antioxidant ascorbic acid also did not cause release of the free reporter
from the DCM-Cys probe.

Figure 4.14 Fluorescence response of DCM-Cys (30 M) incubated at 37 °C for 20 min with 150
M amino acids and other common interferents in 40% DMSO:60% 0.1 M, pH 7.4 PBS. Bars
represent % release of free DCM reporter with respect to that achieved for DCM-Cys incubated
with 60 M Cys for 20 min.
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A significant increase in fluorescence was observed only upon addition of 60 M cysteine,
providing further evidence for the feasibility of the cysteine reaction. The visual color change
under white light (Figure 4.15a) and the fluorescence color change under UV lamp exposure
(Figure 4.15b) of the solutions upon addtion of each analyte is demonstrated as follows. Upon
inspecting the solutions. it is clear that the significant color change from yellow to red occurs
only when the cysteine is present in the media.

Figure 4.15 Visual observation of solutions of DCM-Cys (30 M) in 0.1 M, pH 7.4 PBS/DMSO
60%:40% in the presence of 150 M various other analytes and 60 M cysteine: a) visual color
under white light illumination and b) fluorescence emission under UV-lamp irradiation ( = ̴ 365
nm). Each sample was incubated 20 min at 37 °C after addition of each analyte.
4.3.9 Imaging of Cysteine Presence in Human Cells
Upon demonstration that DCM-Cys allows selective detection of cysteine under low probe:
analyte conditions with relatively short incubation time (<12 min), an analysis was undertaken to
examine the ability of DCM-Cys to act as a possible cysteine detecting probe in thiol upregulated
human cancer cells.
The ability of DCM-Cys to detect cysteine in live cells was evaluated using the human lung
cancer cell line H596. The H596 cell line was chosen due to its known thiol content as
mentioned in Chapter 3.56 Two-dimensional cell cultures were incubated with 30 M DCM-Cys
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for 10 min at 37 °C and subsequently washed with pH 7.4 PBS; then the cells were fixed using
formaldehyde, and the slides were left in the dark in a refrigerator for 24 hours prior to being
imaged. As the negative control experiment, H596 cells were pre-incubated with the known thiol
capping agent N-ethylmaleimide (10 mM NEM) for 30 min at 37 °C and subsequently washed
with PBS buffer to remove any excess NEM. Then the cells were incubated with 30 M DCMCys for 10 min followed by washing with pH 7.4 PBS buffer. Slides were then fixed as
mentioned above. Fluorescence images were obtained using confocal scanning laser microscopy
via excitation at the laser line  = 488 nm and detection at  = 625–750 nm.
As demonstrated by Figure 4.16 (Panel B), unadulterated H596 cells that were exposed to the
DCM-Cys probe exhibited strong red fluorescence when compared to the cells that were first
incubated with NEM (Figure 4.16, Panel C). In Figure 4.16 A is shown untreated H596 cells

Figure 4.16 Microscopy images of human H596 lung cells a) A–C confocal images b) D–F
differential interference contrast images; image A-control experiment without probe, image Bincubated with 30 M DCM-Cys for 10 min at T = 37 °C, image C-pre-incubated with 10 mM
NEM thiol scavenger for 30 min at 37 °C, followed by incubation with 30 M DCM-Cys for 10
min at T = 37 °C. Scale bar = 20 M
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that were used as a background control to make sure that there was no other background
interferences contributing to the observed fluorescence. The clear fluorescent contrast observed
between image B and image C indicated the presence of cysteine in cells. The electrically neutral
DCM-Cys can enter cells (similar to the observation with HMBQ-Nap 1 probe for thiols), and
has the potential ability to report intracellular cysteine presence in a rapid and selective manner.

4.4 Conclusions
I have successfully designed and synthesized two fluorescent probes possessing a reactive
acrylate moiety; Nap-Cys and DCM-Cys, with the intention of selectively detecting cysteine
both in cellular and aqueous media. Out of these two probes, DCM-Cys possesses the ability to
provide detection of cysteine in aqueous buffered media in a relatively short time period (< 20
min). The rapid activation of the DCM-Cys by cysteine is attributed to the acrylate moiety
undergoing nucleophilic attack by the thiol group of cysteine, followed by a rapid cyclization
and elimination reaction to release the free DCM reporter that was detected at max = 640 nm. In
addition to the fluorescence change in the media, a strong change in the color of the solution
from yellow to red upon reaction with cysteine facilitated the visual and colorimetric monitoring
of cysteine at micromolar concentration levels. The feasibility of the smaller sized ring formation
kinetics of cysteine (7-membered) when compared to glutathione (12-membered) and
homocysteine (8-membered) make the DCM-Cys probe highly selective. In addition, any
significant cross reactivity of DCM-Cys with other nucleophilic amino acids and strong reducing
agents in biological media was not observed. This further substantiates the success of DCM-Cys
as a cysteine-selective fluorescent probe. In regards to its high selectivity and rapid response, this
probe has the potential ability to be used as a cysteine detecting probe in actual cellular
environments. This was demonstrated by the successful outcome of cellular images that were
obtained with and without thiol capping agents.
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CHAPTER 5
SUMMARY, CONCLUSIONS, AND OUTLOOK: NIR FLUORESCENT PROBE
FOR THE SELECTIVE DETECTION OF HYDROGEN SULFIDE
5.1 Summary and Conclusions
The overall goal of this research was design, synthesis, and characterization of small
molecule-based fluorescent probes for the detection of thiols in biological environments,
especially in cells. Fluorescence detection methods have several advantages over other
traditional methods. Their great simplicity and low cost of operational requirements, combined
with high sensitivity and less invasiveness, offer up fluorescence methods as a potentially
indispensable tool for biomedical diagnosis. On the other hand, thiols in bodily fluids and
cellular environments are biomarkers of several health complications and altered biochemical
pathways. Therefore, accurate determination of thiol content inside cells has a great importance.
However, drawbacks in currently reported methods, such as slow response time and less
selectivity in biological environments motivated me to develop a new set of thiol probes to
perform detection more efficiently with relatively short time.
As the first part of my project, I have investigated the potential ability of a redox-active
hydroxymethyl benzoquinone (HMBQ) group to act as a trigger motif in self-immolative
delivery systems. Inspired by previously published work by the McCarley group and others, I
successfully synthesized and characterized novel redox-active HMBQ–DOPE-based liposomes
as encapsulated drug delivery agents. According to spectroscopic and light scattering data,
calcein-encapsulated large unilamellar vesicles (LUVs), with an average diameter of 150 nm,
were obtained using the lipid hand-extrusion method. However, in stark contrast to what was
expected, contents release upon HMBQ reduction by the strong reducing agent sodium dithionite
(DT) was not achieved. The reason for this observation was attributed to two possible outcomes.
It could be either the inability of the lipid group to leave the reduced hydroquinone head group,
or it could be the result of nucleophilic attack of the electron-rich amine group of DOPE on the
quinone methide moiety to form a stable hydroquinone species. In order to further understand the
release mechanism, and as a simple method to detect released end products, the nitroanilinebased probe HMBQ-Npc was synthesized and characterized using NMR and absorption
spectroscopies. Both absorption and NMR data confirmed rapid release of the para-nitroaniline
reporter upon HMBQ reduction. According to kinetic parameters obtained by absorption
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spectroscopy data, the purported rate-limiting step of the reaction leading to quinone methide
formation was fitted to first-order kinetics. The linear natural logarithm graph of extent of
product disappearance versus time yielded a highly correlated relationship; thereby
demonstrating disappearance of HMBQ-Npc follows first-order kinetics. The calculated pseudo
first-order rate constant (k1) for the product disappearance was 0.0303 min−1. However, paranitroaniline product formation did not follow simple first-order kinetics, which was evidenced by
the hyperbolic shape of the product formation (para-nitroaniline) graph rather than the expected
linear response. At this moment, there are not enough data to calculate the order of the product
formation reaction. However, rapid elimination of para-nitroaniline was further evidenced by
NMR; the decrease in peak intensity corresponding to probe (HMBQ-Npc), and appearance of
aromatic hydrogen peaks corresponding to product (para-nitroaniline) formation was observed
about 15 min after addition of dithionite. Interestingly, quinone methide elimination was also
observed by NMR experiment; the two peaks that were assumed to correspond to the alkene
hydrogens of the quinone methide appeared shortly after dithionite addition, and they diminished
in intensity when the reaction reached completion. Combining the results observed for both
absorption and NMR spectroscopies, it was concluded that quinone methide formation and
elimination of Nap 2 reporter upon reduction of the HMBQ head group of HMBQ-Npc is a rapid
process. Thus, a possible reason for not observing release of HMBQ-DOPE liposomes could be
the attack of the amine group of the DOPE lipid on the quinone methide to form the
hydroquinone-coupled DOPE species. Due to its rapid elimination kinetics, the HMBQ group
has the potential to be used as a good trigger group in self-immolative delivery systems.
In the third chapter, a novel thiol imaging probe, HMBQ-Nap 1, was successfully
synthesized and characterized, taking advantage of the outcomes observed in the HMBQ-Npc
system in Chapter 2. HMBQ-Nap 1 consists of the HMBQ head group attached to the Nap 2
reporter dye via a carbamate linkage. The HMBQ trigger group can acts as a potential reaction
site for thiols, and the trigger group can function as a PeT quencher of the Nap 2 reporter dye.
Initially, the fluorescence of the Nap 2 reporter dye is efficiently PeT quenched in the probe, as
indicated by the very low quantum yield of the probe (ФHMBQ-Nap1 = 0.003). The calculated
quantum yield of Nap 2 was 65 times brighter (ФNap 2 = 0.19) than the probe, giving rise to good
signal contrast when the free reporter Nap 2 was released from the probe. This vast difference in
quantum yields between probe and reporter makes HMBQ-Nap 1 a good turn-on probe. As an
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added advantage of this probe/reporter system, Nap 2 exhibits a strong Stokes-shift between its
absorption (432 nm) and fluorescence emission maxima (540 nm), as a result of internal charge
transfer taking place in the dye. The absorption maximum of Nap 2 was red shifted about 70 nm
versus that of HMBQ-Nap 1, making the HMBQ-Nap 1/Nap 2 pair an excellent probe/reporter
system with less background interferences. The HMBQ-Nap 1 probe was first tested with
dithionite reductant in order to determine its potential ability to release the Nap 2 reporter upon
reduction. Encouraged by the observed rapid fluorescence after dithionite reduction, fluorescence
studies with thiols were carried out in a similar way. Glutathione, cysteine, and homocysteine
were chosen for the studies, due to their abundance in cellular media, and due to the significant
role they play in physiological systems. As anticipated, a rapid fluorescence increase was
observed, indicating a very strong affinity of thiols for the HMBQ head group. The rapid nature
of the turn-on process was evidenced by the ~150 s time required to reach 90% of the maximum
attainable signal. To determine the concentration dependence of the thiol on the HMBQ-Nap 1
probe system, varying concentrations of thiols were incubated with the probe for 15 min, and the
fluorescence increase was measured. According to the data obtained, it was found that a linear
relationship exists between fluorescence intensity and their concentration between 0–2 M.
From the calibration curve obtained for each thiol, the concentration limit of detection was
determined as 33 nM for GSH, 21 nM for Hcy, and 29 nM for Cys; the limit of quantification
was obtained as 110, 70, and 98 nM respectively. These low limits indicate the potential ability
of HMBQ-Nap 1 to be used to quantify a low concentration range (nM) of thiols in bodily fluids,
such as plasma thiols.1 Next, in order to determine the activation mechanism of HMBQ-Nap 1 by
thiols, NMR and mass spectrometry studies were conducted. As speculated in literature reports
and studies in Chapter 2, the turn-on mechanism of HMBQ-Nap 1 upon reaction with thiols
could be the result of either merely redox activation of, or a nucleophilic addition to, the quinone
moiety. When HMBQ-Nap 1 was treated with 5 equivalents of biological thiol analogue
(mercaptoethanol), a rapid appearance (< 1 min) of NMR spectral peaks corresponding to Nap 2
reporter were observed, with concomitant reduction of peak intensities corresponding to HMBQNap 1. In addition, two other signals in the alkene hydrogen region (5–6 ppm) quickly appeared
after reduction, and they diminished in intensity as time progressed; these were assigned as
quinone methide hydrogen signals. These observations were comparable to what was observed in
the HMBQ-Npc NMR experiment (Chapter 2) and further confirmed that the reaction
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mechanism progressed through quinone methide formation. The final products of the NMR
experiment were characterized by mass spectrometry to identify the end product formed. Results
from the mass spectrometry experiment demonstrated release of free Nap 2 reporter dye, as
noted by the [M−H]− signal at m/z 267.1138 (expected m/z 267.1134; −1.50 ppm error) and
signals corresponding to the reporter produced with the mercapthoethanol addition to quinone
methide as evidenced by the [M−H]− signal at m/z 239.0689 (expected m/z 239.0742; 22.2 ppm
error), and free HMBQ resulting from water addition to the quinone methide; [M−H]− signal at
m/z 179.0688 (expected m/z 179.0708; 11.2 ppm error). However, the absence of the
hydroquinone product of HMBQ provided evidence that the reaction progressed through
nucleophilic addition rather than redox activation by thiols. Furthermore, to determine the
selectivity of the HMBQ-Nap 1 probe in biological media, selectivity studies were carried out by
incubating the HMBQ-Nap 1 probe with other commonly found interferents in biological
systems, such as NADH, amino acids, ascorbic acid, H2S, and the reductase enzyme NQO1. The
results obtained suggest a remarkable stability of HMBQ-Nap 1 in the presence of other analytes
and further reinforce the successful ability of HMBQ-Nap 1 to accurately detect thiols in
biological media without any cross reactivity. Finally, successful outcomes of the biological
evaluation of HMBQ-Nap 1 with the H596 cancer cell line demonstrated the ability of HMBQNap 1 to act as a thiol imaging agent in mammalian cells.
Further extending my scope toward developing thiol-detecting probes, and given the
important role cysteine plays in physiological systems, the two probes Nap-Cys and DCM-Cys
were designed, synthesized, and examined for their ability to detect cysteine. The Nap-Cys probe
consisted of an acrylate moiety as the potential reactive site for cysteine, and this was attached to
the fluorescent reporter Nap 2 via an amino benzyl alcohol linker. The probe was designed, such
that upon reacting with cysteine, it should give rise to a ratiometric response by diminishing the
probe fluorescence band at max = 470 nm, while giving rise to a reporter fluorescence band (Nap
2) at max = 540 nm. However, the expected band increases at 540 nm and decrease at 470 nm
were not observed, even in the presence of 100 equivalents of added cysteine. According to
literature reports, as lactam ring formation was proven to be a feasible process,2 it was concluded
that the downstream process of aza-quinone methide formation upon cyclization was not a
feasible mechanism due to nitrogen being both the leaving and nucleophilic attacking group.
Therefore, in the next approach, DCM-Cys was synthesized using a benzyl alcohol linker instead
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of the amino-benzyl alcohol linker in the Nap-Cys probe. The DCM-Cys probe contains an
acrylate moiety attached to the benzyl alcohol linker between the DCM reporter dye and the
reactive acrylate moiety. The DCM-Cys probe exhibited weak absorbance and fluorescence
bands centered around abs = 440 nm and em = 550 nm. In contrast, the free DCM reporter
showed a large Stokes-shift between its absorbance (abs = 490 nm) and fluorescence (em = 640
nm) maxima, offering less background interferences. DCM-Cys was successfully used as a turn
on response probe at 640 nm to monitor the release of free reporter DCM dye. Upon exposure to
cysteine, DCM-Cys exhibited a rapid turn-on response, indicating the release of the free DCM
dye. The rapidness of the reaction is evidenced by the relative short time period (< 12 min)
required to acquire the maximum attainable fluorescence signal with a low thiol:reporter ratio. In
addition, the prominent color change of the system from yellow to red allowed the visual
detection of the reaction progress. The concentration dependency of DCM-Cys toward cysteine
was monitored by varying the concentration of cysteine and measuring the fluorescence response
at each concentration. By evaluating the data obtained from the calibration plot, it is clear that
DCM-Cys exhibits a linear response up to 30 M of cysteine (1 equivalent) with a concentration
limit of detection of 21 nM and concentration limit of quantification of 70 nM. These recorded
values were well below the lowest known plasma cysteine concentrations, indicating the
successful ability of DCM-Cys to measure lower cysteine content in biological fluids.1 As a
method to detect the end product of the cysteine reaction, mass spectrometric studies were
carried out. Results from the mass spectrometry experiment proved the release of free DCM
reporter as noted by a peak at m/z = 310.0978 ([M−H]−, expected m/z = 310.0979, 0.32 ppm
error). Release of the cyclized lactam product was evidenced by the signal m/z = 176.0371
([M+H]+, expected m/z = 176.0383, 6.8 ppm error). Although the benzyl alcohol linker was not
observed in the mass spectra, the data were sufficient to allow me to conclude that the reaction
progressed through the proposed mechanism. Solution-phase analysis of DCM-Cys reactivity
toward other commonly found bio-thiols in the body, such as GSH, Hcy, and H2S, demonstrated
the probe has remarkably good selectivity. The feasibility of smaller size ring formation of
cysteine (7-membered), when compared to the larger sized ring structures of Hcy (8-membered)
and GSH (12-membered), provided good discrimination between these similar bio-thiols.
Interestingly, DCM-Cys shows a strong affinity for non-protein free thiols in comparison to the
cysteine residues in protein thiols, as seen by the sluggish reaction rate observed for the Cys 34
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residue in bovine serum albumin. The slow reaction rate observed for protein bound cysteines
was attributed to the steric interactions of these reaction sites compared to free cysteines in the
media. Furthermore, the DCM-Cys probe demonstrated its successful ability to be a selective
probe by being remarkably stable in the presence of other commonly found analytes, such as
amino acids, NADH, and ascorbic acid. Finally, the ultimate goal of biological evaluation of
cysteine presence in a living cellular environment was successfully achieved as evidenced by
data obtained by the fluorescence studies of human lung cancer cell line H596.

5.2 Outlook
5.2.1 NIR Fluorescent Probe for the Selective Detection of Hydrogen Sulfide
In a parallel project I was carrying out, I was working on the targeted development of an NIR
fluorescent probe for the selective detection of H2S in cells, due to a rising concern about the
physiological role of this small but important molecule. Hydrogen sulfide (H2S), the smallest
member of the thiol family, despite its traditional consideration as a toxic substance, is
undergoing reclassification as an important endogenously produced molecule for maintaining
normal physiology in the body. H2S, together with NO and CO, belongs to a family of important
gasotransmitters, and it has the ability to freely travel through cell membranes without specific
transporters.3-5 H2S is synthesized in cells via both enzymatic and non-enzymatic pathways. The
enzymatic synthesis is catalyzed by cystathionine-β-synthase (CBS), cystathionine-γ-lyase
(CSE), cysteine-aminotransferase (CAT), and mercaptopyruvate-sulfurtransferase (MST) in the
presence of the thiol-containing biomolecules cysteine and homocysteine.6-7 Non-enzymatic
production of H2S occurs by release from sulfur stores and in the metabolism of polysulfides.8 A
unique aspect of H2S compared to other gasotransmitters, is its different protonation states. In
aqueous solutions, H2S is considerably more acidic (pKa = 6.9) than Cys (pKa = 8.10), GSH (pKa
= 8.72) or Hcy (pKa = 8.25), resulting in about 80% of H2S existing in the reactive anionic form
(HS−).9 H2S has been shown to contribute to several important functions in the body, such as
modulating potassium ion channels and acting as a relaxant of smooth muscle, as well as being a
regulator of cardiovascular and gastrointestinal systems.10 Alteration of H2S production in cells
is linked to several disease conditions, including diabetes, liver damage, Alzheimer’s disease,
and Down syndrome.10
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Concentration levels of H2S have been reported to span a broad range in the literature.11 To
monitor these concentration fluctuations in the body and cellular sites, it is required to have
probes with high H2S sensitivity, selectivity, and real-time detection capability. There are several
major challenges that are needed to address when designing an efficient probe for H2S. Due to
the transient nature of H2S and its relatively low abundance in most tissues,11 the probes need to
provide a fast response toward analyte, and also, they should be selective toward H2S without
giving premature triggers in the presence of other thiols that are usually present in milimolar
concentrations inside cells.11
The design strategies for fluorescent probes for H2S are based on specific chemical reactions
that take advantage of the nucleophilic properties of H2S (HS−) or the strong reducing properties
of H2S. The ability of H2S to reduce azides and other oxidized nitrogen species much faster than
other thiols has been exploited as a very promising route for H2S detection. Upon reduction, the
electron withdrawing azido or nitro groups are converted to a more electron donating amine
group that will result in alterations in the fluorescence properties of the probe being used. 12-15
The strong di-nucleophilic property, when compare to other thiols, has also been explored as a
successful strategy to develop selective probes for H2S. Hydrogen sulfide can react with the
more electrophilic moiety of the probe first to form an intermediate with a free sulfhydryl group,
and when another electrophilic center is positioned at a suitable position, it can undergo Michael
addition with the nearby sulfhydryl to cause a spontaneous cyclization that triggers the
fluorescence change.11, 16-18 Sulfide precipitation is another popular route used for the design of
fluorescence probes. This approach utilizes the displacement of Cu2+ from the fluorophore’s
environment to produce fluorescence turn-on changes via H2S-mediated precipitation of CuS
from Cu2+. At the beginning, the emission of the fluorophore is quenched by the presence of
paramagnetic Cu2+ in the center. However, in the presence of H2S, precipitation of the bound
Cu2+ as CuS allows the fluorescence turn on, thereby facilitating the detection of H2S.19-22
The proposed fluorescent probe (DCM-HS) contains dicyanomethylene-4H-pyran (DCM) as
the NIR fluorescent reporter and an aldehyde and an ester moiety in close proximity to each
other as potential reactive electrophilic centers for hydrogen sulfide. The reactive electrophilic
centers are attached to the DCM fluorophore, via a benzyl alcohol linker. As shown in Figure 5.1
the proposed mechanism for this reporter system is based on the tandem nucleophilic addition
and cyclization strategy for the selective detection of H2S versus other biological thiols. Initially,
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HS− attacks the carbonyl carbon of the aldehyde moiety, reducing it to a secondary alcohol and
in the next step, due to the double nucleophilic property of H2S, it further reacts with the
carbonyl carbon of the neighboring ester moeity. The second addition to the ester moiety will
result in cyclization, eliminating the 1,2-benzenedicarbothioic acid (c) and quinone methide (b).
Formation of the reactive quinone methide and CO2 production is anticipated to facilitate the
cascade of downstream processes that eliminate the linker group, with release of the free DCM
reporter. As expected from my previous outcomes with DCM-Cys, the elimination of the free
reporter should result in the turn-on response at em = 640 nm providing an efficient method to
monitor H2S both in solution and cellular environments.
Taken together, the concept presented in this dissertation facilitated the fluorescent
monitoring of biological relevant thiols both in solution phase and cellular environment with
good selectivity and sensitivity. With a good understanding of the cellular mechanism of action,
in the future, these types of probe systems could possibly make significant contribution to
disease-targeted analyte detection in the biomedical field.

Figure 5.1 Schematic representation of the proposed mechanism of the DCM-HS probe.

5.3 Experimental
5.3.1 Synthetic Materials and Methods
The synthesis plan of the H2S-selective probe, DCM-HS is shown in Scheme 5.1, and the
partially completed synthesis (compound 18 and 19) is described as follows.
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Scheme 5.1 Synthesis of probe DCM-HS

Synthesis of 2-formylbenzoyl chloride (18)
To a cooled (0 °C) suspension of 2-carboxybenzaldehyde (2.25 g, 15.0 mmol) in dry CH2Cl2
(50 mL), oxalyl chloride (2.85 mL, 30.0 mmol) and DMF (22.5 L) were slowly added. The
reaction mixture was stirred at RT for 8 h, and then the mixture was evaporated under vacuum to
remove solvents. The oily material obtained was subsequently dried under vacuum to yield crude
compound 18 as an off-white powder. The product was used in the next step without further
purification.

Synthesis of 4-{[(tert-butyldimethylsilyl)oxy]methyl}phenyl 2-formylbenzoate (19)
To a solution of 15 (47.68 mg, 0.20 mmol) in dry CH2Cl2 (30 mL) at 0 °C, trimethylamine
(0.28 mL, 0.6 mmol) was added, and this was allowed to stir for about 5 minutes. Then the crude
compound 18 was dissolved in small amount of dry CH2Cl2, and the solution was slowly added
into the reaction mixture; the mixture was warmed to RT and stirred overnight. Finally, the
reaction mixture was diluted with distilled water, and then this was extracted into CH2Cl2 (50
mL). The solvent was evaporated, and compound 19 was isolated as a white solid. The
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compound was characterized by ESI-MS: for C21H26O4Si: expected m/z = 371.1680 [M+H]+;
found m/z = 371.1663 [M+H]+; −4.5 ppm error.
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APPENDIX A: SUPPORTING INFORMATION

1

H NMR spectrum of 1,4-Dimethoxy-3,5,6-trimethyl benzene (1) in chloroform-d at 400 MHz
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1

H NMR spectrum of 2,5-Dimethoxy-3,4,6-trimethylbenzaldehyde (2) in chloroform-d at 400 MHz
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1

H NMR spectrum of 1-Hydroxymethyl-2,5-dimethoxy-3,4,6-trimethylbenzene (3) in chloroform-d at 400 MHz
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1

H NMR spectrum of 2,5-Dimethoxy-3,4,6-trimethylsilyl ether (4) chloroform-d at 400 MHz
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1

H NMR spectrum of 2-Hydroxymethyl-3,5,6-trimethyl-1,4-benzoquinone (5, HMBQ) in chloroform-d at 400 MHz
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1

H NMR spectrum of 4-nitrophenyl (2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methyl carbonate (6) in chloroform-d at 400
MHz
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1

H NMR spectrum of HMBQ-Npc in chloroform-d at 400 MHz
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1

H NMR spectrum of Nap reporter in chloroform-d at 400 MHz
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1

H NMR spectrum of HMBQ-Nap 1 in DMSO-d6 at 400 MHz

164

1

H NMR spectrum of 4-(N-methylamino) benzyl alcohol (7) in methanol-d4 at 400 MHz
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1

H NMR spectrum of 4-[[(tert-butyldimethylsilanyl)oxy]methyl]-N-methylaniline (8) in chloroform-d at 400 MHz
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1

H NMR spectrum of N-(4-[[(tert-butyldimethylsilyl)oxy]methyl]phenyl)-N-methylprop-2-enamide (9) in chloroform-d at 400 MHz
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1

H NMR spectrum of N-[4-(hydroxymethyl)phenyl]-N-methylprop-2-enamide (10) in chloroform-d at 400 MHz
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1

H NMR spectrum of Nap-Cys in chloroform-d at 400 MHz
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1

H NMR spectrum of 2-(2-methyl-4H-chromen-4-ylidene)malononitrile (13) in chloroform-d at 400 MHz
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H NMR spectrum of DCM-acetamide (15 A) in DMSO-d6 at 400 MHz
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H NMR spectrum of DCM in DMSO-d6 at 400 MHz
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1

H NMR spectrum of 4-[[(tert-butyldimethylsilyl)oxy]methyl]phenol (14) in chloroform-d at 400 MHz
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1

H NMR spectrum of 4-[tert-butyldimethlsilyl]oxy]methyl]phenyl prop-2-enoate (15) in chloroform-d at 400 MHz
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1

H NMR spectrum of 4-(hydroxymethyl)phenyl prop-2-enoate (16) in chloroform-d at 400 MHz
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H NMR spectrum of DCM-Cys in chloroform-d at 400 MHz
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C NMR spectrum of 2,5-Dimethoxy-3,4,6-trimethylsilyl ether (4) in chloroform-d at 100 MHz
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C NMR spectrum of 2-Hydroxymethyl-3,5,6-trimethyl-1,4-benzoquinone (5, HMBQ) in chloroform-d at 100 MHz
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C NMR spectrum of HMBQ-Npc in chloroform-d at 100 MHz
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C NMR spectrum of HMBQ-Nap 1 in DMSO-d6 at 100 MHz
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C NMR spectrum of Nap-Cys in chloroform-d at 100 MHz
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C NMR spectrum of 2-(2-methyl-4H-chromen-4-ylidene)malononitrile (13) in chloroform-d at 100 MHz
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C NMR spectrum of DCM in DMSO-d6 at 100 MHz
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C NMR spectrum of 4-[tert-butyldimethlsilyl]oxy]methyl]phenyl prop-2-enoate (15) in chloroform-d at 100 MHz
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C NMR spectrum of DCM-Cys in chloroform-d at 100 MHz
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